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GENERAL INTRODUCTION 
When a synthesis of a complex natural product or class of 
natural products is planned, many considerations are brought 
to the fore. Aside from the desire to accomplish an 
esthetically pleasing synthesis, the reactions used must 
proceed in high yield, and guarantee a high degree of regio-
and stereoselectivity. If the reactions employed or 
discovered are operationally convenient, then another 
synthetic goal has been achieved. It was the purpose of this 
research to discover and apply novel synthetic strategies to 
aromatic antitumor antibiotics. Part I describes a facile 
entry to the carbon framework of olivin. Part II describes an 
efficient and convenient preparation of the aromatic subunit 
of alkavinone. Finally, Part III details the total synthesis 
of two important members of the pyranonaphthoquinone class of 
antibiotics. 
Explanation of Thesis Format 
This thesis is written so that each section can be 
regarded as a separate article in publishable form. 
Therefore, the numbering of the figures, schemes, tables, and 
references is independent in each division. 
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PART I: A SYNTHETIC APPROACH TO OLIVIN 
3 
INTRODUCTION 
Olivin and chromomycinone are structural subunits of a 
growing class of potent antitumor antibiotics collectively 
known as the aureolic acids. At the time this work was 
initiated, no total synthesis of these interesting natural 
products had been reported. This manuscript will detail the 
results of a program directed toward the total synthesis of 
olivin in optically active form. 
4 
HISTORICAL 
The first member of the aureolic acid class of antitumor 
antibiotics was isolated at the Abbott Laboratories in 1953 
from an unknown Streptomyces species (1). Microbiological 
testing indicated activity against Gram( + )bacteria ijn, vitro. 
Its high toxicity precluded its use as a potential 
antibacterial agent (lb). The compound was named aureolic 
acid due to its acidic properties. Aureolic acid was later 
discovered as LA-7017 by workers at Lepetit Laboratories (Ic), 
and as mithramycin by workers at Pfizer Laboratories (Id). It 
was not until 1968 that LA-7017 and mithramycin were 
correlated with aureolic acid (le). 
Since the initial isolation of members of the aureolic 
acid class in 1953, two other subclasses of aureolic acid 
antibiotics have been isolated and microbiologically 
characterized. The chromomycins were isolated from 
Streptomyces qriseusis by Shibata et al. in 1960 (2). Later, 
the discovery and isolation of the olivomycins as NSC A-649 
was accomplished by workers at the Bristol Laboratories. The 
antibiotic was found to be active against Gram(+)bacteria, and 
several animal tumors including the Ridgway osteogenic 
sarcoma, the Harding-Passey melanoma in mice, and the Walker 
carcinosarcoma in rats (3). 
Many of the aureolic acid antibiotics have now evolved 
into clinically useful drugs for the treatment of human 
5 
cancers. Mithramycin (aureolic acid) has been approved for 
use in the treatment of testicular cancers (4). The medicinal 
and biochemical aspects of this class of interesting drugs 
have been the subject of several reviews (5-10). The most 
important aspects of structure will be summarized here and, 
along with more recent information, the studies relating to 
the mode of DMA binding, and syntheses of the polysaccharide 
and aglycone subunits. 
The structures of the three subclasses of aureolic acid 
antibiotics; the aureolic acids, the chromomycins, and the 
olivomycins, are based in part upon two aglycones, olivin (11) 
(la) and chromomycinone (12) (lb). 
The aureolic acids and the chromomycins have in common the 
aglycone chromomycinone, while the olivomycins contain the 
tetrahydroanthracene subunit known as olivin. The structures 
of the two aglycones are nearly identical except for the 
methyl group at position 7. 
QCH.- OH 
OH OH 0 
la R= H: olivin 
^ R= CH^; chromomycinone. 
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The above aglycones are linked at both the phenolic 6- and 
hydroxylic 2-positions by dideoxypyranose sugar residues. The 
C-6 position is most often linked with a disaccharide residue, 
while a trisaccharide is the common substituent at the C-2 
position. The structure of one member of each subclass of 
aureolic acids has recently been revised. Thiem and Meyer 
13 1 have used a combination of detailed high field C and H NMR 
analyses to arrive at the nature of the interglycosidic 
linkages of chromomycin (13) and olivomycin A (14). Their 
initial studies of the interglycosidic linkages of mithramycin 
were conclusive at all but one linkage (14). Fortunately, a 
combination of synthetic and spectroscopic techniques led to 
the assignment of the previously unknown linkage (15). 
The complete structure of olivomycin A (2) is shown below. 
The compositions of some selected aureolic acid antibiotics 
are provided in Table 1. Additionally, the structures of the 
dideoxy sugars are shown in figure 1. 
It has long been known that chromomycin Ag, mithramycin, 
and olivomycin A complex with double-stranded DNA (15). Each 
inhibits DNA-dependent RNA synthesis by complexing with DNA. 
Unique to this class of antibiotics is the fact that Mg(II) or 
another divalent metal cation is necessary for complexation to 
occur (17). Furthermore, intercalation of the aglycone 
moieties with the purine and pyrimidine bases of DNA is not 
the important binding interaction (18). This is surprising in 
7 
Table 1. Compositions of some selected aureolic acid 
antibiotics 
Compound Aglycone Sugars' 
mithramycin 
olivomycin A 
olivomycin B 
olivomycin C 
chromoraycinone 
olivin 
olivin 
olivin 
olivomycin olivin 
chromomycin chromomycinone 
oliose, olivose, olivose, 
olivose, D-mycarose 
acetyloliose, divomose, 
olivose, olivose, 
4-isobutyrylolivomycose 
acetyloliose, olivomose, 
olivose, divose, 
4-acetylolivomycose 
oliose, olivomose, 
olivose, olivose, 
4-isobutyrylolivomycose 
acetyloliose, olivomose, 
olivose, olivose 
acetyloliose, olivomose, 
olivose, olivose, 
4-isobutyrylolivomycose 
Named in the order A, B, C, D, E as shown in structure 2 
for olivomycin A. ~ 
Olivomycin D contains only four dideoxy sugars. 
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OR 
OH 
R= H : D-oliose 
R= COCHg: D-acetyloliose 
D-olivomose 
:H 
HO 3^0 OH 
HO 
D-olivose 
HO 
CH 
CH. 
I 
OH 
OH 
D-mycarose 
OH 
R= COCHg: L-4-acetylolivoinycose 
R= COCHtCHglg: L-4-isobutyrlolivomycose 
Figure 1. Structures of the dideoxy sugars commonly 
found in the aureolic acid group 
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OCH 
CH 
HO 
OCOCH QCH, OH 
0 0 
A OH 
OH OH 
,0 
CH 
HO HO 
CH 
CH 
0 
0 OH E 
2 olivomycin A 
light of the structural similarities with the anthracyclines 
which are known DNA intercalating agents. 
In a recent spectroscopic study of the mechanism of 
complexation of olivomycin and Mg(ll), it was determined that 
complexation was a two step process. In the first step. 
Mg(II) binds to the A-ring keto-oxygen. In the subsequent 
step, the olivomycin-Mg(II) complex collapses to a stable, 
more compact conformation (19). In the presence of DNA, the 
first step is followed by the binding of the O-acyl group of 
the 4-isobutyrylolivomycose residue and hydroxy! groups of 
olivomose and 4-isobutyrylolivomycose to Mg(II). The more 
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compact conformation of olivomycin-Mg(II) facilitates its 
binding to the narrow groove of DNA (20). A similar study 
suggests that two tautomeric forms of olivomycin A may play a 
role in the pharmacokinetics of the aureolic acid group (21). 
Based on kinetic evidence, a group of Soviet workers 
postulated that a major complexation interaction occurs 
between the sugar-phosphate backbone of DNA and the glycoside 
residues of olivomycin. It was also suggested that a 
pronounced binding specificity of olivomycin for dG*dC rich 
regions of DNA was due to hydrogen bonding between a guanine 
2-amino group and the phenolic olivin ring system (22). 
Van Dyke and Dervan have recently reported the base 
sequence binding preferences of chromomycin A^, mithramycin, 
and olivomycin A. Utilizing a combination of (methidium-
propyl-EDTA)iron(II) cleavage of drug protected DNA 
restriction fragments (23) and Maxam-Gilbert sequencing 
methods, the preferred sites on a 70 base sequence of DNA were 
determined. Apparently, binding sites are a minimum of three 
base pairs in size, and must contain at least two contiguous 
and complementary dG.dC base pairs on double-stranded DNA. 
Additionally, olivomycin A and chromomycin Ag, which share 
OH OH 0 OH O OH 
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common hexopyranose sugars, were remarkably similar in binding 
specificity (24). 
The fact that no accurate model of antitumor action yet 
exists has not hindered synthetic efforts in the area. 
Synthetic endeavors along two fronts, the polysaccharide units 
and the aglycones, have been in progress since 1960. The 
syntheses of all of the monosaccharides have now been 
completed (25), and the saccharide synthesis program has been 
reviewed through 1977 (5). 
The synthesis of the disaccharide units has been largely 
due to the work of Thiem. The preparation of the B-A fragment 
of mithramycin was accomplished by silver(I) mediated 
condensation of the glycone components 3 and 4 (26). 
lAc 
CH CH 
AcO 
AcO HO 
Br OCH 
OAc 
Aco^ 
2 OCH2 
A different method was employed to construct the E-D 
disaccharide unit of chromomycin A^. Condensation of glycol 5 
and 6 through the use of N-iodosuccinimide (NIS) provided 7 
which was partially hydrogenated to afford 8 (27). 
The synthesis of the B-A disaccharides and D-C subunits of 
chromomycin A3 and olivomycin A (28, 29) and the E-D-C subunit 
of olivomycin A (30) parallel the work provided above. Model 
12 
CH •J r» 
HO CHj BnO 
HO 
CH 
NIS 
5 + 6 OBn OBn 
OH X 
7 ; X = I 
H X = H 
system studies have also been done by Thiem and coworkers 
which clearly indicate that coupling of saccharide units to 
the olivin or chromomycinone aglycones is feasible. Thus, the 
tetralone 9, when reacted with 10 and NIS, produces the model 
tetralone olivoside 11 (31). 
While the syntheses of the various oligosaccharide 
subunits of the aureolic acid class have been rather straight­
forward, comparable success in the synthesis of the aglycones 
chromomycinone and olivin has not been realized. The 
aglycones of the aureolic acid group present interesting 
challenges for the natural products chemist. 
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OCH^ OH 
HO 
R 
OH OH 0 
R = H; olivin 
R = CHg: chromomycinone 
By consideration of the structures of la and lb, various 
regiochemical and stereochemical issues become apparent. Of 
these, the relative stereochemistry at C-3, C-2, and C-1' and 
the necessity for regiocontrol in the construction of the CBA 
ring system pose special problems. To this date, the Diels-
Alder cycloaddition (32) and anionic reactions have been used 
to address these problems of regio- and stereocontrol. 
Synthetic approaches based on Diels-Alder methodology were 
initiated by Franck and John (33). In a model system study, 
cyanobenzocyclobutane 12 and glycol 13 were heated to afford 
14 and 15 via the o-quinone methide of 12. 
OCH 
o 
12 CN J R R' 
^ R' = CN, R = H 
15 R' H, R = CN 
14 
While both 14 and 15 had the correct relative stereochemistry 
at the C-3 and C-1' centers, significant amounts of the 
corresponding regioisomeric pair was also formed. To complete 
the model study, Diels-Alder adducts 14 and 15 were subjected 
to g-elimination and the acetonide rearranged to provide 16. 
Unfortunately, when 16 was vicinally hydroxylated, a mixture 
of epimeric acyloins 17 was obtained (34). 
1. Et N 
2 .  H  
acetone 
OCH, 0 
Encouraged by these results, Dalta, Franck, and Noire 
synthesized naphthocyclobutene 18 via a multistep route (35). 
Regrettably, 18 could only be induced to react with 
N-phenylmaleimide under forcing conditions and in low yield to 
provide 19. 
MeO 
OMe OMe 
fn 
,N 
H ,P 
MeO 
OMe OMe » " 0 OR 
19 
R = CHgCHgSiMe^ 
15 
These results did not auger well for a total synthesis of 
olivin, in that substantially less reactive dienophiles would 
later be required and this strategy was not pursued further. 
In 1983, Kraus and Hagen reported a synthetic approach to 
olivin and the anthracyclinone rhodomycinone (36). Reaction 
of furan 20 with maleic anhydride provided the Diels-Alder 
adduct 21. Elaboration of 21 to the olivin ring system was 
readily achieved employing Friedel-Crafts methodology. 
Synthetic efforts toward a model A ring and side chain 
were reported in 1980 by Thiem and Wessel (37). The dianion 
of D-threose-trimethylenedithioacetal 22, which was 
efficiently prepared from D-galactose, reacted with 
benzaldehyde to produce the epimeric alcohols 23 and 24. 
Although a mixture of addition products was obtained, this 
approach appears feasible provided that good stereoselection 
can be achieved with a suitably functionalized aldehyde. 
An approach to a synthon for the aglycone of olivin was 
reported by Roush and coworkers in 1983 (38). Enone 25 was 
16 
B • R OH 
Ph CH 3 1. n-BvoLi 
2. PhCHO 3 
22 Oh 
23 R = OH, R' = H 
R = H, R' = OH 
viewed as an excellent progenitor to the AB ring system and 
side chain of olivin. 
To that end/ the readily available aldehyde 26 was reacted 
with the (Z)-boronate 27 to provide 28 with high 
diastereoselectivity. Elaboration of alcohol 28 to 29 was 
routine. To date, however, no reference to the preparation of 
25 and thence to olivin has appeared. 
In 1984, the first total synthesis of tri-O-methylolivin 
was reported by Weinreb and coworkers (39). Drawing upon 
results obtained from earlier model system studies, enol silyl 
R 
olivin [Z[)> 
0 
25 R R' = (CHglg 
17 
g4-"' A A/ 
CHO I ^ 
CH. 
2 6  
OH CH, 
EtO, OBn ^"3 
29 
R = R' = (CHglg 
ether 30 was epoxidized and hydrolyzed with concomitant 
epoxide rearrangement to provide 31 as a 1:1 mixture of ring 
epimers. After manipulation of the functionality present in 
31, a properly elaborated g-methoxystyrene synthon 32 was 
obtained. 
1. MCPBA 
R = H, R' = SiEt, 
H ^"3 0 
OTHP 
An elegant tandem Michael addition-Claisen condensation 
reaction of 32 with orsellinate anion 33 afforded the phenolic 
ketone 34 in good overall yield. Ketone 34 was then trans-
formed in three steps to afford exclusively the trans-acyloin 
35. 
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OCH 
CH MeO^Yx% MeO 
CH 
CO-Me OTHP 
OMe OMe OH 34 
OH QCH OCH 
^H MeO MeO 
CH CH 
OTHP 
'OH OH 
OMe OMe OMe OMe 
35 36 
In a five step sequence involving protection of the acyloin, 
deprotection of the tetrahydropyranyl group, oxidation, and 
deprotections, the synthesis of tri-O-methylolivin 36 was 
complete. Weinreb's work provides an excellent example of 
CBA-ring system regiocontrol. Although adequate control at 
the C-2, C-3, and C-1' stereocenters was achieved, the 
numerous protection and deprotection steps severely diminished 
the efficiency of the synthesis. A highly stereocontrolled 
synthesis of tri-O-methylolivin was later reported by Franck 
and coworkers (40). 
The correct absolute configuration of the side chain was 
established beginning with the D-fucose derivative 37. Wittig 
reaction with carboethoxy triphenylphosphorane produced 
predominantly the ^ olefin 38. Rearrangement of the acetonide 
unit to the more stable threo glycol and lactonization 
19 
produced 39, Franck's synthon for the A-ring and side chain of 
olivin. 
CH 
0 39 
Wittig 
OCH , OH OCH 3 
37 
The fortuitous obtention of 38 in the Wittig reaction of 
37 opened a highly efficient pathway to tri-O-methylolivin 
(41). In a condensation analogous to that seen in Weinreb's 
synthesis, naphthoate anion 40 produced 41 on reaction with 
lactone 39. After basic hydrolysis and decarboxylation, 
ketone 42 was obtained in 51% overall yield. 
In the key Michael addition-Claisen condensation, 
conjugate addition from the face opposite the allylic methoxyl 
group in 39 led to complete stereochemical control at C-3. 
After Swern oxidation and chemoselective enol silyl ether 
formation, 43 was oxidized and rearranged in situ to produce 
an 8:1 mixture of acyloins 44 with the trans-isomer 
predominating. Hydrolysis of the silyl ether and acetonide 
protecting groups was then achieved in one step to provide 
tri-O-methylolivin 36. 
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QCH 
CH MeO 39 
CH 
CO-Me 
OMe OMe OMe •Me 
40 41 
PCH OCH. 
MeO MeO 
CH OH 
OMe 0 OMe OMe 43 
a. 
R = SiMe_t-Bu 
V OCH 
MeO. 
CH 
OMe OMe 
44 
In comparison of the two successful syntheses of 
tri-O-methylolivin, some important points are brought to the 
fore. First, regiocontrol in construction of the CBA ring 
system is paramount, Stereocontrol in the A-ring and side 
chain, particularly at C-2 and C-3, is absolutely essential to 
the outcome of any synthesis of olivin. Finally, a synthetic 
plan toward olivin should be generalizable to that of 
chromomycinone. A tabular analysis of the Weinreb and Franck 
syntheses is provided in Table 2. 
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Table 2. A comparison of the Weinreb and Franck syntheses of 
tri-O-methyl olivin 
Criterion Weinreb's synthesis Franck's synthesis 
ratio of C-C bond 
forming steps to 
total steps required 
total steps 
overall yield (%) 
starting material 
for side chain/A 
ring preparation 
starting material 
for BC ring system 
0.11 
19 
0.51 
H 
COgMe CH] 
0 . 2 0  
15 
5.65 
MeO MeO. CH 
OMe OMe 
22 
RESULTS AND DISCUSSION 
Since their initial isolation in 1953, the aureolic acid 
group has evolved into an important class of antitumor 
antibiotics. Their high cytostatic activity, coupled with 
their unique assemblage of functionality, has prompted 
considerable attention from synthetic chemists. Both the 
tandem Michael addition-Claisen condensation and the Diels-
Alder reaction have been used in synthetic approaches to the 
aglycones of this class of antibiotics. However, only the 
anionic approach has consistently been successful. 
Our approach to olivin was initiated prior to the reported 
syntheses of tri-O-methylolivin. We envisioned a Diels-Alder 
based CB + A + CBA ring construction of olivin wherein the A 
unit would also contain latent functionality for the side 
chain. The Diels-Alder reaction of a highly activated 
2-substituted naphthoquinone in concert with a polarized, 
carbohydrate diene was anticipated to occur with high regio-
selectivity. Removal of the activating functionality and 
adjacent carbonyl would then provide the olivin skeleton. 
Manipulation of the carbohydrate synthon and stereocontrolled 
C-5 methyl group introduction appeared to be a viable route to 
the aglycone (Scheme I). 
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H î« 
OH OH 0 
OMe 0 
MeO 
3 O 
COJR 
OMe 
OR 
Literature precedent pertaining to the regioselectivity of 
the proposed Diels-Alder reaction was found in the work of 
Goldsmith et al. (42). In their studies toward the synthesis 
of ajugarin I, the Diels-Alder reaction of carbomethoxy-g-
benzoquinone 45 and 2,4-pentadien-l-ol 46 was studied. Only 
47 resulting from an "ortho" Diels-Alder transition state 
orientation was formed. 
O 11 
M 
1. OH 
0 45 
COgMe ^  
0 OH 
CO.Me 
Specific additions of 1-aryl-substituted butadienes to 45 have 
also been studied (43). Das and coworkers have studied 
24 
the cycloaddition of 2-acetyl-£-benzoquinone 48 with the 
styrene derivative 49 (44). Results paralleling those of 
Goldsmith were obtained. 
Finally, previous results from these laboratories indicated 
that Diels-Alder reactions between highly activated 
benzoquinones and butadienes with opposing directional 
substituents occur with a high degree of regioselectivity 
(45). 
With ample literature precedent for a regioselective 
Diels-Alder cycloaddition, we set out to test this new 
approach to olivin. Requisite for our studies was the 
25 
availability of naphthoquinone esters such as 51. Previous 
results from our laboratory (46) indicated that the 
MeO 1 .  COUR 
2. oxidation 
OMe OMe 0 
.50 51 
cyanophthalide annulation procedure would be applicable for 
the preparation of 51. However, the anticipated difficulty in 
preparing the needed cyanophthalide 50 led us to an 
alternative method (vide infra) . 
MeOH 
AlCl 
OMe OMe 
MeO 
OMe OMe 
OMe 
Friedel-Crafts acylation of a-resorcyclic acid dimethyl ether 
with succinic anhydride afforded the known spirobislactone 52 
in good yield on a 20 g scale (47a). Treatment of 52 with 
acidic methanol produced the known sparingly soluble 
pseudoester 53 (47b). Dieckmann condensation (48) of 53 and 
in situ deprotonation afforded 54 in 57% yield. 
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MeO 
53 
t-BuOK/t-BuO^ 
DMSO 
MeO 
54 OMe OH 
OMe OMe 
E = COgMe 
MeO 
I  r l  
OMe OMe 
OMe 
Although the generality of the above three step procedure 
remains to be determined, any benzoic acid derivative 
acylating specifically at the ortho-position relative to the 
carboxyl function should provide similar results. 
A preliminary test for Diels-Alder regioselectivity was 
then undertaken. Oxidation of 54 with silver(I) oxide and 
immediate reaction of the unpurified quinone with 2-trimethyl-
silyloxybutadiene at ambient temperature produced the adduct 
55 in high yield. That 55 was indeed one regioisomer was 
evident from its NMR spectrum. Proof that 55 was the 
desired "para" regioisomer stemmed from selective proton 
decoupling studies. The olefinic enol ether proton of 55 
appeared as a broad triplet (J = 5 Hz) at 4.81 ppm in the 
27 
yOTMS 
Ag-O // \ MeO T T if -> 
OMe 
2 " OTMS 
nondecoupled spectrum. When the C-5 methylene protons 
(anthraquinone numbering) were irradiated, the triplet at 4.81 
ppm collapsed to a singlet. Irradiation of the C-8 protons 
had no effect on the multiplicity of the signal at 4.81 ppm. 
Since four bond allylic coupling constants are typically two 
Hertz or less (49), the above experiments demonstrate that 
"para" regiospecificity had been obtained. 
We next turned our attention to the preparation of a 
suitable diene synthon for the A ring and side chain of 
olivin. The commercially available diacetone-a-D-glucose 56 
was chosen for this purpose. By a modification of the 
Heathcock procedure (50), the known methyl ketone 57 (51) was 
prepared in five steps and in 40-50% overall yield without 
purification of intermediates. 
A 
1. BnCl, Me^° 
® NaH \ 0 1. MeMgBr ^ 
OH yi :—> %o > 
0^ 2; H3O+ ^y^^2. Jones' ox. 
56 NalO^ Ph ^ Ph 
28 
To complete the preparation of the carbohydrate diene, we 
envisioned addition of 1-ethoxyvinyllithium to 57 followed by 
dehydration to 58, 
In the event, addition of an excess of 1-ethoxyvinyl-
lithium (52) to 57 resulted in a rapid reaction, and upon 
workup produced an approximately 1:1 mixture of inseparable 
epimeric alcohols 59. Unfortunately, when the mixture of 
alcohols was submitted to mild acidic treatment, only highly 
polar unidentifiable products were obtained. Since the acidic 
conditions may promote carbocationic rearrangements (53), 
derivatization of 59 followed by type eliminations were 
next explored. However, only intractable tars were obtained 
under the following conditions: phosphorous 
oxychloride/pyridine (54), thionyl chloride/pyridine (55), 
trifluoromethanesulfonyl chloride/sodium hydride (56), and 
acetic anhydride/4-dimethylaminopyridine. 
Another tactical approach to the desired carbohydrate 
substituted butadiene was then examined. It was hoped that 
57 
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acetylide anion addition, followed by hydrolysis of the 
resulting carbinol, would produce an a-hydroxy methyl ketone, 
If the a-hydroxymethyl ketone could be produced, elaboration 
to the diene 58 might naturally follow. Surprisingly, 
treatment of methyl ketone 57 with sodium acetylide resulted 
in a facile g-elimination to provide 60, a known compound 
(57). Clearly the acetylide anion was not a strong enough 
iiti o 
NaC=CH 
THF 
60  
nucleophile, and deprotonation with subsequent g-elimination 
ensued. 
In light of these results, a strategy not involving prior 
carbonyl addition was indicated. A recent report by Scott, 
Crisp, and Stille had described palladium(O) catalyzed cross 
couplings of a variety of vinyl, alkyl. and acetylenic 
stannanes with vinyl triflates (58). While the methyl ketone 
57 was relatively hindered toward nucleophilic addition, 
examples of cross couplings of very hindered enol triflates 
had been accomplished by Stille. The regiospecific formation 
of vinyl triflates from a variety of enolates prompted us to 
investigate this mode of diene preparation (59). 
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Deprotonation of 57 under strict kinetic enolate forming 
conditions followed by addition of N-phenyltrifluoromethane-
sulfonimide provided vinyl triflate 61 in 77% yield. 
Treatment of 61 with 1-ethoxyvinyltri-n-butylstannane under 
the general conditions set forth by Stille [LiCl, 2% 
PdfPPhg)^] did not afford any of the desired butadiene. 
However, use of the corresponding vinyl zinc reagent (60) and 
employment of a different palladium(O) catalyst led to the 
formation of the desired butadiene 58 in 62% yield. To my 
knowledge, this is the first example of a cross coupling" 
involving vinyl triflates and organozinc reagents (61). 
OTf 
OBn 
61  
Tf = SOgCFg 
1.5% Pd(dba) 
PPh, 14h 
31 
A possible mechanism for this new cross coupling is 
detailed below in Scheme II. 
Scheme II 
^OTf R ( ZnfCliOSOgCFg T — >= ZnCl OEt » 
PdLgOTf R 
>= 
paL 
2 
OEt 
LgPdtO) + Ï 
• Jj'-ï L = PPhg 
Displacement of the triflate in the initially formed vinyl-
palladium(II) intermediate by the vinylzinc followed by 
reductive elimination generates the diene product and 
regenerates the palladium(O) catalyst (62). The failure of 
the Stille cross coupling may be due in part to the steric 
hindrance to attack of the organostannane (transmetallation) 
on the initially formed palladium(II) intermediate. The 
vinylzinc reagent is clearly more nucleophilic than the vinyl-
stannane and this enhanced reactivity may account for the 
w/ 
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success of the organozinc modification. Similar cross 
couplings of situ generated alkylzinc reagents and vinyl 
bromides have been reported by Negishi and coworkers (63). 
With the complex carbohydrate substituted diene in hand, 
we focused our attention on the crucial Diels-Alder reaction 
that would join the CB and A ring components. Due to the poor 
solubility properties of pseudo-ester 53 (vide supra), the 
corresponding benzyl pseudo-ester was prepared. Treatment of 
spirobislactone 52 with excess benzyl alcohol in refluxing 
benzene containing a catalytic amount of £-toluene-sulfonic 
acid resulted in the formation of the desired 62 in 80% yield 
accompanied by small amounts of ketodiester 63. By using 
MeO MeC PhCH_OH •OBn 
+ 
p-TSA,PhH 
OBn OBn 
0 OMe 
63 
prolonged reaction times, the amount of 63 produced was held 
to a minimum. 
Dieckmann condensation produced 64 in 66% yield. 
Oxidation of 64 with eerie ammonium nitrate (64) in aqueous 
acetonitrile produced naphthoquinone 65 in 97% yield. Diels-
Alder cycloaddition of 65 and 58 was complete after 10 hours 
of stirring in benzene at ambient temperature. The 
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OH 
MeO MeO 
62 t-BuOK/t-BuDH CAN 
DMSO 
OMe OMe OH 
64 
0 
65 
E' = COgBn 
clean methylene signals in the H NMR spectrum for a benzyl 
ester and ether at 5.04 ppm and 4.48 ppm respectively (both AB 
quartets), attested to the presence of only one diastereomer. 
The product was formulated on the basis of secondary orbital 
interactions and steric considerations as 66 (vide infra). 
25°C MeO 
65 + 58 
lOh 
87%. 
OMe 0 
OBn 
Although the stereochemistry at the ring juncture formed 
in the cycloaddition reaction relative to that of the 
carbohydrate residue is of no consequence to the overall 
outcome of this approach, an analysis of the factors 
responsible for the production of only one diastereomer seems 
appropriate. In Diels-Alder cycloadditions of quinones with 
electron withdrawing substituents and dienes bearing 
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substituents in the 2- and 3-positions, two considerations are 
important in predicting the major product(s) (65). First, the 
relative importance of quinone carbonyls versus the electron 
attracting substituent in controlling secondary orbital 
interactions must be considered (66). Molecular orbital 
calculations using the MNDO MO method of Kanematsu and 
coworkers clearly indicate that the LUMO coefficients at C-1 
and C-4 of 67 are much larger than those of C-7 and C-8 (67). 
By analogy, the quinone carbonyls of 65 would be expected to 
have larger LUMO coefficients than the carbonyl of the benzyl 
ester, and thus control secondary orbital interactions in the 
In light of the previous discussion, only two endo 
transition states need to be considered for the product 
analysis; endo-syn, wherein the ethereal benzyl group projects 
toward the naphthoquinone, and endo-anti, with the benzyl 
group projecting away from the quinone. The two transition 
0.150 
67 0.232 
Diels-Alder transition state. 
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states and the resulting products that would be formed are 
shown in figure 2. 
OBn 
OEt 
endo-syn MeO 
OMe O 
66' 
OBn 
OBn 
endo-anti 
MeO 
OMe 0 
56 
Figure 2. Endo transition states for the cycloaddition 
reaction of 65 and 58 
In the endo-syn transition state, severe steric repulsion 
of the benzyl ether group and one carbonyl of the quinone is 
evident. In the endo-anti transition state, these inter­
actions are absent. Thus, the probable structure of the 
Diels-Alder adduct of 55 and 58 is 56. 
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The obtention of Diels-Alder adduct 66 demonstrates our 
strategy for the synthesis of the olivin aglycone is feasible. 
Although efforts to synthesize olivin from 66 were temporarily 
halted at this point, the following partial proposed synthesis 
from 66 should prove practicable (Scheme III). Reduction of 
66 at the most electrophilic carbonyl employing the conditions 
of Inoue et al. (68) should yield 68 selectively. In their 
studies, a similar selectivity was achieved due to the 
inductive electron withdrawal of an adjacent carbomethoxyl 
group. 
R' = CMe. 
OH 
.. LiAlHtOR')] 
In addition to this same interaction in 66, the electron 
donating effect of the C-1 and C-3 methoxyl groups should 
enhance the selectivity. 
Saponification of 68 followed by treatment of the acid 
with the dimethylacetal of dimethylformamide and mild heating 
should produce 69 after aromatizatibn of the B ring (69). 
Should this reaction prove troublesome, a three step procedure 
involving saponification, tosylation, and decarboxylative 
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S-elimination should be workable. Once 69 is in hand, 
hydrolysis "of the labile end ether, reenolization to the 
conjugated enol acetate, and oxidation should provide the 
trans acyloin 70 (70). The latter two steps have already been 
accomplished in a related model system by a coworker in these 
laboratories (71). Compound 70 has all of the necessary 
2. MCPBA 
O 
functionality intact for eventual conversion to tri-O-methyl-
olivin or a similar olivin derivative. 
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Scheme III 
MeO 
OMe 
1. KOH 
2. Me^NCH(OMe)^ OBn 
or TsCl 
1. HgO^ then ACgO/H^ 
2. MCPBA 
MeO 
•' OAc 
OMe OH O 
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EXPERIMENTAL 
General 
Unless otherwise noted, materials were obtained from 
commercial suppliers and were used without purification. THF 
and diethyl ether were distilled from sodium benzophenone 
ketyl under nitrogen prior to usage. Benzene was distilled 
from lithium aluminum hydride. Dichloromethane was distilled 
from calcium hydride. Unless otherwise noted, all reactions 
were conducted under an argon atmosphere. Unless otherwise 
noted, all organic extracts were dried over anhydrous sodium 
sulfate. Melting points were determined on a Fisher-Johns 
melting point apparatus and are uncorrected. Infrared spectra 
were obtained on a Beckman IR-4250 or a Perkin-Elmer model 
1320 spectrophotometer. Nuclear magnetic resonance spectra 
were determined on a Varian EM-360 spectrometer. High field 
(300 MHz) proton spectra were obtained with a Nicolet 
Magnetics Corporation NMC-1280 spectrometer. All chemical 
shifts are reported in g relative to tetramethylsilane as an 
internal standard. Coupling constants (J) are reported in Hz. 
Abbreviations: s = singlet, d = doublet, t = triplet, q = 
quartet, bs = broad singlet, m = multiplet, ABq, AB quartet. 
Carbon-13 NMR spectra were determined on a Nicolet NMC-1280 
spectrometer and are reported in ppm relative to the central 
peak of CDClg (77.05 ppm). High-resolution mass spectra were 
recorded on a Kratos model MS-50 spectrometer. Low-resolution 
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mass spectra were recorded on a Finnegan 4023 mass 
spectrometer. Silica gel used for flash chromatography (72) 
was 230-400 mesh (Kieselgel 60) purchased from EM Science. 
Gravity column chromatography was performed on 60-200 mesh 
silica gel purchased from Davison Chemical (WR Grace Inc.). 
Elemental analyses were performed by Galbraith Laboratories, 
Inc. 
1/4-Dihydroxy-5,7-dimethoxy-2-naphthoic Acid, Methyl 
Ester (54) 
To a solution of pseudo-ester 53 (402 mg., 1.29 mmole) in 
20 mL of dry dimethylsulfoxide at 20°C was added potassium 
tert-butoxide/tert-butyl alcohol complex (770 mg, 4.15 mmole) 
in 10 mL dimethylsulfoxide. The resulting red solution was 
stirred at ambient temperature for 4 h, then acidified with 
1.5 N HCl until the red color was discharged. The resulting 
yellow solution was poured into 50 mL water, and extracted 
with ether. The combined extracts were washed with brine and 
dried. Chromatography on silica gel using 3:1 hexanes/ethyl 
acetate as solvent afforded 207 mg (57%) of 54: mp 166-168°C; 
300 MHz NMR (CDClj) g 3.93 (s, 3 H), 3.97 (s, 3 H), 4,02 
(s, 3 H), 6.6 (d, 1 H, J = 2.1 Hz), 7.00 (s, 1 H), 7.29 (d, 1 
H, J = 2.1 Hz), 8.62 (s, 1 H), 11.33 (s, 1 H); IR (CDCl^) 
3680, 3420, 3040, 2980, 1665, 1618, 1588, 1435, 1210, 1165, 
1140, 1040, 1010, 890 cm"^; MS, m/e 278, 246, 218, 190, 123; 
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high-resolution mass spectrum for requires 278.07904, 
measured 278.07877. 
(±)-(8ag,lOag)-10a-Carbomethoxy-l,3-dimethoxy-7-
[ (trimethyls ilyl)oxy]-5,8,8a,lOa-tetrahydro-9,10-
anthracenedione (55) 
To a solution of 54 (27.1 mg, 0.097 mmole) in 5 mL of dry 
benzene at 5°C was added silver(I) oxide (46.3 rag, 0.20 
mmole). The reaction mixture was shielded from light and 
stirred at ambient temperature for 75 min. The resulting 
yellow-orange solution was filtered through Celite and the 
solvent removed iji vacuo to yield the naphthoquinone as a deep 
orange solid: 60 MHz NMR (CDCl^) 6 4.01 (bs, 6 H), 6.80 
(d, 1 H, J = 2 Hz), 7.22 (s, 1 H), 7.28 (d, 1 H, J = 2 Hz); IR 
(CDCI3) 2930, 1735, 1647, 1588, 1230, 1140, 1075 cm~^. 
The naphthoquinone was used immediately without further 
purification. To a solution of the naphthoquinone in 2 mL of 
methylene chloride was added l-(trimethylsilyloxy)-l,3-
butadiene (50 pL, 0.27 mmole) at 0°C. The reaction mixture 
was slowly warmed to ambient temperature and stirred 6 h at 
ambient temperature. The solvent was removed on a rotary 
evaporator and the remaining volatiles removed iji vacuo to 
yield 31.3 mg (77%) of 55 as a beige solid; beige needles 
recrystallized from hexane-diethyl ether, mp 171-172°C; 300 
[4H2 NMR (CDCI3) S 0.21 (s, 9 H), 21.8 (m, 2 H), 2.58 (m, 2 
H), 3.73 (s, 3 H), 3.80 (t, 1 H), 3.90 (s, 3 H), 3.91 (s, 3 
H), 4.81 (bt, 1 H), 6.73 (d, 1 H, J = 2.4 Hz), 7.13 (d, 1 H, J 
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= 2.4 Hz); NMR 194.02, 192.37, 170.21, 164.57, 161.31, 
147.89, 136.46, 116.51, 105.25, 102.67, 100.52, 59.66, 56.39, 
55.77, 52.76, 49.95, 27.75, 27.45, 0.162 ppm; IR (CHgClg) 
3040, 2950, 2895, 2840, 1738, 1683, 1593, 1455, 1315, 1215, 
1205, 1150, 850, 648 cm"^; MS, m/e 418, 403, 390, 371, 359, 
344, 327, 313; high-resolution mass spectrum for ^21^26^7^^ 
requires 418.14479, measured 418.14509. 
6-Deoxy-l,2-0-(1-methylethylidene)-3-0-(phenylmethyl)-
g-D-xylo-hexofuranos-5-ulose (57) 
The literature procedure (48) for the corresponding ethyl 
ketone was modified. To a stirred suspension of hexane washed 
sodium hydride (2.35 g, 97.9 mmole) in 100 mL of THF was added 
diacetone-D-glucose (25.0 g, 95.9 mmole) in 50 mL of THF 
dropwise. To the resulting suspension was added 12.5 mL of 
dimethylsulfoxide and the reaction mixture warmed to a gentle 
reflux to dissolve the suspension. After the suspension had 
dissolved, benzyl chloride (11.04 mL, 96.0 mmol) was added and 
reflux was continued for 3 h. The reaction mixture was 
cooled, poured into 620 mL of water, and the aqueous solution 
saturated with sodium chloride. The saturated sodium chloride 
solution was extracted three times with 100 mL portions of 
diethyl ether, and the ethereal layers were combined and 
washed with four 100 mL portions of water, dried, and the 
solvent removed iji vacuo to yield 33.3 g (99%) of the benzyl 
ether which was used without purification. 
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The benzyl ether (33.3 g, 95.0 itvmole) was dissolved in 250 
itiL of 60% Cv/v) acetic acid and stirred at ambient temperature 
for 22 h. The solvents were removed iji vacuo, and the residue 
was dissolved in 50 mL of toluene and evaporated vacuo 
(repeated two times). The crude 5,6-diol was dissolved in 375 
mL of absolute ethanol, treated with 40 mL of saturated sodium 
bicarbonate solution and 21 g of sodium metaperiodate in 750 
mL of water. After 2.5 h of stirring at ambient temperature, 
the reaction mixture was treated with 500 mL of ethanol and 
the precipitated salts were filtered, and the filtrate 
concentrated vacuo. The residue was repeatedly treated 
with 100 mL of ethanol, filtered, and concentrated until no 
further precipitation occurred on addition of ethanol. The 
resulting aldehyde which was contaminated with residual 
ethanol and water was coevaporated three times with toluene, 
dissolved in 75 mL of THF, and treated at 0°C with methyl-
magnesium bromide (54.6 mL of a commercial 2.7 M THF solution, 
147.5 mmole) dropwise over 30 min. The light yellow solution 
was stirred 10 min at 0°C, then poured into 250 mL of 
saturated ammonium chloride and 100 mL of diethyl ether. The 
organic layer was separated and the aqueous layer was 
extracted twice with 50 mL portions of diethyl ether. The 
ethereal layers were washed with 150 mL of 1 N HCl, 150 mL of 
saturated sodium bicarbonate and dried to afford 23.1 g (81%) 
of the carbinol as a mixture of diastereomers by TLC. 
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To a solution of the carbinol (5.4 g, 18.1 mmole) in 150 
itiL of acetone at -65°C was added 8 ml of the Jones reagent, 
prepared by the method of Djerassi et al. (73), and slowly 
warmed to -5°C over 1 h. An additional 4 ml of the Jones 
reagent was then added and stirring continued for 2 h at 0°C. 
The reaction was then quenched with 3 ml of isopropanol, and 
filtered through 4 inches of Florisil. The solvents were 
removed vacuo, and the residue was flash chromatographed on 
40 g of silica gel eluting with 2.3:1 hexanes-diethyl ether to 
afford 2.8 g of pure 57 which crystallized on standing: mp 
56-57°C (lit. (49) 55-56°C); 300 MHz NMR (CDCI3) 5 1.33 (s, 
3 H), 1.47 (s, 3 H), 2.22 (s, 3 H), 4.265 (d, 1 H, J = 3.9 
Hz), 4.53 (ABq, 2 H, J^^^ = 11.7 Hz), 4.605 (d, 1 H, J = 3.6 
Hz), 4.63 (d, 1 H, J = 3.6 Hz), 6.08 (d, 1 H, J = 3.6 Hz), 7.3 
(m, 5 H); NMR 72.34, 81.84, 83.69, 85.35, 105.82, 112.07, 
127.48, 127.83, 128.28, 136.84, 206.15 ppm; IR (film) 3060, 
3025, 2982, 2930, 2860, 1718, 1453, 1382, 1372, 1353, 1216, 
1162, 1110, 1075, 1025, 855, 735, 695 cm"^; Anal. Calcd for 
^16^20*^5' 65.75: H, 6.85. Found: C. 65.48; H, 7.08. 
Attempted Addition of Sodium Acetylide to (57) 
To a solution of 57 (177 mg, 0.60 mmole) in 5 mL of THF at 
0°C was added sodium acetylide (1 ml of a 11-15% commercial 
suspension, ~ 2 mmole) dropwise. After warming the suspension 
to ambient temperature and stirring for 1.5 h, the reaction 
mixture was quenched with a pH = 7.0 phosphate buffer and 
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poured into water. The aqueous layer was extracted twice with 
two 20 itiL portions of diethyl ether, and the ethereal layers 
were dried. The solvents were removed vacuo to afford 93 
rag (92%) of 60 as a clear oil; compound 60 is a known 
compound (54). 60 MHz NMR (CDCI3) 6 1.50 (s, 6 H), 2.35 
(s, 3 H), 5.4 (dd, 1 H, J = 10 Hz, 4 Hz), 6.05 (d, 1 H, J = 4 
Hz), 6.20 (d, 1 H, J = 10 Hz). 
5,6-Dideoxy-5-[(trifluoromethanesulfonyl)oxy]-1,2-0-
(1-methylethylidene)-3-0-(phenylmethyl)-a-D-xylo-hex-5-
enofuranose (61) 
To a solution of diisopropylamine (0.63 mL, 4.5 mmole) in 
25 mL of THF at 0°C was added n-butyllithium (1.82 mL of a 
2.47 M solution in hexanes, 4.5 mmole) dropwise. After 
stirring 10 min at 0°C, the solution was cooled to -70°C and 
57 (1.06 g, 3.58 mmol) in 10 mL of THF was added dropwise 
never allowing the internal temperature to rise above -65°C. 
When the addition was complete, the reaction mixture was 
stirred at -70°C for 30 min. To the resulting solution was 
added N-phenyltrifluoromethanesulfonimide (1.53 g, 4.28 mmole) 
in 4 mL of THF and the reaction mixture was slowly warmed to 
ambient temperature over 16 h. The solvents were removed in 
vacuo and the residue was flash chromatographed on silica gel 
eluting with 5:1 hexanes-diethyl ether to provide 920 mg (77%) 
of 61 as a clear oil: 300 MHz ^h NMR (CDCl^) 6 1.32 (s, 3 H), 
1.49 (s, 3 H), 4.10 (d, 1 H, J = 3.3 Hz), 4.60 (ABq, 2 H, 
= 11.7 Hz), 4.625 (d, 1 H, J = 3.6 Hz), 4.75 (m, 1 H), 5.385 
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(dd, 1 H, J = 3.6 Hz, 0.9 Hz), 5.465 (dd, 1 H, J = 3.6 Hz, 1.2 
Hz), 5.99 Cd, 1 H, J = 3.6 Hz), 7.30 (m, 5 H); NMR 26.40, 
27.03, 72.69, 78.88, 81.46, 82.53, 105.31, 106.32, 112.62, 
127.82, 128.12, 128.53, 137.01, 149.63 ppm; IR (CCl^) 3060, 
3040, 2985, 2930, 2870, 1675, 1596, 1452, 1420, 1383, 1372, 
1215, 1140, 1075, 1030, 939, 790, 695 MS m/e 409, 333, 
291, 260, 129, 91; high-resolution mass spectrum for 
C16H16O7SF3 requires 409.05693, measured 409.05690. 
5,6-Dideoxy-5-etheneyl-6-ethoxy-l,2-0-(l-methylethylidene)-
3-0-(phenylmethyl)-a-D-xylo-hept-6-enofuranose (58) 
To a solution of ethyl vinyl ether (0.20 mL, 2.0 mmole) in 
16 mL of THF at -78°C was added tert-butyllithium (1.17 mL of 
a 1.7 M solution in pentane, 2.0 mmole). The solution was 
slowly warmed to 0°C over 30 min whereupon the yellow color 
faded to a clear colorless solution. After warming to ambient 
temperature, zinc chloride (300 mg, 2.2 mmol) in 5 mL of THF 
was added. After 5 min bis(dibenzalacetone)palladium(0) (14.5 
mg, 0.024 mmole) and triphenylphosphine (13 mg, 0.05 mmol) in 
5 mL of THF were added followed by 61 (173 rag, 0.40 mmol) in 2 
mL THF. The reaction mixture was stirred 14 h at ambient 
temperature, stripped down to dryness, taken up in 20 mL of 
diethyl ether and poured into a dilute pH = 7.0 phosphate 
buffer. The layers were separated and the aqueous layer was 
extracted with 20 mL of diethyl ether. The ethereal layers 
were combined, washed with brine and dried. The solvents were 
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removed iji vacuo and the residue was flash chromatographed on 
silica gel eluting with 5:1 hexanes-diethyl ether to provide 
86.8 mg (62%) of 58 as a pale yellow oil: 300 MHz NMR 
(CDCI3) 5 1.308 (t, 3 H, J = 6.9 Hz), 1.32 (s, 3 H), 1.50 (s, 
3 H), 3.74 (dq, 2 H, J = 6.9), 4.025 (d, 1 H, J = 2.7 Hz), 
4.045 (d, 1 H, J = 3.0 Hz), 4.25 (d, 1 H, J = 2.7 Hz), 4.48 
(bs, 2 H), 4.60 (d, 1 H, J = 3.9 Hz), 4.95 (bs, 1 H), 5.56 
(bs, 1 H), 5.78 (bs, 1 H), 5.99 (d, 1 H, J = 3.6 Hz), 7.27 (in, 
5 H); NMR 14.33, 26.34, 26.86, 62.83, 72.37, 79.13, 82.21, 
82.53, 83.49, 104.17, 111.43, 114.63, 127.54, 127.69, 128.16, 
137.60, 137.92, 158.06 ppm; IR (CCl^) 3060, 3025, 2985, 2930, 
2860, 1650, 1490, 1455, 1415, 1210, 1160, 1072, 695 cm~^; MS 
m/e 347, 346, 255, 229, 178, 149, 129, 105; high-resolution 
mass spectrum for C^gHggOg requires 346.17803, measured 
346.17812. Compound 58 is unstable at room temperature and 
was used immediately after purification. 
3-(3-Benzylpropanoatyl)-3-benzyloxy-4,6-d imethoxy-
1(3 H)-isobenzofuranone (62) 
To a suspension of impure 52 (15.0 g, ~ 45 mmole) in 250 
mL of benzene was added benzyl alcohol (45 ml, 435 mmole) and 
£-toluenesulfonic acid monohydrate (2 g, 10.5 mmole) and the 
mixture heated at reflux for 5 d, cooled and poured with 
vigorous stirring into 1.2 L of cold water. The resulting 
gummy orange solid was filtered, dried vacuo, and 
chromatographed on 600 g of silica gel eluting with 1:1 
48 
hexanes-diethyl ether to afford 13.86 g (66%) of 62 as a clear 
pale yellow oil; 300 MHz NMR (CDCI3) 5 2.43 (m, 2 H), 2.73 
(m, 2 H), 3.81 (s, 3 H), 3.86 (s, 3 H), 4.20 (ABq, 2 H, = 
11.1 Hz), 5.03 (s, 2 H), 6.69 (d, 1 H, J = 1.8 Hz), 6.92 (d, 1 
H, J = 1.8 Hz), 7.31 (m, 10 H); NMR 28.56, 32.91, 55.65, 
55.84, 66.04, 66.16, 96.03, 99.11. 104.98, 109.22, 125.91, 
127.53, 127.61, 127.95, 128.01, 128.33, 130.72, 135.88, 
136.90, 155.65, 163.88, 167.39, 172.28 ppm; IR (film) 3060, 
3025, 2930, 2830, 1760, 1730, 1618, 1490, 1447, 1422, 1318, 
1140, 1040, 1020, 896, 720, 685 cm"^; MS m/e 462, 356, 299, 
265, 248, 219, 165, 91; Anal. Calcd for ^21^2S^1' 70.10; 
H, 5.63. Found: C, 70.12; H, 5.77. Characterization for 
2-(4-benzyl-4-oxo-butanoatyl)-3,5-diméthoxy-benzoic acid, 
benzyl ester (63), clear oil: 300 MHz ^H NMR (CDCl^) 5 2.63 
(t, 2 H, J = 7.8 Hz), 3.08 (t, 2 H, J = 7.8 Hz), 3.76 (s, 3 
H), 3.83 (s, 3 H), 5.12 (s, 2 H), 5.25 (s, 2 H), 6.61 (d, 1 H, 
J = 2.4 Hz), 7.05 (d, 1 H, J = 2.4 Hz), 7.35 (m, 10 H); 
NMR 28.50, 39.30, 55.77, 56.17, 66.27, 67.62, 103.08, 106.18, 
126=24, 128,12, 128,47, 128,54, 128,59, 128.66, 129.97, 
135.39, 136.30, 157.49, 161.11, 165.78, 172.70, 202.70 ppm; IR 
(film) 3040, 2965, 2845, 1730, 1715, 1605, 1455, 1325, 1240, 
1210, 1145, 1058, 840, 780, 725, 692 cm"^; MS m/e 462, 299, 
265, 219, 165, 91; high-resolution mass spectrum for ^21^2^^! 
requires 462.16786, determined 462.16830. 
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1,4-Dihydroxy-S,7-dimethoxy-2-naphthoic Acid, 
Benzyl Ester (64) 
To a solution of potassium tert-butoxide/tert-butanol 
complex (650 mg, 3.5 mmole) in 8 mL of dimethylsulfoxide at 
ambient temperature was added 62 (506 mg, 1.09 mmole) in 2 mL 
of dimethylformamide with stirring. After stirring at ambient 
temperature for 75 min the red solution was quenched with 1.5 
N HCl until the red color was discharged. The resulting 
yellow solution was poured into 50 mL of water and extracted 
three times with 25 mL portions of diethyl ether. The 
extracts were combined, washed with brine, and dried. Flash 
chromatography on silica gel with 4:1 hexanes-ethyl acetate as 
eluant provided 303 mg (79%) of 64. A small sample was 
crystallized from ethyl acetate: mp softens 145°C, melts 
174.5-176°C; 300 MHz NMR (CDCI3) 6 3.94 (s, 3 H), 4.02 (s, 
3 H), 5.40 (s, 2 H), 6.63 (d, 1 H, J = 2.1 Hz), 7.06 (s, 1 H), 
7.31 (d. 1 H. J = 2.1 Hz). 7.38 (m. 5 H), 8.63 (s.. 1 H), 11,33 
(s, 1 H); NMR 55.54, 56.32, 66.99, 95.95, 101.25, 104.46, 
106.98, 114.75, 127.80, 128.18, 128.41, 128.66, 135.48, 
146.14, 152.31, 156.81, 157.97, 170.56 ppm; IR (CDCl^) 3420, 
3200-2800, 2965, 1660, 1618, 1585, 1448, 1390, 1208, 1165, 
1140, 1040, 790, 690 cm"^; MS m/e 355, 354, 265, 263, 219, 91; 
Anal. Calcd for C, 67.77; H, 5.09. Found; C, 
67.62; H, 5.37. 
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2-Carbobenzyloxy-5,7-dimethoxy-l,4-naphthalenedione (65 ) 
To a solution of 64 (175 itig, 0.49 nunole) in 20 itiL of 
acetonitrile and 5 mL of THF at ambient temperature was added 
with stirring a solution of eerie ammonium nitrate (600 mg, 
1.08 mmole) in 2 mL of water. The resulting yellow-orange 
solution was stirred at ambient temperature for 30 min and 
then poured into water. The aqueous layer was extracted twice 
with 30 mL portions of chloroform, the organic extracts 
combined, washed with water, and dried over magnesium sulfate. 
The solvents were removed vacuo to provide 168 mg (97%) of 
65 as a yellow-orange solid. A small sample was 
recrystallized from carbon tetrachloride-methylene chloride: 
mp 147-148°C; 300 MHz ^H NMR (CDCl^) 6 3.93 (s, 3 H), 3.95 (s, 
3 H), 5.34 (s, 2 H), 6.73 (d, 1 H, J = 2.4 Hz), 7.16 (s, 1 H), 
7.24 (d, 1 H, J = 2.4 Hz), 7.38 (m, 5 H); NMR 56.07, 
56.55, 67.78, 104,08, 104.51, 114.59, 128.37, 128.59, 128.74, 
135.16, 136.07, 136.88, 141.50, 162.06, 163,06, 165.35, " 
181.17, 182.02 ppm; IR (CDCl^) 2960, 2940, 1735, 1650, 1592, 
1560, 1455, 1350, 1318, 1220, 1155, 807 cm"^; MS m/e 353, 352, 
263, 218, 189, 146, 91; Anal. Calcd for CggH^gOg: C, 68.16; 
H, 4.54. Found; C, 67.94; H, 4.56. 
6-[3aR-(3aa,5g,63,6aa)-3-0-Benzyl-2,2-dimethyltetrahydro-
furo[2,3-d]-1,3-dioxolyl]-lOa-carbobenzyloxy-7-ethoxy-l,3-
dimethoxy-5,8,8a,lOa-tetrahydro-9,10-anthracenedione (66) 
To a solution of 65 (97 mg, 0.27 mmole) in 4 mL of toluene 
at 0®C was added 58 (113 mg, 0.32 mmole) in 1 mL of toluene. 
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The reaction mixture was slowly warmed to ambient temperature 
and stirred at ambient temperature for 10 h. The solvent was 
removed ijn vacuo and the residue filtered through 10 g of 
silica gel to afford 165 mg (87%) of 66 as a white solid; mp 
68-69®C; 300 MHz NMR (CDCI3) 6 1.13 (t, 3 H, J = 6.9 Hz), 
1.28 (s, 3 H), 1.46 (s, 3 H), 2.25 (m, 1 H), 2.70 (m, 1 H), 
2.95 (ra, 1 H), 3.68 (dq, 2 H, J = 6.9 Hz), 3.74 (m, 2 H), 3.85 
(s, 3 H), 3.89 (s, 3 H), 4.00 (d, 1 H, J = 3.3 Hz), 4.48 (ABq, 
2 H, J = 12.3 Hz), 5.04 (ABq, 2 H, J = 12.6 Hz), 5.14 
^ "in y ciii 
(d, 1 H, J = 3.9 Hz), 5.88 (d, 1 H, J = 3.9 Hz), 6.68 (d, 1 H, 
J = 2.4 Hz), 7.05 (d, 1 H, J = 2.4 Hz), 7.4-7.1 (m, 10 H); IR 
(CDCI3) 3080, 3060, 3020, 2985, 2930, 1735, 1680, 1590, 1560, 
1450, 1365, 1310, 1200, 1155, 1065, 1015, 900, 685, cm~^; MS 
m/e 698, 581, 533, 478, 397, 343, 107, 91; high-resolution 
mass spectrum for requires 698.27272, measured 
698.27361. 
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PART II. SYNTHETIC APPROACHES TO THE 
-DEOXYANTHRACYCLINONES; A FORMAL SYNTHESIS 
OF AKLAVINONE 
59 
INTRODUCTION 
The potent antitumor activity of the 11-deoxyanthracycline 
class of natural products has stimulated considerable 
synthetic interest toward their preparation. 
This manuscript will detail the results of a program 
directed toward the total synthesis of aklavinone. 
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HISTORICAL 
The anthracyclines are a growing class of medicinally 
important antitumor antibiotics originally isolated as colored 
pigments from soil bacteria. The name anthracycline is due to 
the structural features associated with these molecules. They 
are linearly fused tetracyclic compounds containing the 
anthraquinone chromophore. The general structure and 
numbering convention of the anthracyclines is shown below. 
All anthracyclines contain carbohydrate residues in the 
form of a Q-pyranoside linkage which is often located at the 
C-7 position of the aglycone. The presence of a glycoside 
linkage is necessary for biological activity, although 
anthracyclines are isolated in the aglycone form. The 
aglycones of the anthracycline class are structurally diverse, 
as are the carbohydrate residues commonly attached. 
Oxygenation in the basic aglycone structure is usually in the 
form of phenol, hydroxyl, ketone, or ester functionality. 
Selected examples of the anthracyclines and aglycones are 
61 
shown below, along with structures of some important 
L-pyranose sugars. 
Rhodomycinones 
Isorhodomycinones 
CO.CHg or OH 
COgCHg or OH 
OR^ 0 OH 
ÔR4 
^1 R2 ^3 R4 
Daunomycin CH3 OH H Daunosamine 
Adriamycin CH3 OH OH Daunosamine 
11-Deoxyadriamycin CH^ H OH Daunosamine 
Carminomycin H OH H Daunosamine 
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Pyrromycin 
Cinerubin A 
Cinerubin B 
Rhodosamine 
Rhodosamine(a-1/4-)2-deoxy-L-fucose-
(a-l»4)-L-cinerulose 
Rhodosamine(a-1,4)-2-deoxy-L-fucose-
((x-l/4-)-cinerulose B. 
Me Me Me 
OH NH NMe 
OH OH OH 
Rhodosamine 2-deoxy-L-Fucose Daunosamine 
Me 
OH 
0 J 
L-Cinerulose 
Me 
O 
J 
H 
Cinerulose 
Daunomycin and adriamycin are first generation 
anthracycline antitumor agents that have been used in the 
treatment of a wide variety of human cancers. Daunomycin is 
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particularly useful in the treatment of mycloblastic and 
lymphoblastic leukemias (1), while adriamycin is effective 
against breast and bladder adenocarcinoma, testicular 
carcinoma, Hodgekin's disease, and acute leukemias (2). 
Unfortunately, both of these chemotherapeutic agents are also 
characterized by severe side effects which include 
immunodepression, gastroenteritis, and cardiac toxicity. 
Aclacinomycin A is a second generation anthracycline 
antitumor antibiotic that was isolated in 1975 by Oki and 
coworkers from Streptomyces galileus strain MA144-M1 (3). The 
structure of aclacinomycin A 1 was subsequently elucidated (4) 
and is shown below. Aclacinomycin A was found to be active 
against several animal cancers including rat hepatomas, P388 
and L1210 leukemias in mice, and Ehrlich ascite tumor. 
Additionally, aclacinomycin A is 10-15 times less cardiotoxic 
than the related anthracycline adriamycin (5). More 
importantly though, it is effective when administered to 
patients suffering from acute leukemias, malignant lymphoma, 
and lung, breast, and stomach cancers (6). 
The biochemical, pharmacodynamic, and chemical aspects of 
aclacinomycin A and other anthracycline antibiotics have been 
studied extensively and are the subjects of several books 
(6-11) and recent reviews (12-16). The useful clinical 
applications of aclacinomycin A and advances in the enzymatic 
glycosidation of aklavinone (2) (17), the aglycone of 
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OH 
OH OH 
0 
1 aclacinoinycin A 
Me 
NMe 
0 
Me 
OH 
'''OH 
Me 
OH OH OH 
2 aklavinone 
aclacinomycin A, has directly influenced the synthetic 
interests of chemists. Additional impetus for synthetic study 
toward aklavinone has stemmed from reports of the synthesis of 
the trisaccharide residue of aclacinomycin A (18) and of its 
successful chemical coupling with aklavinone (19). This 
historical will summarize the results of several synthetic 
approaches to aklavinone and closely related analogs in the 
11-deoxyanthracyclinone series. 
In any synthetic approach to aklavinone, two very 
important criteria must be satisfied for an efficient 
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synthesis to ultimately result. The first is the 
regioselective formation of the tetracyclic system. More 
specifically, synthetic chemists have employed many different 
types of reactions including the Diels-Alder cycloaddition, 
the Friedel-Crafts acylation, and various anionic reactions. 
Of these, the Diels-Alder reaction has provided the highest 
degree of convergency in the syntheses of aklavinone. The 
second challenging aspect encountered in a synthetic approach 
to aklavinone is the stereospecific introduction of the C-7 
hydroxyl function. This requirement has been met by a 
stereocontrolled benzylic bromination/solvolysis sequence that 
has been used in virtually every synthesis of aklavinone. 
Two of the early syntheses of aklavinone were based upon 
Friedel-Crafts ring closure methodology. Confalone and 
Pizzolato were responsible for a D + BA route in 1981 (20). 
Compound 3, the product of an ortho-specific Lewis acid 
catalyzed Fries rearrangement, underwent cyclization under the 
influence of boric acid-sulfuric acid to provide the 
anthraquinone 4 in 57% yield. Anthraquinone 4 was elaborated 
in a lengthy sequence to nitrile 5. Epoxidation, hydrolysis 
of the nitrile, stereospecific hydrogenolysis of the epoxide, 
and benzylic bromination provided 6 in low overall yield from 
nitrile 5. Solvolysis of bromide 6 was stereospecific, 
presumably via the protonated enone 6a, to afford racemic 
66 
OMe O OH 
OMe . 0 OH 
0_Me 
*' OH 
H 
4-
OMe • O OH i i 
OMe O OH 
aklavinone by hydration directed by the hydroxyl function at 
C-9. 
C^Me 
4» ''OH 
OuMe 
2 
Although the Confalone synthesis was regio- and stereo-
controlled, the overall yield of aklavinone was low. A more 
convergent synthesis, also of the D + BA type, was 
subsequently reported by Kende and Rizzi (21). Addition of 
the ortho-metallated carboxamide 7 to the highly functional-
ized aldehyde 8 produced the phthalide 9 in high yield. 
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Hydrogenolysis of the phthalide and Friedel-Crafts ring 
closure provided the anthraquinone 10 in 60% yield after 
aerial oxidation. 
CHO 
OMe . 8 
R = SiMSgt-Bu 
OMe 
O^Me 
OH O OH 
OMe OMe 9 
1. Zn,NaOH 
2. (CFgCOIzO 
OMe 0 OMe 10 
Elaboration of 10 to the aklavinone intermediate 6 and 
thence to racemic aklavinone was accomplished by reactions 
similar to those used in the Confalone synthesis. 
While only two successful approaches to aklavinone have 
involved Friedel-Crafts ring closure methodology, no fewer 
than six synthetic routes involving carbanionic intermediates 
in carbon skeletal preparation have been published. The 
anionic pathways can be further subdivided into approaches 
involving aldol-type condensations, phthalide annulations, and 
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vicarious nucleophilic aromatic substitution. Synthetic 
approaches involving aldol-type condensations will be covered 
first. 
The intramolecular aldol condensation has been an 
important strategy in the syntheses of aklavinone. One of the 
first syntheses of aklavinone was based largely on this 
approach (22). Treatment of ketoester 11 with potassium 
carbonate afforded a mixture of diastereomeric aldol products 
with the correct isomer 12 as a minor product in 36% yield. 
Fortunately, all of the isomers could be equilibrated to the 
desired relative stereochemistry by a combination of acidic 
and basic treatments to provide 12 in approximately 60% yield 
after two equilibrations. Although little stereocontrol was 
obtained in the cyclization, this is the only synthesis of 
aklavinone in which functionality at C-7 is intact prior to 
the construction of the tetracyclic system. Furthermore, this 
route has been extended to an asymmetric synthesis of 
aklavinone (23). An analogous intramolecular condensation was 
later reported by Krohn (24). 
OMe 
11 1 2  
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A similar approach was used by Marayuma and coworkers; 
however, both the A and B rings were formed by a tandem 
Michael addition-aldol condensation (25). Thus, 13 underwent 
biscyclization upon treatment with potassium hydride in the 
presence of a [2.2.2] cryptand to provide 14. In this 
OMe OH 
13 
R = SiMegt-Bu 
KH 
OH 
14 
biomimetic reaction, the presence of the crown ether was 
essential to the obtention of a favorable mixture of 
diastereomers at C-9 and C-10. 
In 1981, Li and Wu reported a stereospecific and 
convergent synthesis of aklavinone (26). In this route, 
cyanophthalide anion 15 reacted with the elaborated enone 16 
to afford anthraquinone 17 in good yield after aerial 
oxidation. Conversion of 17 to the aklavinone precurser 20 
involved a stereoelectronically controlled epoxide ring 
opening of 18 and hydrogénation of the resulting bromide. 
A general synthesis similar to that shown above was 
recently reported by Hauser and Mai (27). Phthalide 
annulation between sulfone 21 and cyclohexenone 22 provided 
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iMe 
1 .  
CN 
air 
17 OMe 0 OH O 16 
|0_Me 
OMe OH 
18 
1. NaBr 
» 
Pd 
OH 
OH OMe 
^ ^ X = Br 
20 X = H 
the naphthalenone derivative 23 in excellent yield. Following 
a four step conversion of 23 to 24, treatment of 24 with 
magnesium methoxide effected an intramolecular aldol 
condensation to provide 25 in 70% yield. As expected, 
significant amounts of the diastereoraeric product were also 
produced. 
One of the first synthetically useful examples of a 
vicarious nucleophilic aromatic substitution was reported by 
Murphy and Cara (28). In their approach to aklavinone, the 
enone 26 reacted with the preformed anion of the acetonitrile 
derivative to provide the aklavinone precurser 27 in good 
yield. 
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CO^Me 
22 
SOgPh 
21 
OMe 
OBn 
OMe OH 
COgMe 
23 
COgMe 
Mg(OMe)2 
COgMe 
OMe 0 OH 0 
NC 
xs NaCHgSOMe 
Presumably, the phenylthioacetonitrile anion undergoes 
Michael addition to the enone, followed by vicarious 
substitution onto the anthraquinone moiety, and finally, 
expulsion of thiophenoxide. Although 27 closely resembles the 
Confalone intermediate 5 (vide supra), no reports on its 
ultimate conversion to aklavinone have appeared in the 
literature. 
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The final strategy to be discussed is the Diels-Alder 
approach. As in the case of the phthalide annulation 
methodology, the tetracyclic skeleton is amenable to a highly 
convergent DC + BA strategy. Boeckman and Sum have employed 
this strategy in the form of a naphthoquinone-vinylketene-
acetal cycloaddition (29). Thus, heating cyclobutane 28 in 
the presence of juglone 29 produced two separable anthra-
quinones 30 and 31 in a ratio of 4.4:1. Unfortunately, direct 
+ 
EtO 
EtO 
2. NaOMe 
2 8  
Rj = H, = OH 
Rj = OH, R = H 
Arndt-
Eistert 
OEt OEt OMe OMe 
32 33 
conversion of the major regioisomer 30 to aklavinone proved 
troublesome. Ultimately, Arndt-Eistert homologation of an 
A-ring cleavage product 32 produced 33 which was transformed 
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to aklavinone by an intramolecular aldol condensation 
identical to that seen in Mauser's work (vide supra). A 
similar vinyl ketene acetal cycloaddition-ring-cleavage route 
was also reported by Gesson and coworkers (30) in their 
synthesis of auromycinone, a C-9 methyl analog of aklavinone. 
A related approach was later published by Bauman, Hawley, 
and Rapoport which judiciously utilized preexisting ketene 
acetal functionality for an expedient conversion of the Diels-
Alder adduct to aklavinone (31). Deprotonation of 34 and 
silylation produced 35. Without purification, 35 underwent 
cycloaddition with the bromojuglone derivative 36 to afford 
37. In this case, in situ elimination of HBr and the silyl 
group produced the aromatic B-ring. 
;o_Me 
34 
;0-Me 
RO 
+ 
OH 0 
35 
OH OH 
37 R = SiMe_t-Bu 
Br 
OMe 
OR 
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Compound 37 is easily transformed to aklavinone using the 
previously defined procedures of Confalone and Kende (vide 
supra). The Rapoport synthesis provides an excellent example 
of regiocontrol in formation of the tetracyclic skeleton of 
aklavinone. Considering the Diels-Alder reaction, the 
combined polarizing effects of the bromine and peri-hydroxyl 
group in 36 resulted in the exclusive formation of the correct 
regioisomer. This, coupled with the ease in preparation of a 
variety of bromojuglone derivatives (32), makes the vinyl 
ketene acetal cycloaddition route applicable to the synthesis 
of a wide variety of anthracyclinones with A-ring substitution 
similar to aklavinone. 
In summary, 11-deoxyanthracyclinones such as aklavinone 
are a valued group of antitumor agents. Their clinical 
efficacy in conjunction with their reduced side effects has 
made them valuable targets for the synthetic chemist. 
Synthetic approaches involving the Friedel-Crafts reaction, 
anionic reactions, and the Diels-Alder cycloaddition have been 
used for their construction. While the anionic approaches 
have provided the highest degree of regiochemical control, the 
Diels-Alder pathways are the most direct. Nearly every 
approach has involved a benzylic bromination/solvolysis 
sequence to introduce the C-7 hydroxyl function. Although 
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this sequence provides adequate stereocontrol, alternative 
methods for A-ring functionalization and carbon skeleton 
construction are needed. 
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RESULTS AND DISCUSSION 
Our approach to aklavinone was initiated during the course 
of our synthetic studies toward olivin, the aglycone of the 
aureolic acid antibiotic olivomycin A (part I). We envisioned 
enone 38 as a potential DCB ring system synthon. A Diels-
Alder cycloaddition with a suitably functionalized diene at 
the non-quinonoid olefin of 38 would produce a precurser to 
aklavinone with much of the functionality of the A-ring 
intact. 
OR 
38 
OR OH 
39 
Unfortunately, even if 38 could be prepared, it would 
rapidly tautcmerize to the anthraquinone 39. An attractive 
equivalent to 38 in which either X or Y blocks aromatization 
to the anthraquinone represented an interesting alternative. 
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In the case of 40, no ambiguity regarding the site 
selectivity of the Diels-Alder reaction would be present. 
Furthermore, if X and Y were functional groups that could be 
readily removed, a controlled avenue for aromatization of the 
B-ring at some later stage would be possible. Finally, a 
route involving enone 40 as a dienophile would avoid the 
familiar bromination/solvolysis sequence to introduce the 
hydroxyl group at C-7. 
A requirement of 40 would be its preparation in a 
regiospecific manner. Based on our findings in the olivin 
study, we anticipated that it would be available from a Diels-
Alder reaction of an activated naphthoquinone derivative. Our 
retrosynthetic analysis for aklavinone based on the concept of 
a blocked anthraquinone tautoraer is summarized in Scheme I. 
For our model studies we desired as an activating group, 
X, a methyl ester. Since sulfides are easily removed by a 
variety of methods, the phenylthio group was chosen as the 
blocking functionality, Y. Introduction of a phenylthio group 
via conjugate addition of benzenethiol to 2-carbomethoxy-l-4-
naphthoquinone had precedent in the £-benzoquinone series. 
Muller and coworkers studied the addition of a variety of 
nucleophiles to carbomethoxy-g-benzoquinone (33). High yields 
of the hydroquinone addition products were obtained when 
pyridine derivatives were employed as catalysts. 
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Scheme I. 
ÇOgMe 
OMe 0 
X = an electron withdrawing group 
Y = a stable blocking group 
XH 
DMAP 
PhH 
U 
X 
OH 
X = S, NR, 0 
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In the event, treatment of 2-carbomethoxy-l,4-
naphthoquinone (41) (34) with benzenethiol in the presence of 
dimethylaminopyridine (DMAP) resulted in a rapid reaction. 
Upon workup however, only the naphthhydroquinone 42 and 
diphenyldisulfide were isolated. Clearly, an oxidation-
reduction reaction had occurred. 
+ (PhS) 
OH 42 
CO^Me 
PhSH + 
0 
Employing a full equivalent of DMAP or using the sodium salt 
of benzenethiol led to identical results. Use of Lewis or 
protic acid catalysis in hopes of further activating the 
quinone toward nucleophilic addition also failed. Apparently, 
the stabilizing effect of the annuiated benzene ring slowed 
the rate of nucleophilic addition to the quinone, allowing 
electron-transfer to become the dominant reaction pathway. 
In light of these results we elected to reverse the order 
of addition of functionality to the naphthoquinone moiety. 
Since Kolbe-Schmitt carboxylation (35) of a phenylthio-
naphthoquinone followed by esterification and oxidation was 
viewed as awkward and low yielding, the nitrile function was 
considered as a substitute for the ester. Although cyanide 
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additions to aryl-substituted naphthoquinones were known, it 
was by no means a general reaction (36). Nevertheless, 
treatment of 2-phenylthionaphthoquinone (43) (37) with sodium 
cyanide in a four component aqueous solvent system produced 
the cyanonaphthalene derivative 44 in 94% yield. Oxidation to 
the corresponding naphthoquinone 45 was accomplished in high 
yield with eerie ammonium nitrate (CAN) in aqueous 
acetonitrile (38). Thus, the DC portion of the model blocked 
anthraquinone tautomer was available in approximately 75% 
overall yield beginning with commercially available 
1,4-naphthoquinone. 
SPh 
•SPh 
OH 
43 44 
SPh 
CAN 
CN 
0 
We next investigated the Diels-Alder behavior of quinone 
45. Treatment of 45 with excess 1-acetoxy-l,3-butadiene at 
130°C for 20 hours produced a 2.5:1 mixture of "endo" and 
"exo" Diels-Alder adducts respectively. The two products were 
easily separated by fractional crystallization. That the 
major Diels-Alder product 46a was the "endo" isomer was 
evident from its -y NMR spectrum. The methyl group of the 
allylic acetate appeared at 1.17 ppm; strongly shielded in 
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OAc OAc 
46a 46b 
comparison to the same protons of the "exo" isomer which 
appeared at 2.11 ppm. This exceptionally high-field shift of 
the axial acetate results from a conformation placing it 
directly below the aromatic ring (39). Similarly, the axial 
methine proton of 46b also exhibits a ring current shielding, 
albeit only a 0.20 ppm shift (40). 
The Diels-Alder reaction of 45 with 1-trimethylsilyloxy-
1,3-butadiene (41) required only a few hours at 80°C for 
completion. Adduct 47, the only product formed, was isolated 
by direct crystallization of the crude reaction product in 
over 95% yield. In this example, only the "endo" isomer was 
formed as evidenced by a singlet appearing at -0.35 ppm for 
the trimethylsilyloxy group. 
OTMS 
Q SPh 
45 
47 OTMS 
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Reacting 45 with mixed vinyl ketene acetal 49 (42) produced no 
Diels-Alder adduct and only intractable tars at room 
temperature. Identical observations were made when the ketene 
acetal was added to a solution of the quinone at -78°C. 
Independent results from these laboratories indicate that 
electron transfer or a similar ionic pathway intervenes in 
Diels-Alder reactions of 49 with activated quinones (43). Had 
49 OTMS 
OEt 
4 5 — — — — — — ^  
OTMS 
p. SPh 
48 
this reaction been successful, a simple hydrolysis reaction 
would have provided the DCS synthon^48. 
An alternative sequence involving desilylation of 47 
followed by oxidation was next examined. Unfortunately, under 
a variety of reaction conditions commonly used to cleave silyl 
groups- decomposition to a purple solution was observed. The 
NMR spectra of the crude reaction products indicated a 
facile retro-aldol reaction was occurring (Scheme II). 
Apparently, the cyano group, with its strong inductive effect 
facilitated cleavage adjacent to the allylic alcohol. 
Ultimately, quinhydrones, which are highly colored quinone-
hydroquinone complexes, were produced (44). 
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Scheme II 
SPh 
H"*" or F" 
47 
OTMS 
quinhydrone 
oligomers 
HSPh 
CHO 
CHO 
We were pleased to find that direct oxidation of the silyl 
ether 47 with the Jones' reagent in acetone produced the 
requisite enone 48 in high yield. Evidently, 
protiodesilylation under the acidic conditions produced an 
0 SPh 
Jones' ox. 
47 
0 CN O ^ 
allylic alcohol which was oxidized at a much faster rate than 
the destructive retro-aldol reaction described above (45). 
Although 48 was similarly sensitive to traces of acid or base, 
it was easily purified by crystallization from anhydrous 
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diethyl ether. In this way, multigram quantities of 48 were 
available in 60-65% yield from napthoquinone 45. 
Having established a high-yielding route to 48, we next 
investigated the crucial Diels-Alder reaction that would 
append the A-ring to the blocked anthraquinone tautomer. 
Reaction of 48 with diene 50 (46) at 110°C for 24 hours 
produced 51 as a mixture of "exo" and "endo" isomers in low 
yield accompanied by substantial amounts of unidentified polar 
materials. Unfortunately, the cycloaddition was not 
o-ms 
ix — > 
reproducible and in many instances failed completely. In 
addition to the low yield obtained, hydrolysis of the 
3-methoxy silyl end ether resulted in extensive A-ring 
aromatization and retro-aldol cleavage of the B-ring (47). 
As a possible solution to these problems, we considered 
dienone 52 as an alternative dienophile. Dienone 52, by 
virtue of its increased planarity, was expected to be more 
reactive than 48, The presence of an olefin in the B-ring of 
a Diels-Alder product of 52 would allow for an situ 
SPh 
•OTMS 
OMe 
51 
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0 CN 0 
vinylogous elimination of HCN, and thus solve the problem of 
B-ring cleavage. 
To prepare 5 2 ,  we envisioned oxidation of 48 to the 
sulfoxide followed by pyrolytic cis-elimination of 
benzenesulfenic acid (48). In the event, oxidation of 48 with 
meta-chloroperbenzoic acid (MCPBA) was rapid at 0°C. Upon 
workup however, the unexpected anthraquinone 53 was isolated 
in high yield! Apparently, oxidation was followed by 
immediate sulfoxide elimination to produce 52 (49). Dienone 
52 must undergo a [1,5] suprafacial carbon shift, 
tautomerization then provided 53. 
MCPBA ^ 52 
- (PhSOH) 
A literature search revealed that facile rearrangements 
such as this are not uncommon in "blocked aromatic"-
cyclohexadienone systems (50-52). It is interesting to note 
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that 54, prepared from 46a by an analogous oxidation-sulfoxide 
elimination sequence, was completely stable and did not 
decompose until heated to its melting point. Clearly, 
formation of the anthraquinone accompanied by aromatization 
provides considerable driving force for this rearrangement. 
0 
OAC 
54 
Although it was disappointing that neither 48 or 52 could 
be used for direct attachment of the A-ring, the facile [1,5] 
nitrile shift was viewed as a synthetically useful reaction. 
If an acetic ester residue could be incorporated into 48 as 
shown (Scheme II), sulfoxide elimination would provide 56 
after the nitrile transfer. A similar intermediate, 57, had 
been employed by Kishi in his elegant synthesis of aklavinone 
( 2 2 )  .  
Realizing that conjugate addition of an acetate ester 
enolate to 48 would fail due to its extreme base sensitivity, 
an alternative mode of addition that would occur under neutral 
conditions was sought. The Tamura addition of silyl ketene 
acetals (53) served this need admirably. Reaction of 48 with 
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Scheme III 
0 CN 0 
0»Me 
OMe 0 OH 
CO^Me 
COgMe 
the mixed ketene acetal 58 (54) in anhydrous acetonitrile at 
45°C produced ester 59 in 62% yield. 
48 
.58 psiMe-t-Bu 
^OEt 
CH^CK 
CO.St 
O OSiMegt-Bu 
59 
The 300 NMR spectrum of 59 exhibited an eight line AB 
quartet of doublets for the methylene protons adjacent to the 
ester and a sharp doublet at 4.96 ppm (J = 3.1 Hz) for the 
olefinic enol ether proton. 
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Dehydrogenation of 59 to the corresponding enone 55 proved 
impossible. Attempts with palladium(II) acetate (55), 
dichlorodicyanobenzoquinone (DDQ) (56), and triphenylcarbenium 
tetrafluoroborate/collidine (57) all returned unreacted enol 
silyl ether. Apparently, the pseudo-axial methine proton, 
which is located on the concave face of 59, is far too 
hindered for abstraction by these reagents. 
We next investigated electrophilic additions of formyl 
cation equivalents to 59. If successful, removal of the 
nitrile and thiophenyl groups followed by B-ring aromatization 
would provide an advanced intermediate in the Kishi synthesis. 
Treatment with trimethyl orthoformate under the Noyori 
conditions (58) failed to produce any of the desired g-keto 
acetal 60. Treatment with dithienium tetrafluoroborate (59) 
also failed, returning the enol ether unscathed. 
SPh 
OMe 
OMe 
60 
SPh 
\y 
^ OSiMe„t-Bu 
59 
In light of these results, it was not surprising that 
N-bromosuccinimide (NBS) (60) and phenylselenenyl chloride 
(61), reagents known to react well with silyl enol ethers, 
also failed to provide any addition products. At this point, 
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convincing rational for the unreactive enol ether is lacking. 
The low reactivity cannot be purely steric in nature. Since 
the thiophenyl and acetic ester groups occupy pseudo 
equatorial positions, they should not severely interfere with 
electrophilic addition to the enol ether site. 
• Taking full advantage of the unyielding enol ether group, 
treatment of 59 with MCPBA cleanly and selectively produced 
the sulfoxide 61 as a 2.5:1 mixture of diastereomers in 98% 
yield. Heating the isomers to 80*C effected syn-elimination 
to provide diene 62 in 88% yield. This result was surprising 
p SOPh 
59 MCPBA 
80°C, CCI4 
0 
OR 
COgBt 
< 
EtgN 
62 0 OSiMegt-Bu 
COgEt 
O 
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since elimination of HCN to afford the anthraquinone 63 should 
have been rapid. 
Diene 62 did eliminate HCN on treatment with triethylamine 
to produce 63. Without purification, 63 was hydrolyzed with 
aqueous HCl to produce 64 in good overall yield from 62. For 
simplification of the NMR spectra of these intermediates and 
for literature comparison of physical data, the corresponding 
methyl ester of 64 was prepared. Substituting 1-methoxy-l-
(tert-butyldimethylsilyloxy)ethylene 65 for 58 in the Tamura 
reaction, and under essentially identical reaction conditions, 
66 was obtained. Compound 66 was identical in every respect 
with the compound prepared by Krohn et al. (62). 
The obtention of 62 allowed for a reinvestigation of the 
nitrile shift approach to aklavinone. Due to its increased 
planarity, dehydrogenation of 62 was anticipated to occur 
because the methine proton was no longer sterically shielded 
as in 59 (vide supra). Indeed, dehydrogenation with DDQ 
produced a new product. However, NMR analysis of the product 
was only consistent with the formation of triene 67. 
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Apparently, nucleophilic attack on silicon by the DDQ 
0 
0 CN oSlMe^t-Bu 
67 
hydroquinone anion was not favorable, and only elimination of 
a proton from the presumed cationic intermediate resulted 
(63). Finally, addition of formyl cation equivalents to 62 
failed, returning unreacted diene. 
Model studies were suspended at this point in favor of a 
formal total synthesis of aklavinone. In order to achieve 
this goal, a methoxyl group at C-8 of 45 (naphthoquinone 
numbering) was necessary. Given that this compound could be 
readily prepared, an intermediate in the Kishi synthesis would 
be available by repetition of the reactions used to prepare 
64. 
Toward this end, treatment of juglone acetate (68) (64) 
with benzene thiol produced quinone 59 in 80% yield (65). The 
literature report indicated that this reaction was completely 
regioselective. In our hands, a 97:3 ratio of the desired 
2-phenylthionaphthoquinone and its 3-phenylthio isomer were 
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OAc 0 
1. PhSH 
2. HCl, EtOH 
3. Mel, Ag20 
SPh 
69: R = 
R = 
71; R = 
Ac 
K 
OMe 
indicated by "H NMR analysis at 300 MHz. Fisher transester-
ification followed by methylation (56) produced naphthoquinone 
71 in high yield. In the course of the latter two steps, the 
contaminating isomer was easily removed by crystallization. 
Cyanide addition to 71 was complicated by slow aerial 
oxidation of the hydroquinone product. Thus, the crude 
addition product was treated without purification with CAN to 
produce the desired 3-cyanonaphthoquinone 72 in 92% yield. 
NaCN 
71 > 
SPh 
CAN 
OMe 
SPh 
OMe 
.72 
The remainder of the formal synthesis closely paralleled 
that of the deoxy-compound, and is shown in Scheme IV. Diels-
Alder cycloaddition of 72 with 1-trimethylsilyloxybutadiene 
occurred in 90% yield to produce 73 which was oxidized in 88% 
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yield to afford enone 74. Ketene acetal addition and 
oxidation produced sulfoxide 76 as a 3:1 mixture of 
diastereomers. Without purification, the diastereomers were 
heated to effect cis-elimination. Elimination of HCN provided 
anthraquinone 77. Finally, hydrolysis of 77 with HCl in 
aqueous THF produced the desired anthraquinone 78. Thus, an 
operationally convenient and direct route to the DCB subunit 
of aklavinone was achieved (67). 
Scheme IV 
72 
1 
2. Jones' ox. 
OTMS 
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OMe 
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X = 0 
OSiMe_t-Bu 
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.75: X = SPh 
76: X = SOPh 
94 
In principle, only one substituent should be required to 
prevent tautomerization to an anthraquinone. To test this, a 
direct synthesis of 82 from the known 3-phenylthiojuglone 79 
(55) was developed. Diels-Alder cycloaddition of 80 proceeded 
OTMS 
SPh 2. Jones' ox. 
SPh 0 OR OMe 
8 2  
OSiMe-t-Bu 
OMe 
CH^CN 
OH OMe 0 
with high regioselectivity, and by NMR analysis, only the 
"ortho" product was detected. Jones* oxidation of the 
resulting Diels-Alder adduct 81 afforded 82 in high yield. 
However, when enone 82 was reacted with the ketene acetal 
under conditions which were previously successful, only 
l-hydroxy-8-methoxyanthraquinone 83 was isolated. Despite 
several modifications (68) including an attempt at 7 kbar 
pressure (69), only decomposition of 82 to 83 was observed. 
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A similar system wherein the acetyl group served as a 
blocking function was also prepared. In this system, 
elimination and aromatization were considered unlikely. Thus, 
2-acetylnaphthoquinone 84 (70) underwent a facile Diels-Alder 
reaction to provide 85 in excellent yield. Desilylation and 
Jones' oxidation then afforded 86. Surprisingly, when treated 
with the ketene acetal, 86 was silylated to produce 87. 
Additionally, Diels-Alder attempts with 86 and a variety of 
dienes failed, returning unreacted 86. 
COMe 
-OTMS 
(to ^ 85) 
2. Jones' ox. 
86 
0SiMe2t-Bu 
OMe 
SiMe2t-Bu 
Despite the well-known electron-withdrawing effect of the 
sulfoxide group, and the use of vinyl sulfoxides as 
dienophiles, only two reports on the use of sulfinyl quinones 
in Diels-Alder reactions have appeared (71). One report 
originating from these laboratories indicated that 
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naphthoquinones monosubstituted with the sulfoxide group at 
the 2-position are powerful dienophiles. The reaction below 
illustrates their utility in the preparation of 
dihydroanthraquinones (72). As an extension of this work, an 
investigation of the Diels-Alder behavior of 2,3-disubstituted 
sulfinylnaphthoquinones was undertaken. 
To produce a suitable system for this study, 2-methyl-3-
phenylthionaphthoquinone 88 was prepared following a 
literature procedure (73). Oxidation with MCPBA afforded the 
sulfoxide 89 in 80% yield. Cycloaddition of 89 with 1-tri-
methylsilyloxy-1,3-butadiene was complete after only a few 
hours at 50°C. The extremely hygroscopic nature of the Diels-
Alder adduct 90 made its isolation in pure form difficult. 
However, heating 90 at 130°C effected sulfoxide elimination 
and desilylation to afford the blocked anthraquinone 911 That 
91 had been formed was based on its spectroscopic data. The 
300 MHz NMR spectrum exhibited a sharp cinglet at 15.6 ppm 
for the strongly hydrogen bound enol in addition to a sharp 
doublet of doublets (J = 10.2 and 4.2 Hz) at 6.28 ppm for the 
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olefinic proton adjacent to the enol. Apparently, 
desilylation was due to the benzenesulfenic acid coproduced in 
the sulfoxide elimination. In practice, all three chemical 
steps could be accomplished in one pot in 45% yield (Scheme 
V). 
Scheme V 
MCP3A 
SOPh 
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46% OTMS 
50°C 
130°C 
0 SOPh: OTMS 
Heating 91 at 280°C for 30 minutes resulted in the 
extrusion of methane gas to provide 92. Literature precedent 
suggested that cleavage to a radical pair followed by hydrogen 
atom abstraction was the likely mechanism (74). The formation 
of anthraquinone 92 was confirmed by comparison with an 
authentic sample. 
98 
91 280°C 
.92 
0 OH 
With these results, we desired to investigate the behavior 
of a corresponding allyl derivative of 89. In this system, 
alternate Woodword-Hoffman "allowed" pathways for 
rearrangement exist. Additionally, if rearrangement to a 
ketonaphthoquinone such as 93 occurred, a new approach toward 
aklavinone involving a Michael addition-intramolecular aldol 
condensation would be possible. 
Scheme VI. 
OMe 0,. .0 OMe 0 O 
i I 93-
COgMe 
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Toward this end, the known allyl-substituted 
naphthoquinone 94 (75) was prepared. Benzenethiol addition 
and oxidation proceeded smoothly to afford 96 in 85% overall 
MCPBA 
SPh 
OMe OMe OMe 
96 95 
yield. Treatment of 96 with l-trimethylsilyloxy-l,3-butadiene 
at ambient temperature resulted in a rapid reaction. Upon 
workup, however, a plethora of products were formed. 
Interestingly, conducting the Diels-Alder reaction at 80°C 
produced 98 as the only isolable product in 60% yield. 
Evidently, the desired sulfoxide elimination and desilylation 
steps had occurred followed by an apparent retro-Claisen 
rearrangement 1 
The reversibility of the allylphenyl ether Claisen 
rearrangement has been well established (76, 77). It is 
noteworthy that in "blocked aromatic" systems such as ours, 
rearrangement often continues to ultimately produce 
2-allylphenols (78, 79). Unfortunately, when 98 was heated 
100 
OTMS 
OMe 0 SOPh'OTMS 
R= H, CH3 
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to temperatures sufficient to cause expulsion of methane gas 
from 91, only unreacted 98 and tarry materials were recovered. 
Evidently, the high barrier to disruption of aromaticity in 
the anthracene system precludes equilibration back to 97 and 
thence to 93. 
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EXPERIMENTAL 
General 
Unless otherwise noted, materials were obtained from 
commercial suppliers and were used without purification. THF 
and diethyl ether were distilled from sodium benzophenone 
ketyl under nitrogen prior to usage. Benzene was distilled 
from lithium aluminum hydride. Dichloromethane was distilled 
from calcium hydride. Unless otherwise noted, all reactions 
were conducted under an argon atmosphere. Unless otherwise 
noted, all organic extracts were dried over anhydrous sodium 
sulfate. Melting points were determined on a Fisher-Johns 
melting point apparatus and are uncorrected. Infrared spectra 
were obtained on a Beckman IR-4250 or a Perkin-Elmer model 
1320 spectrophotometer. Nuclear magnetic resonance spectra 
were determined on a Varian EM-360 spectrometer. High field 
(300 MHz) proton spectra were obtained with a Nicolet 
Magnetics Corporation NMC-1280 spectrometer. All chemical 
shifts are reported in 5 relative to tetramethylsilane as an 
internal standard. Coupling constants (J) are reported in Hz. 
Abbreviations: s = singlet, d = doublet, t = triplet, q = 
quartet, bs = broad singlet, m = multiplet, ABq, AB quartet. 
Carbon-13 NMR spectra were determined on a Nicolet NMC-1280 
spectrometer and are reported in ppm relative to the central 
peak of CDClg (77.06 ppm). High-resolution mass spectra were 
recorded on a Kratos model MS-50 spectrometer. Low-resolution 
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mass spectra were recorded on a Finnegan 4023 mass 
spectrometer. Silica gel used for flash chromatography (80) 
was 230-400 mesh (Kieselgel 60) purchased from EM Science. 
Gravity column chromatography was performed on 60-200 mesh 
silica gel purchased from Davison Chemical (WR Grace Inc.). 
Elemental analyses were performed by Galbraith Laboratories, 
Inc. 
2-Phenylthio-lf4-naphthalenedione (43) 
To a solution of sublimed naphthoquinone (8.19 g, 51.8 
mmole) in 530 mL of absolute ethanol was added benzenethiol 
(5.43 mL, 53.0 mmole) and the brown solution stirred at 
ambient temperature for 16 h, whereupon a white precipitate 
had formed. The brown solution was treated with 30 g of 
iron(III)trichloride in 50 mL of water and stirred 2 h at 
ambient temperature. To this golden orange solution was added 
200 mL of water and the yellow crystals which formed were 
filtered, washed with water, and dried iji vacuo to provide 
12.63 g (91%) of 43: mp 160-162°C (lit. (37) 159-161°C); 60 
MHz NMR (CDCI3) 6 6.12 (s, 1 H), 7.2-8.2 (m, 9 H); IR 
(CDCI3) 3060, 1665, 1645, 1590, 1555, 1332, 1297, 1255, 1120, 
855 cm ^. 
2-Cyano-l,4-dihydroxy-3-phenylthionaphthalene (44) 
To a solution of sodium cyanide (7.0 g, 142.2 mmole) in 
330 mL of 50% (V/V) aqueous ethanol at ambient temperature was 
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added 43 (12.63 g ,  47.4 mmole) in 330 mL of dioxane and 85 itiL 
of THF via an addition funnel dropwise. After the addition 
was complete, the reaction mixture was stirred 30 min at 
ambient temperature and then stood at 0® for 16 hours. The 
reaction mixture was then acidified with 100 mL of 1.5 N HCl 
and an additional 500 mL of water added. The resulting light 
brown precipitate was filtered and dried iji vacuo to afford 
11.78 g (84%) of 44 as a beige powder, yellow-gold needles 
from ethanol/water: mp 202-203°C with decomposition; 300 MHz 
^H NMR (CDCI3, Dg acetone) 6 7.10-7.30 (m, 5 H), 7.67 (m, 2 
H), 8.35 (m, 2 H), 8.70 (s, 1 H), 10.35 (bs, 1 H); IR (mull) 
3410, 3300-3100, 2210, 1570, 1450, 1370, 935, 770, 738 cm"^; 
NMR 100.17, 107.36, 116.51, 124.26, 126.53, 127.68, 
127.74, 128.24, 128.77, 129.68, 136.95, 150.83, 154.04 ppm; MS 
m/e 295, 294, 293, 215, 154, 136, 77; high resolution mass 
spectrum for C^^H^^OgSN requires 293.05105; determined 
293.05099. Anal. Calcd for Ci^H^^OgSN: C, 69.61; H, 3.75. 
Found: C, 69.74; H, 3.84. 
2-Cyano-3-phenylthio-l,4-naphthalenedione (45) 
To a solution of 44 (2.93 g, 10.0 mmole) in 300 mL of 2:1 
acetonitrile-THF was added slowly a solution of eerie ammonium 
nitrate (12.06 g, 22.0 mmole) in 50 mL of water. After 
stirring at ambient temperature for 30 min, the solvents were 
removed jji vacuo and the residue dissolved in 300 mL of 
chloroform, washed with three 200 mL portions of water, dried 
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over magnesium sulfate, and filtered. The solvents were 
removed vacuo and the residue crystallized from 
hexanes/efehyl acetate to provide 2.66 g (91%) of 45 as bright 
orange needles: mp 167-168°C; 300 MHz NMR (CDCl^) 6 
7.3-7.45 (m, 3 H), 7.48 (bd, 2 H), 7.65 (m, 2 H), 7.95 (m, 2 
K); IR (CDClg) 2930, 2830, 2220, 1680, 1658, 1590, 1460, 1280, 
1170, 820, 750, 710 cm"^; NMR 110.06, 115.50, 119.73, 
126.37, 126.98, 127.21, 129.54, 130.96, 131.07, 134.20, 
134.94, 135.27, 160.88, 176.81, 179.75 ppm; MS, m/e 292, 291, 
262, 235, 214, 182, 154, 126, 104, 76; high resolution mass 
spectrum for C^^HgOgSN requires 291.03540, determined 
291.03500; Anal. Calcd for C^^HgOgSN: C, 70.08; H, 3.09. 
Found; C, 69.88; H, 3.10. 
(1 a,4ag,8as)-l-Acetoxy-8a-cyano-4a-phenylthio-l,4-dihydro-
9,10-anthracenedione (46a) 
A solution of 45 (290 mg, 1.0 mmole) and 
1-acetoxy-l,3-butadiene (0.59 mL, 5.0 mmole) in 10 mL of" 
benzene was placed in a thick-walled sealable tube and cooled 
to -78°C under a static argon atmosphere. The tube was then 
flame sealed and after warming to ambient temperature, was 
placed in an oil-bath at 130°C. After heating for 20 h at 
130*C, the tube was cooled to -78°C and opened. The solvent 
and excess diene were removed vacuo, and the residue was 
flash chromatographed on silica gel eluting with 3.5:1 
hexanes/ethyl acetate to provide 30 mg of 45 and 249 mg (69%) 
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of 46a and 46b as a white solid, recrystallized from 
hexanes/ethyl acetate to provide 46a: mp 165-166*0; 300 MHz 
NMR (CDCI3) 5 1.17 (s, 3 H), 2.65 (bd, 1 H, J = 18.6 Hz), 
3.18 (dd, 1 H, J = 20.8 Hz and 5.1 Hz), 5.73 (d, 1 H, J = 4.8 
Hz), 5.85 (m, 1 H), 6.15 (m, 1 H), 7.20-7.35 (m, 4 H), 7.41 
(bt, 1 H, J = 7.2 Hz), 7.80 (m, 2 H), 8.05 (m, 2 H); IR (film) 
3060, 2920, 2245, 1755, 1700, 1590, 1440, 1370, 1250, 1210, 
1015 cm"^; NMR 19.44, 30.54, 57.74, 59.10, 69.42, 114.18, 
120.80, 126.97, 127.34, 129.25, 130.81, 131.90, 133.55, 
133.62, 134.91, 135.70, 137.22, 167.63, 186.04, 186.58 ppm; MS 
m/e 403, 361, 294, 252, 250, 180, 151, 110; high resolution 
mass spectrum for requires 403.08784, determined 
403.08750; Anal. Calcd for CggH^^O^SN: C, 68.47; H, 4.22. 
Found; C, 68.31; H, 4.53. 
(la, 4ae,8a6)-8a-Cyano-4a-phenylthio-l-(trimethylsilyl)oxy-
1,4-dihydro-9,10-anthracenedione (47) 
To a suspension of 45 (7.50 g, 25.8 mmole) in 50 mL of 
benzene was added 1-(trimethylsilyl)oxy-l,3-butadiene (6.75 
mL, 38.3 mmole) and the mixture was stirred at 40°C for 16 
hours. The resulting light brown solution was concentrated in 
vacuo and the residue crystallized from diethyl ether/hexanes 
to afford 10.66 g (95.5%) of 47 as clear needles: mp 
153.5-154.5°C; 300 MHz ^H NMR (CBCI3) 5 -0.35 (s, 9 H), 2.60 
(bd, 1 H, J = 18.6 Hz), 3.13 (ddd, 1 H, J = 18.6, 5.1, and 1.5 
Hz), 4.68 (d, 1 H, J = 4.5 Hz), 5.76 (m, 1 H), 5.97 (m, 1 H), 
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7.15-7.30 (m, 4 H), 7.37 (m/ 1 H), 7.21 (apparent dp, 2 H, J = 
7.2 and 1.2 Hz), 7.90 (dd, 1 H, J = 7.5 and 1.5 Hz), 8.15 (dd, 
1 H, J = 7.5 and 1.5 Hz); IR (CDCI3) 3070, 3050, 2950, 1695, 
1592, 1255, 1085, 845, 685 cm"^; NMR -0.84, 30.61, 57.52, 
60.92, 71.86, 115.17, 124.52, 126.42, 126.61, 127.72, 129.08, 
129.14, 130.54, 133,00, 134.29, 134.36, 136.48, 137.17, 
186.74, 188.19 ppm; MS m/e 433, 324, 282, 234, 197, 110; high 
resolution mass spectrum for C2^H2202SNSi requires 433.11680, 
determined 433.11697; Anal. Calcd: C, 66.49; H, 5.31. Found: 
C, 66.87; H, 5.42. 
(4a6,8a6)-8a-Cyano-l-oxo-4a-phenylthio-4(2H)-9,10-
anthracenedione (48) 
To a solution of 47 (6.15 g, 14.2 mmole) in 200 mL of 
acetone at 0°C was added 16 mL of a 7 N Jones' reagent 
dropwise. The reaction was carefully monitored by TLC and 
after 30 min the reaction mixture was diluted with diethyl 
ether (100 mL) and quenched with 10 mL of 2-propanol. The 
salts were filtered and the filtrate was concentrated in 
vacuo. The residue was dissolved in 150 mL of diethyl ether 
and washed several times with 50 mL portions of brine and 
dried. The solvents were removed vacuo and the residue 
crystallized from diethyl ether to afford 3.30 g (65%) of 48: 
mp 144-146°C; 300 MHz ^H NMR (CDCl^) 5 3.05 (dt, 1 H, J = 18.9 
and 2.4 Hz), 3.34 (dd, 1 H, J = 18.9 and 6.3 Hz), 6.14 (dd, 1 
H, J = 10.2 and 2.4 Hz), 7.22 (m, 1 H), 7.24-7.35 (m, 4 H), 
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7.45 (m, 1 H), 7.80 (m, 2 H), 8.02 (m, 1 H), 8.15 (m, 1 H); IR 
(CH2CI2) 3060, 2215, 1710, 1685, 1585, 1370, 1250, 1205 citi"^; 
NMR 32.07, 61.21, 66.19, 111.42, 126.06, 126.70, 128.02, 
129.43, 131.23, 131.83, 132.26, 135.49, 137.40, 152,46, 
182.31, 182.88, 186.58 ppm; MS m/e 359, 250, 222, 206, 166, 
139, 110; high resolution mass spectrum for 
requires 359.06162, determined 359.06202; Anal. Calcd: C, 
70.18; H, 3.62. Found; C, 70.27; H, 3.73. 
2-Cyano-l-hydroxy-9,10-anthracenedione (53) 
To a solution of 48 (113 mg, 0.314 mmole) in 6 mL of 
methylene chloride at 0°C was added meta-chloroperbenzoic acid 
(60 mg, 0.345 irimole) and the mixture stirred at 0°C for 5 
hours. The solvent was removed jji vacuo and the residue was 
suspended in diethyl-ether and stirred 5 hours. The solid 
remaining was filtered and dried to afford 72 mg (92%) of 53 
as a light yellow sparingly soluble powder: mp > 250°C; 300 
MHz NMR (CDCI3) 0 7.57 (d, 1 H, J = 9 Hz), 7.90 (m, 2 H), 
8.20 (m, 2 H), 8.29 (d, 1 H, J = 9 Hz); IR (mull) 3480, 3390, 
2210, 1670, 1585, 1375, 1310, 1280 cm"^; NMR 112.80, 
120.33, 124.59, 125.17, 125.63, 126.33, 131.23, 131.38, 
132.04, 132.78, 134.97, 165.61, 179.04, 179.72 ppm; MS m/e 
249, 221, 193, 164, 138; high resolution mass spectrum for 
requires 249.04260, determined 249.04264. 
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(la,Sag)-l-Acetoxy-8a-cyano-l(2H)-9,10-anthracenedione (54) 
To a solution of 46a (83 mg, 0.20 mmole) in 5 mL of 
methylene chloride at 0®C was added meta-chloroperbenzoic acid 
(35 mg, 0.20 mmole) and stirred at 0°C for 4 hours. The 
solution was concentrated ^  vacuo and the residue 
chromatographed on silica gel elating with 4:1 hexanes/ethyl 
acetate to afford 6 mg of 46a and 41 mg (73%) of 64 as beige 
needles from hexanes/ethyl acetate; rap 146-149°C; 300 MHz 
NMR (CDCI3) 6 1.85 (s, 3 H), 5.92 (dd, 1 H, J = 5.1 and 0.9 
Hz), 6.65 (m, 2 H), 7.64 (dd, 1 H, J = 5.1 and 0.9 Hz), 7.84 
(m, 2 H), 8.16 (d, 1 H, J = 7.5 Hz), 8.31 (d, 1 H, J = 7.8 
Hz); IR (film) 3000, 2210, 1748, 1710, 1665, 1590, 1565, 1290, 
1260, 1235, 1015, 860, 715 cm"^; NMR 32.32, 59.62, 77.30, 
126.11, 140.36, 140.49, 140.64, 141.88, 142.05, 142.35, 
145.85, 146.88, 147.04, 148.24, 167.08, 180.78, 182.22 ppm; MS 
m/e 251, 234, 222, 178, 151, 130, 102; high resolution mass 
spectrum for C^jH^^O^N requires 293.06881, determined 
293.06839. 
(3g,4ag,8ag)-3-Carboethoxymethyl)-8a-cyano-4a-phenylthio-
1-(tert-butyld imethyls ilyl)oxy-3,4-dihydro-9,10-
anthracenedione (59) 
To a solution of 48 (1.12 g, 3.12 mmole) in 18 mL of 
anhydrous acetonitrile was added 1-ethoxy-l-(tert-buty1-
dimethylsilyDoxyethylene (1.26 g, 6.24 mmole) at ambient 
temperature. The mixture was warmed to 40-45°C for 5 hours 
and then concentrated in vacuo. The residue was flash 
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chromatographed on silica gel eluting with 5:1 hexanes/ethyl 
acetate to afford 1.09 g (62%) of 59 as a white solid, 
colorless prisms from hexanes/ethyl acetate: mp 126-127°C; 
300 MHz NMR (CDCI3) 5 -0.12 (s, 3 H), 0.20 (s, 3 H), 0,82 
(s, 9 H), 1.26 (t, 3 H, J = 7.2 Hz), 1.88 (dd, 1 H, J = 13.7 
Hz and 9.9 Hz), 2.38 (dd, 1 H, J = 14.9 and 8.7 Hz), 2.46 (dd, 
1 H, J = 15.0 Hz and 5.7 Hz), 2.62 (dd, 1 H, J = 13.7 Hz and 
6.8 Hz), 2.85 (m, 1 H), 4.15 (q, 2 H, J = 7.2 Hz), 4.96 (d, 1 
H, J = 3.0 Hz), 7.28 (m, 5 H), 7.40 (m, 1 H), 7.80 (m, 2 H), 
7.94 (m, 1 H), 8.11 (m, 1 H); IR (film) 3060, 2960, 2935, 
2845, 1735, 1715, 1680, 1592, 1460, 1255, 840, 775 cm"^; 
NMR 17.81, 29.76, 60.11, 60.54, 61.70, 95.99, 109.67, 115.04, 
126.79, 128.87, 130.56, 131.12, 131.64, 137.70, 144.96, 
170.95, 185.37, 186.13 ppm; MS ra/e 504, 452, 416, 295; high 
resolution mass spectrum for C^^H^^O^SNSi requires 546.17706, 
determined 546.17690; Anal. Calcd: C, 68.11; H, 6.41. Found: 
C, 68.28; H, 6.49. 
(3g,4ag,8ag)-3-Carboethoxymethyl-8a-cyano-4a-
phenylsulfinyl-l-(tert-butyldimethvlsilyl)oxy-3,4-
dihydro-9,10-anthracenedione (61) 
To a solution of meta-chloroperbenzoic acid (73 mg, 0.423 
mraole) in 8 mL of methylene chloride at 0°C was added a 
solution of 59 (216 mg, 0.385 mmole) in 2 mL of methylene 
chloride dropwise. The reaction mixture was stood at 0®C 16 
hours and concentrated ^  vacuo. The residue was 
chromatographed on silica gel eluting with 2:1 hexanes/ethyl 
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acetate to afford 213 mg (98%) of 61 as a 2.5:1 mixture of 
diastereomers. The major isomer was crystallized from 
hexanes/ethyl acetate as white needles: mp 185-187°C; 300 MHz 
NMR (CDCI3) 6 -0.11 (s, 3 H), 0.20 (s, 3 H), 0.83 (s, 9 H), 
1.26 (t, 3 H, J = 7.2 Hz), 1.94 (dd, 1 H, J = 13.0 and 9.9 
Hz), 2.40 (m, 3 H), 2.85 (m, 1 H), 4.14 (q, 2 H, J = 7.2 Hz), 
4.93 (d, 1 H, J = 3.0 Hz), 7.28 (m, 2 H), 7.48 (m, 2 H), 7.59 
(m, 1 H), 7.75 (m, 1 H), 7.86 (m, 2 H), 8.14 (dd, 1 H, J = 7.5 
and 0.9 Hz); IR (film) 3060, 2920, 1710, 1670, 1655, 1590, 
1255, 1205, 900, 830, 720 cm~^; MS m/e 520, 452, 412, 396, 
367, 339, 320, 295, 126, 110; high resolution mass spectrum 
for C^-j^H^^OgSNSi (M^'-C^Hg) requires 520.12502, determined 
520.12563. 
(3g,Sag)-3-Carbomethoxymethyl-8a-cyano-l-(tert-
butyldimethylsilyl)oxy-3(2H)-9,10-anthracenedione (62) 
A solution of 61 (820 mg, 1.45 mmole) in 40 mL of carbon 
tetrachloride was refluxed for 10 hours. The solvent was 
removed jjn vacuo and the residue was flash chromatographed on 
silica gel to provide 450 mg of 61 and 240 mg of 62 (83%) as a 
pale yellow oil which crystallized on standing at 0°C: mp 
120.5-122°C; 300 MHz ^H NMR (CDCl^) 6 0.24 (s, 3 H), 0.30 (s, 
3 H), 0.93 (s, 9 K), 2.49 (dd, 1 H, J = 15.9 and 6.6 Hz), 2.59 
(dd, 1 H, J = 15.9 and 6.6 Hz), 3.59 (m, 1 H), 3.67 (s, 3 H), 
5.09 (dd, 1 H, J = 3 and 0.9 Hz), 6.96 (m, 1 H), 7.75 (m, 2 
H), 7.84 (m, 1 H), 8.14 (m, 1 H); IR (film) 3060, 2950, 2920, 
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2880, 2 8 5 5 ,  2230, 1730, 1670, 1635, 1590, 1435, 1250, 1160, 
1020, 840, 780, 650 cm"^; NMR -4.90, -4.67, 18.08, 25.51, 
33.91, 39.39, 51.76, 53.73, 105.62, 116.10, 127.44, 127.52, 
129.76, 133.86, 134.02, 134.91, 139.26, 141.54, 170.72, 
183.02, 185.24 ppm; MS m/e 437, 422, 380, 353, 320, 294, 264; 
high resolution mass spectrum for Cg^H^^OgNSi requires 
437.16586, determined 437.16551. 
3-(Carbomethoxymethyl)-l-hydroxy-9,10-anthracenedione (64) 
To a solution of 62 (160 mg, 0.366 mmole) in 10 mL of 
benzene at ambient temperature was added triethylamine (0.11 
mL, 0.73 mmole) and the mixture was stirred at ambient 
temperature for 10 hours. The benzene was removed on a rotary 
evaporator and the residue dissolved in 20 mL of THF and 2 mL 
of 2 N HCl added. The mixture was stirred at ambient 
temperature for 16 hours, and poured into 50 mL of water. The 
aqueous phase was extracted with three 20 mL portions of 
methylene chloride, the organic extracts combined, and dried 
over magnesium sulfate. The solvents were removed vacuo 
and the residue filtered under pressure through a plug of 
silica gel eluting with 5:1:1 hexanes/ethyl acetate/methylene 
chloride to provide 92 mg (85%) of 64 as a yellow solid, 
bright yellow needles from hexanes/diethyl ether: mp 
147-148=C (lit. (62) 147°C); 300 MHz NMR (CDCI3) 5 3.74 (s, 
2 H), 3.76 (s, 3 H), 7.21 (d, 1 H, J = 1.5 Hz), 7.70 (d, 1 H, 
J = 1.5 Hz), 7.79 (m, 2 H), 8.25 (m, 2 H), 12.90 (s, 1 H); IR 
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(film) 3700-3200, 3058, 2960, 2920, 2850, 1720, 1670, 1635, 
1580, 1475, 1435, 1350, 1225, 1140, 835, 810, 785 cm~^; 
NMR 41.32, 52.38, 115.11, 120.65, 124.64, 126.81, 127.36, 
129.12, 129.50, 133.46, 134.14, 134.56, 143.62, 162.64, 
170.23, 182.04, 188.10 ppm; MS m/e 296, 253, 237, 209, 181, 
152, 105; high resolution mass spectrum for requires 
296.06848, determined 296.06831. 
5-Acetoxy-2-phenylthio-l,4-naphthoquinone ( ^9 ) 
To a solution of juglone acetate (1.80 g, 8.33 mmole) in 
60 mL of absolute ethanol at ambient temperature was added 
benzenethiol (0.43 mL, 4.17 mmole) in 13 mL of ethanol. After 
stirring at ambient temperature for 30 min, the reaction 
mixture was refluxed for 90 min and cooled to ambient 
temperature. After standing 48 hours long needles of 69 were 
formed. The mixture was filtered and the crystals washed with 
cold 50% ethanol to afford 960 mg (78%) of 6^, orange-brown 
needles from ethanol: mp 186-188°C; 300 MHz NMR (CDClg) 6 
5.97 (s, 1 H), 7.36 (d, 1 H, J = 7.8 Hz), 7.51 (m, 5 H), 7.72 
(t, 1 H, J = 7.8 Hz), 8.11 (d, 1 H, J = 7.8 Hz); IR (CHgClg) 
3050, 1770, 1668, 1645, 1190, 1100, 850 cm"^; MS m/e 324, 282, 
254, 237, 173, 120; high resolution mass spectrum for 
^18^12^4^ requires 324.04564, determined 324.04577. 
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5-Hydroxy-2-phenylthio-l,4-naphthoquinone (7^^) 
To a suspension of 69 (940 mg, 2.90 mmole) in 112 mL of 
absolute ethanol at ambient temperature was added 47 mL of 
concentrated hydrochloric acid (HCl). The suspension was 
refluxed for 15 min whereupon dissolution occurred. The 
reaction mixture was cooled and the resulting precipitate of 
70 filtered. The filtrate was concentrated iji vacuo and the 
precipitate and filtrate were dissolved in methylene chloride. 
The organic phase was washed with 200 mL of water, and the 
aqueous phase reextracted with two 100 mL portions of 
methylene chloride. The organic extracts were combined, 
washed with water, dried over magnesium sulfate, and filtered. 
The solvents were removed iji vacuo to provide 813 mg (99%) of 
70 as a light yellow powder, orange needles from diethyl 
ether: mp 140-142°C with decomposition; 300 MHz NMR 
(CDClg) 5 6.14 (s, 1 H), 7.34 (d, 1 H, J = 7.5 Hz), 7.64 (m, 
H), 7.75 (d, 1 H, J = 7.5 Hz), 12.16 (s, 1 H); IR (CHCI3) 
3500-2700, 3055, 1665, 1630, 1598, 1560, 1450, 1350, 1245, 
1220, 850, 705, 690 cm~^. 
5-Methoxy-2-phenylthio-l, 4-naphthoqu inone ( 7^^) 
To a solution of 70 (790 mg, 2.80 mmole) in 31 mL of 
chloroform was added silver(I) oxide (2.60 g, 11.2 mmole) and 
methyl iodide (1.80 mL, 28.0 mmole) and the reaction mixture 
allowed to stir at ambient temperature in the dark for 16 
hours. The suspension was filtered through Celite and 
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concentrated vacuo. Flash chromatography on silica gel 
elating with 2:1 hexanes/ethyl acetate afforded 750 mg (90%) 
of 71 as a yellow solid-, yellow needles from diethyl ether: 
mp 101-103°C; 300 MHz NMR (CDCI3) S 3.96 (s, 3 H), 6.02 (s, 
1 H), 7.30 (d, 1 H, J = 8.4 Hz), 7.45-7.60 (m, 5 H), 7.63 (t, 
1 H, J = 8.4 Hz), 7.78 (dd, 1 H, J = 7.8 and 1.0 Hz); IR 
(film) 3040, 1662, 1640, 1590, 1465, 1275, 1230, 840 cm"^; 
NMR 56.55, 118.70, 119.71, 127.56, 130.25, 130.34, 130.55, 
133.96, 134.34, 135.69, 153.17, 159.35, 181.56, 182.03 ppm; MS 
m/e 296, 237, 221, 187, 159, 110; high resolution mass 
spectrum for C^^H^gOgS requires 296.05072, determined 
296.05041. 
3-Cyano-5-methoxy-2-phenylthio-1,4-naphthoquinone (72) 
To a solution of sodium cyanide (435 mg, 8.8 mmole) in 40 
mL of 50% (V/V) ethanol was added 71 (740 mg, 2.50 mmole) in 
20 mL of 3:1 dioxane/THF dropwise. After the addition was 
complete, the reaction mixture was stirred vigorously for 30 
min. The reaction mixture was treated with 15 mL of 2 N HCl 
and poured into 60 mL of water. The aqueous solution was 
extracted twice with 15 mL portions of methylene chloride, the 
organic extracts dried, filtered, and concentrated jji vacuo to 
yield an orange-brown solid. This solid was dissolved in 40 
mL of 7:5 acetonitrile/THF and treated with ceric ammonium 
nitrate (3.4 g, 6.20 mmole) in 12 mL of water. After stirring 
6 min at ambient temperature, the solution was diluted with 30 
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mL of methylene chloride and poured into 150 mL of water. The 
layers were separated and the aqueous phase was extracted with 
60 itiL of methylene chloride. The organic extracts were 
combined, washed with water, dried (MgSO^), and filtered. The 
filtrate was concentrated iji vacuo and the residue 
crystallized from ethyl acetate to provide 720 mg (90%) of 72 
as violet needles; mp 227-229°C; 300 MHz NMR (CDCl^) ô 
4.00 (s, 3 H), 7.36 (m, 1 H), 7.49 (m, 3 H), 7.60 (m, 2 H), 
7.75 (m, 2 H); IR (CHgClg) 2980, 1660, 1650, 1588, 1470, 1310, 
1235, 1200, 840, 780 cm"^; NMR 54.96, 109.17, 113.32, 
117.60, 117.70, 128.24, 128.96, 133.29, 134.75, 165.28, 
176.39, 182.53 ppm; MS m/e 321, 292, 236, 212, 166, 134, 76; 
high resolution mass spectrum for requires 
321.04597, determined 321.04584; Anal. Calcd: C, 67.28; H, 
3.42. Found: C, 67.48; H, 3.27. 
( 1 cir 4a S; 8a g)-8a-Cyano-8-methoxy-4a-phenylthio-l-
(trimethylsilyl)oxy-l,4-dihydro-9,lo-anthracenedione {73) 
Following the same procedure as that used to prepare 47, 
72 (587 mg, 1=83 mmole) and 1-trimethylsilyloxy-l,3-butadiene 
(1.35 mL, 7.3 mmole) produced 745 mg (88%) of 73 as an off-
white foamy solid: 300 MHz ^H NMR (CDCl^) S -0.31 (s, 9 H), 
2.55 (m, 1 H, collapses to a dt on irradiation of olefinic 
proton at 6 4.65), 2.98 (dd, 0.5 H, J = 5.1 and 1.6 Hz), 3.04 
(dd, 0.5 H, J = 5.1 and 1.6 Hz), 4.01 (s, 3 H), 4.65 (d, 1 H, 
J = 4.8 Hz), 5.75 (m, 1 H), 5.93 (ddd, 1 H, J = 16, 7.5, and 
117 
2.4 Hz), 7.26 (m, 5 H ) ,  7.38 (m, 1 H), 7.62 (dd, 1 H, J = 8.1 
and 1.5 Hz), 7.67 (d, 1 H, J = 8.1 Hz); IR (film) 3020, 2950, 
1680, 1580, 1290, 1220, 840 cm~^; MS m/e 394, 354, 326, 264, 
142; high resolution mass spectrum for C2gH2gO^SSiN requires 
463.12737; determined 463.12695. 
(4ag,8ag)-8a-Cyano-8-methoxy-l-oxo-4a-phenylthio-
4(2H)-9,10-anthracenedione (74) 
Following the same procedure as that used to prepare 48, 
oxidation of 73 (425 mg, 0.92 mmole) produced 300 mg (84%) of 
74 as white prisms from diethyl ether: mp > 200°C with 
decomposition; 300 MHz ^H NMR (CDCl^) S 2.97 (dt, 1 H, J = 19, 
2.5, and 2.5 Hz), 3.23 (ddd, 1 H, J = 19, 6.1, and 0.9 Hz), 
4.01 (s, 3 H), 6.09 (ddd, 1 H, J = 10.2, 2.7, and 0.9 Hz), 
7.17 (m, 1 H), 7.30 (m, 5 H), 7.45 (m, 1 H), 7.62 (dd, 1 H, J 
= 8.1 and 0.9 Hz), 7.68 (d, 1 H, J = 8.1 Hz); IR (CDCI3) 3010, 
1710, 1690, 1585, 1290 cm"^; NMR 32.11, 56.82, 60.92, 
111.48, 119.01, 120.12, 120.50, 126.17, 126.85, 128.77, 
129.34, 131.05, 133.36, 135.98, 137.53, 152.11, 159.92, 
180.72; 183.31, 186.48 ppm; MS m/e 389, 280, 252, 224, 110; 
high resolution mass spectrum for C22H15O4SN requires 
389.07219; determined 389.07182. 
( 3 g, 4a 3,8a g ) -3-Carboiuethoxymethyl-8a-cyano-8-
methoxy-4a-phenylthio-l- ( tert-butyldimethylsilyl )oxy-
3,4-dihydro-9,10-anthracenedione (75) 
To a solution of 74 (200 mg, 0.514 mmole) in 3 mL of 
acetonitrile at ambient temperature was added l-methoxy-l-
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tert-butyldimethylsilyloxyethylene (215 mg, 1.13 mmole) in 0.5 
itiL of acetonitrile. The reaction mixture was placed in an oil 
bath at 45"C and stirred 16 hours. After this time,, the 
reaction mixture was concentrated vacuo and the residue 
flash chromatographed on silica gel using 5:1 hexanes/ethyl 
acetate as eluant to provide 222 mg (74%) of 75 as a white 
solid; mp 153-155°C; 300 MHz NMR (CDCl^) S -0.05 (s, 3 H), 
0.18 (s, 3 H), 0.82 (s, 9 H), 1.85 (dd, 1 H, J = 13.5 and 9.9 
Hz), 2.30 (dd, 1 H, J = 11.0 and 8.4 Hz), 2.44 (dd, 1 H, J = 
11.0 and 8.4 Hz), 2.50 (dd, J = 13.5 and 6.7 Hz), 2.71 (m, 1 
H), 3.66 (s, 3 H), 3.91 (s, 3 H), 4.89 (d, 1 H, J = 3.0 Hz), 
7.24-7.34 (m, 5 H), 7.4 (m, 1 H), 7.68 (m, 2 H); IR (CHgClg) 
2970, 1730, 1710, 1685, 1240 cm~^; MS m/e 520, 468, 404, 311, 
275; high resolution mass spectrum for CggH^gOgSiSN requires 
502.17197 (M*'-Me), determined 502.1722. 
(3ft,-4ag, 8a3)-3-Carbomethoxymethyl-8a-cyano-8-methoxy-4a-
phenylsulfinyl-l-(tert-butyldimethylsilyl)oxy-
3,4-dihydro-9,10-anthracenedione (76) 
To a solution of 75 (95 mg, 0.165 mmole) in 5 mL of 
methylene chloride at 0" was added meta-chloroperbenzoic acid 
(38 mg, 0.181 mmole). The solution was stirred at 0°-5°C for 
16 hours and the solvents were removed vacuo to provide a 
beige solid. The solid was filtered through a short plug of 
silica gel with 1:1 hexanes/ethyl acetate to afford 95 mg 
(97%) of 76 as a 2.5:1 mixture of diastereomers which were 
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used in the next step without separation: IR (film) 2960, 
1730, 1710, 1670, 1435, 1260, 1205, 1075, 1045 cm"^. 
3-(Carbomethoxymethy1)-l-hydroxy-8-methoxy-
9,10-anthracenedione (78) 
A suspension of the residue in 15 mL of carbon 
tetrachloride was heated at reflux for 16 hours. The solvent 
was removed vacuo and the yellow residue passed through a 
short column of silica gel under pressure eluting with 2:1:1 
hexanes/ethyl acetate/methylene chloride. The solvents were 
removed to afford a light yellow oil which was dissolved in 10 
mL of benzene. To a benzene solution was added triethylamine 
(52 liL) and the solution stirred at ambient temperature for 3 
hours. The solvent was removed iji vacuo and the residue taken 
up in 6 mL of THF. To the THF solution was added 3 mL of a 2 
N HCl and 0.6 mL of methanol and the whole stirred at ambient 
temperature for 15 hours. The majority of the solvents were 
removed jji vacuo and the residue was dissolved in 30 mL of 
chloroform and transferred to a separatory funnel. The 
organic phase was washed twice with water and dried over 
magnesium sulfate. Flash chromatography on silica gel eluting 
with 2.5:1:1 hexanes/ethyl acetate/chloroform afforded 28 mg 
(52% overall yield from 76) of 78 as a yellow solid, yellow 
needles from methylene chloride/hexanes: sublimes at 165®C; 
300 MHz NMR (CDCl^) S 3.72 (s, 2 H), 3.73 (s, 3 H), 4.08 
(s, 3 H), 7.22 (d, 1 H, J = 1.5 Hz), 7.37 (d, 1 H, J = 8.4 
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Hz), 7.68 (d, 1 H, J = 1.5 Hz), 7.76 (t, 1 H, J = 8.4 Hz), 
7.96 (d, 1 H, J = 8.4 Hz), 12.92 (s, 1 H); IR (CDCI3) 3680, 
1635, 1470, 1380, 1095 cm"^; MS m/e 326, 280, 249, 221; high 
resolution mass spectrum for C^gH^jOg requires 326.07904, 
determined 326.0787. 
5-Methoxy-3-phenylthio-l,4-naphthoquinone (80) 
To a solution of 79 (540 mg, 1.91 mmole) in 25 mL of 
chloroform was added silver(I) oxide (1.76 g, 7.6 mmole) and 
methyl iodide (1.19 mL, 19.1 mmole) and the mixture stirred at 
ambient temperature in the dark for 24 hours. The reaction 
mixture was filtered through Celite and concentrated iji vacuo 
to leave a yellow solid which was flash chromatographed on 
silica gel eluting with 2:1 hexanes/ethyl acetate to afford 
462 mg (82%) of 80 as a light yellow solid, yellow needles 
from methylene chloride/hexanes: mp 185-188°C; 300 MHz ^H NMR 
(CDCl,) 6 4.02 (s, 3 a), 6.03 (s, 1 H), 7.26 (m, 1 H), 
7.45-7.60 (m, 5 H), 7.65 (m, 2 H); IR (CDCl^) 3060, 3010, 
2940, 2840, 1665, 1658, 1585, 1290, 1270, 830 cm"^. 
(la,4as,Sag)-8-Methoxy-l-(trimethylsilyl)oxy-8a-
thiophenyl-l,4-dihydro-9,10-anthracenedione (81) 
To a solution of 80 (49 mg, 0.155 mmole) in 8 mL of 
toluene was added 1-trimethylsilyloxy-l,3-butadiene (0.15 mL, 
0.825 mmole) and the reaction mixture heated at reflux for 56 
hours. The reaction product was concentrated ûi vacuo and 
rapidly flash chromatographed on silica gel to provide 54 mg 
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(74%) of 81 as an unstable pale yellow oil: 300 MHz NMR 
(CDCI3) 6 -0.26 (s, 9 H), 2.45 (m, 1 H), 3.09 (m, 1 H), 3.97 
(s, 3 H), 4.27 (d, 1 H, J = 5.0 Hz), 5.78 (iti, 1 H), 5.98 (m, 1 
H), 7.15-7.30 (m, 6 H), 7.45-7.65 (m, 2 H). 
(4a g,8a 3)-8-Methoxy-l-oxo-8a-thiopheny1-4(2H)-
9,10-anthracenedione (82) 
To a solution of 81 (30 mg, 0.068 ramole) in 5 mL of 
acetone was added Jones' reagent (8 drops of a 7 N solution) 
at 0°C. The reaction mixture was stirred 8 minutes at 0° and 
treated with 0.5 mL of isopropanol and 20 mL. of diethyl ether 
and filtered through Celite. The filtrate was concentrated in 
vacuo below 30°C to afford 82 as a yellow unstable oil: 300 
MHz NMR (CDCl^) ô 2.92 (m, 2 H), 3.52 (t, 1 H, J = 6.3 Hz), 
3.76 (s, 3 H), 6.14 (m, 1 H), 6.93 (apparent dt, 1 H, J = 9.9 
and 4.2 Hz), 7.15-7.40 (m, 4 H), 7.45-7.55 (m, 2 H), 7.60-7.70 
(m, 2 H). 
(1 a,4a g,8a g)-8a-Acetyl-l-(trimethylsilyl)oxy-
1,4-dihydro-9,10-anthracenedione (85) 
To a suspension of 2-acetyl-l,4-naphthoquinone (600 mg, 
3.0 mmole) in 15 mL of benzene at 10°C was added 1-trimethyl-
silyloxy-1,3-butadiene (1.03 mL, 5.9 mmole). The reaction 
mixture was slowly warmed to ambient temperature and stirred 
at ambient temperature for 16 hours. The reaction product was 
concentrated vacuo and the residue filtered quickly through 
a short plug of silica gel to afford 970 mg (94%) of 85 
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contaminated with approximately 8% of the "exo" Diels-Alder 
adduct, beige prisms from diethyl ether/hexanes: mp 
158-160°C; 300 MHz NMR (CDCI3) 5 -0.32 (s, 9 H), 2.00 (dd, 
1 H, J = 18.1 and 6.9 Hz), 2.40 (s, 3 H), 3.12 (dd, 1 H, J = 
18.0 and 1.5 Hz), 3.87 (d, 1 H, J = 6.9 Hz), 4.80 (m, 1 H), 
5.88 (m, 2 H), 7.60-7.80 (m, 2 H), 7.90-8.05 (m, 2 H); IR 
(film) 3060, 3025, 2950, 1720, 1705, 1670, 1595, 1250, 730 
— 1  
cm 
(4ag,8a3)-8a-Acetyl-l-oxo-4(2H)-9,10-anthracenedione (86) 
To a solution of 85 (166 mg, 0.48 mmole) in 10 mL of 
acetone at 0°C was added Jones' reagent (55 drops of a 7 N 
solution). After stirring 15 minutes at 0°C, the reaction 
mixture was treated with 1.0 mL of isopropanol and 30 mL of 
diethyl ether and filtered through Celite. The filtrate was 
concentrated vacuo, diluted with 10 mL of 1:1 diethyl 
ether/methylene chloride and filtered through a plug of glass 
wool. The filtrate was evaporated to dryness to afford 92 mg 
(71%) of 86 as a beige powder: mp 130-132°C; 300 MHz ^H NMR 
(CDCI3) 5 2.38 (s, 3 H), 2.57 (m, 1 H), 3.27 (m, 1 H), 4.25 
(t, 1 H, J = 2.0 Hz), 6.11 (bd, 1 H, J = 10.2 Hz), 7.09 (m, 1 
H), 7.77 (m, 2 H), 8.05 (m, 2 H); IR (film) 1720, 1692, 1670, 
1270, 1250, 730 cm~^. 
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2-Methyl-3-phenylsulfinyl-l,4-naphthoquinone (89) 
To a solution of 88 (5.0 g, 17.8 mmole) in 120 mL of 
methylene chloride at -5°C was added meta-chloroperbenzoic 
acid (3.74 g, 21.7 mmole) and the reaction mixture slowly 
warmed to ambient temperature. After stirring three hours at 
ambient temperature, the reaction mixture was cooled to 0®C 
and isobutylene gas passed in for 30 min. The reaction 
mixture was poured into 100 mL of water and carefully basified 
with saturated aqueous sodium bicarbonate solution. The 
layers were separated and the organic phase washed twice with 
100 mL portions of water and dried. The drying agent was 
filtered and the filtrate concentrated to ca. 50 mL jji vacuo. 
To the concentrated solution was added 200 mL of hexanes and 
the solution stood overnight. The resulting crystals were 
filtered to afford 4.16 g (79%) of 89; mp 126-129°C; 300 MHz 
NMR (CDCI3) 5 2.52 (s, 3 H), 7.45-7.60 (m, 3 H), 7.72 (m, 2 
H), 7.84 (m, 2 H), 8.01 (m, 2 H); IR (CHCI3) 3005, 1665, 1280, 
1045, 705 cm"l; NMR 9.24, 124.69, 126.90, 126.66, 129.08, 
130.67, 130.94, 131.41, 133.98, 134.06, 142.75, 147.95, 
149.34, 181.89, 183.31 ppm; MS m/e 296, 280, 247, 172, 125; 
high resolution mass spectrum for requires 
296.05072; determined 296.05033. 
l-Hydroxy-4a-methyl-4(2H)-9,10-anthracenedione (91) 
In a dry 30 mL sealable tube was placed 89 (510 mg, 1.72 
mmole), 1-trimethylsilyloxy-l,3-butadiene (0.75 mL, 4.3 
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mmole), and trimethylphosphite (0.40 mL, 3.45 mmole) and 
diluted with 10 mL of carbon tetrachloride. The solution was 
cooled to -78®C and sealed under high vacuum. The tube was 
placed in an oil bath at 60®C for 1 h, then heated at 130°C 
for 12 hours. The tube was cooled to -78°C, opened, and 
concentrated ^  vacuo. The light yellow semi-solid residue 
was flash chromatographed on silica gel eluting with 4:1 
hexanes/ethyl acetate to afford 154 mg (46%) of 91 as a light 
yellow oil: 300 MHz NMR (CDCl^) 6 1.36 (s, 3 H), 2.65 
(apparent dt, 1 H, J = 19.2 and 2.4 Hz), 2.80 (dd, 1 H, J = 
19.2 and 6.3 Hz), 6.28 (dd, 1 H, J = 10.2 and 2.7 Hz), 6.94 
(m, 1 H), 7.65 (m, 1 H), 7.78 (m, 1 H), 8.06 (d, 1 H, J = 7.5 
Hz), 8.12 (d, 1 H, J = 7.5 Hz), 15.58 (s, 1 H); IR (film) 
3080, 2980, 2940, 1695, 1640, 1600, 1570, 1460, 1300, 1150, 
910, 740 cm"l; NMR 27.52, 32.69, 45.20, 109.76, 125.07, 
127.01, 127.88, 132.10, 133.12, 134.23, 136.39, 145.84, 
167.11, 186.76, 200.05 ppm; MS m/e 240, 225, 142, 125. 
8-Methoxy-2-phenylthio-4-(2-propenyl)-1,4-naphthoquinone (95 ) 
To a solution of 94 (1.00 g, 4.38 mmole) in 50 mL of 
methylene chloride at -20®C was added benzenethiol (0.90 mL, 
8.76 mmole) followed by para-toluenesulfonic acid monohydrate 
(5 mg, 0.026 mmole). The reaction mixture was slowly warmed 
to ambient temperature and was stirred 3.5 h at ambient 
temperature. The reaction product was concentrated vacuo, 
dissolved in 25 mL of acetonitrile, and treated with 70% 
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aqueous ferric trichloride (10 mL). After stirring 2 h at 
ambient temperature, the crude reaction product was poured 
into 100 mL of water, extracted twice with 50 mL portions of 
methylene chloride. The organic extracts were combined, 
washed with water, and dried over magnesium sulfate, and 
filtered. The solvents were removed vacuo and the residue 
crystallized from hexanes/ethyl acetate to afford 1.35 g (93%) 
of 95 as red-orange needles: mp 112-113°C; 300 MHz NMR 
(CDCI3) 5 3.65 (bd, 2 H, J = 6.3 Hz), 3.85 (s, 3 H), 5.05-5.25 
(m, 2 H), 5.85 (m, 1 H), 7.15-7.30 (m, 4 H), 7.36 (m, 2 H), 
7.62 (t, 1 H, J = 8.1 Hz), 7.73 (dd, 1 H, J = 8.1 and 0.9 Hz); 
IR (CHCI3) 3005, 1662, 1650, 1590, 1275, 1240 cm"^; NMR 
33.19, 56.52, 117.34, 117.80, 119.30, 121.03, 127.14, 129.08, 
130.62, 133.29, 134.39, 134.55, 147.75, 148.07, 159.59, 
178.94, 182.47 ppm; MS m/e 336, 288, 259, 110; high resolution 
mass spectrum for ^20^16^3^ requires 336.08202; determined 
336.08213. 
8-Methoxy-2-phenylsulf inyl-4-(2-propenyl)-
1,4-naphthoquinone (96) 
Following the procedure for the preparation of 89, 95 (1.0 
g, 2.97 mmole) afforded 0.99 g (94%) of 96 as a dark red oil; 
300 MHz ~H NMR (CDCl^) Ô 3.94 (s, 3 H), 3.90-4.15 (m, 2 H), 
4.95-5.15 (m, 2 H), 5.80 (m, 1 H), 7.28 (dd, 1 H, J = 8.1 and 
2.1 Hz), 7.35-7.55 (m, 3 H), 7.60-7.70 (m, 2 H), 7.87 (m, 2 
H); NMR 26.29, 56.54, 118.10, 118.21, 118.69, 119.67, 
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125.29, 129.24, 130.75, 133.75, 133.80, 135.55, 143.49, 
148.17, 150.38, 159.65, 181.85, 183.52 ppm. 
1,10-Dihydroxy-9-ni8thoxy-5- ( 2-propenyl ) oxyanthracene ( 98 ) 
A solution of 96 (100 mg, 0.284 mmole) and 1-trimethyl-
silyloxy-1,3-butadiene (0.20 mL, 1.13 mmole) in 10 mL of 
carbon tetrachloride was heated at reflux for 20 h. The 
reaction mixture was cooled, concentrated ijn vacuo, and the 
residue flash chromatographed on silica gel eluting with 2:1 
hexanes/ethyl acetate to afford 51 mg (60%) of 98 as a light 
yellow oil, blue-green fluorescence in dilute solution: 300 
MHz NMR (CDCI3) 6 4.05 (s, 3 H), 4.78 (m, 2 H), 5.79 (m, 1 
H), 6.84 (d, 1 H, J = 7.5 Hz), 7.24 (m, 1 H), 7.30-7.50 (m, 3 
H), 7.65-7.80 (m, 3 H), 9.85 (s, 1 H); IR (film) 3500-3200, 
3060, 2940, 2840, 1615, 1600, 1445, 1400, 1265, 1090, 1040, 
910, 805, 690, 670 cm"*; NMR 56.36, 64.96, 106.08, 114.14, 
116.81, 118.53, 120.94, 121.34, 124.45, 127.99, 128.79, 
129.61, 143.02, 145.16, 149.17, 156.59 ppm. 
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PART III: SYNTHETIC APPROACHES TO THE 
ANTIBIOTICS: TOTAL SYNTHESIS OF 
DEOXYFRENOLICIN 
PYRANONAPHTHOQUINONE 
NANAOMYCIN A AND 
133 
INTRODUCTION 
Nanaomycin A and deoxyfrenolicin are members of the 
pyranonaphthoquinone class of antibiotics. Due to their 
useful biological activity and interesting structures, this 
class of antibiotics has received considerable attention from 
the synthetic viewpoint. 
This manuscript will discuss the details of a synthetic 
program which resulted in a general synthesis of the 
moderately complex pyranonaphthoquinones nanaomycin A and 
deoxyfrenolicin. 
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HISTORICAL 
The pyranonaphthoquinone antibiotics are a growing class 
of compounds isolated from various species of Streptomyces. 
All contain the 2,3-fused pyran-naphthoquinone ring system in 
addition to alkyl and acetic acid residues. The general 
structure and numbering scheme for the pyranonaphthoquinone 
antibiotics is shown below. 
OH 
8 
7 
O 
Although nearly all biologically active members of this 
class contain alkyl and acetic acid groups in a trans 
relationship on the pyran ring, a wide variety of additional 
functionality may also be present. Spiroketal, lactone, 
carbohydrate, and carbocyclic units are commonly appended to 
the basic structural unit shown above. For this reason, 
information pertaining to each subclass of antibiotics will be 
presented separately. 
The nanaomycin (NNM) subclass is the largest of the 
pyranonaphthoquinone antibiotics. Nanaomycins A 1 and B 8 
were isolated in 1974 from Streptomyces rosa variant notoensis 
strain 08-3966 (1). The two antibiotics were found to inhibit 
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a variety of Gram-positive bacteria, mycoplasmas, and fungi at 
low concentrations. Additionally, the toxicities (LD^q) of 
the two new antibiotics were low in mice (lb). The structures 
of nanaomycins A and B as well as the other known nanaomycins 
are shown below. 
1: R = COgH, nanaomycin A 
2: R 
3 ^ 
4: R 
CONHg, nanaomycin C 
COgCHg, nanaomycin aA 
CHgOH, nanaomycin gA 
R 
9: R 
COgH, nanaomycin B 
COgCHg, nanaomycin aB 
0 
^5^ R = CO^H, nanaomycin E 
,6^ R = COgCHg, nanaomycin aE 
,7^ R = CHgOH, nanaomycin BE 
The probable biosynthetic p; 
elucidated through the use of r; 
0 0^ 
0 
10: (-)-nanaomycin D 
11: {+)-nanaomycin D 
^ ' = kalafungin 
thway for nanaomycin was 
diolabeled acetate (2). As in 
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other quinone containing antibiotics, the nanaoraycins are 
synthesized from acetate via a polyketide intermediate (Scheme 
The isolation and structure elucidation of nanaomycins C 
2 (3), D 10 (4), and E 5 (5) soon followed. All three members 
fsj /vA* 
were isolated from the same Streptomyces species as the 
nanaomycins A and B. Indeed, nanaomycins A-E have been shown 
to interconvert by either microbial or chemical transforma­
tions during their biosynthesis (6). Utilizing cerulenin, a 
specific inhibitor of fatty acid and polyketide biosynthesis, 
the pathway NNM-D NNM-A NNM-E NNM-B was proposed (Scheme 
II). The formation of NNM-C was only observed when an excess 
amount of NNM-A was present in the culture medium, therefore, 
its participation in the bioconversion sequence is 
questionable. 
I) 
Scheme I. 
tCOgENZ 0 
* - denotes the position of a label 
Due to the novel biochemical transformations implied in 
the above scheme, detailed studies relating to the mechanism 
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Scheme II, 
[polyketide-enzyme] 
NNM-D 
NNM-C 
NNM-A NNM-E 
NNM-B 
<— : microbial transformation 
^ : chemical transformation 
of each transformation were warranted. Omura et al. 
demonstrated that the conversion of NNM-A to NNM-B is a two-
step process, and confirmed NNM-E as the intermediate (figure 
1) (7). Additionally, the first biosynthetic step in the 
nanaomycin interconversion was shown to involve reduction of 
NNM-D to a hydroquinone, cleavage to an enone intermediate, 
and tautomerization to produce NNM-A (Figure 2) (8). 
h"*" + o HjO + 
CO_H 
NNM-A 
2 
NADPH NADP" 
N N M - A ^  
monooxygenase 
CO-H 
NADPH NADP^ 
V / . 
NNM-B 
synthetase 
CO_H 
NNM-E NNM-B 
Figure 1. Bioconversion of NNM-A to NNM-B. 
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1 
H 
NADH NAD"* 
V / 
QH OH 
NNM-D 
reductase «.fW 
o 
CO_H CO.H 
Figure 2. Bioconversion of NNM-D to NNM-A. 
Kalafungin 11, the enantiomer of nanaomycin D, was 
isolated in 1958 by workers at the Upjohn Company from 
Streptomyces tanashiensis strain kala (UC-5063) (9). The 
absolute configuration of kalafungin was determined by 
comparison of its optical rotary dispersion curve with those 
of the known compounds elutherin 12a and isoelutherin 12b 
( 1 0 ) .  
The isolation and biological properties of five other 
nanaomycin related antibiotics were reported in 1983. 
Nanaomycins aA 3, BA 4,aB 9, aE S, and g E 7 were isolated from 
«N/ /N/ /S/ rs  ^ /V 
139 
QH 
0 R 
12a; Rt = CH., R_ = H 
12b: Rg^ = H, Rg = CH^ 
Streptomyces strain OM-173 (11). From this study and the 
findings of others (3, 9), it is clear that modification of 
the substituent at C-12 to anything other than an acid or 
lactone lowers the antimicrobial activity considerably. 
However, removal of oxygenation at C-9 does not seem to affect 
the activity at all (12). Interestingly, the C-9 acetate of 
nanaomycin A has strong anti-bacterial activity, while a 
similar methyl ether has extremely low activity (1). 
A subclass of pyranonaphthoquinone antibiotics that are 
C-1 n-propyl analogs of the nanaomycins also exists. 
Frenolicin 13 (13, 14), deoxyfrenolicin 14 (14, 15), and 
frenolicin B 15 (15) have been isolated and their structures 
determined. The frenolicin subclass are similarly active 
against bacteria, pathogenic fungi- and mycoplasmas. However, 
they differ from the nanaomycins in absolute configuration at 
the C-1 and C-3 positions. Thus, the frenolicins have 
configurations IR and 3R and the nanaomycins have 
configurations IS and 3S. Notably, frenolicin B is 
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particularly effective against Eiitieria tenella, a pathogenic 
fungus that causes serious problems in the poultry industry 
( 1 6 )  .  
Lactoquinomycin 16 (17) and lactoquinomycin B 17 (18) are 
pyranonaphthoquinone antibiotics produced from Streptomyces 
tanashiensis strain IM8442T. Isolated in 1985 and 1986, these 
compounds are similar to the frenolicins in absolute 
configuration, but have a methyl group at C-1 as in the 
nanaomycin series. In addition to their good anti-bacterial 
activity, they are excellent cytotoxins, showing strong 
inhibitory activity vitro against K562 human myeloid 
leukemia, L1210 and P388 murine leukemia, and L5178 murine 
lymphoblastoma in culture (19). High in vivo activity against 
Ehrlich ascites carcinoma in mice was also observed (18). 
15 0 
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OH 0 
17 0 
HO R 
More importantly, these compounds exhibit low acute toxicity 
in mice. Although additional testing is necessary, the 
lactoquinomycins appear promising as antitumor agents. 
More complex members of the pyranonaphthoquinone family 
also exist. Griseusins A 18 and B 19 were isolated from 
Streptomyces qriseusis strain K-63 by Tsuji and coworkers in 
1975 (20). Their gross structures and absolute stereo­
chemistry were later determined by spectroscopic comparison 
(21) with the known compound actinorhodinindazolquinone (22). 
However, by chemical synthesis the originally assigned 
absolute stereochemistry was found to be antipodal (23). 
Granaticin 20 can be isolated from Streptomyces olivaceus 
or Streptomyces limogenes (24, 25). Its structure was 
determined by a variety of spectroscopic methods including 
x-ray crystallographic analysis (26) and is shown above. 
Granaticin is highly active against Gram-positive bacteria and 
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QH 
OAc 
0 
OAc 
18 
pH 
OH 
Me 
OH 
20  O 
shows significant vivo antitumor activity against P-388 
lymphocytic leukemia in mice (25). 
Although the actual mode of action for the pyranonaphtho-
quinone antibiotics is presently unknown, Moore has postulated 
a "bio-reductive alkylation mechanism" (27). The proposed 
mechanism is illustrated below with kalafungin (scheme III). 
Reduction, followed by equilibration to a quinone methide may 
occur» This is similar to the bioconversion of NNM-D to NNM-A 
(figure 2). Nucleophilic trapping of the quinone methide by 
an enzyme or another biological nucleophile is a possible 
pathway for antimicrobial activity. Another mechanism 
involving the formation of semiquinone radicals with 
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Scheme III. 
1 
COgH 
OH O 
+ 2 Nu 
O COgH 
subsequent production of the superoxide radical has been 
suggested (28). However, the recent isolation of a 
N-acetyleysteinyl conjugate 21 from granaticin producing 
strains of Streptomyces violaceoruber supports the 
"bio-reductive alkylation" mechanism (29). 
Due to their useful antimicrobial and antitumor 
properties, the pyranonaphthoquinones have received 
considerable attention from the synthetic standpoint. To 
date, total syntheses of the elutherins, the nanaomycins. 
p. 
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kalafungin, the frenolicins, and the griseusins have been 
reported. Although the elutherins do not show significant 
biological activity, their total synthesis has been of 
importance for the testing of general synthetic strategies, 
and for structural comparison with the more complex pyrano-
naphthoquinones. The total syntheses of the elutherins 
(30-33) will not be covered in this historical; the interested 
reader is encouraged to refer to the references provided for 
an entry into the literature. 
The successful total syntheses of the pyranonaphtho-
quinones have involved a variety of interesting strategies. 
Formation of the naphthoquinone-pyran ring system has been 
accomplished by the following methods; reductive alkylation 
of a naphthoquinone, acid or base catalyzed etherification, 
organometallic processes, and addition of nucleophiles to 
activated naphthoquinones. However, in almost every case, 
poor stereoselectivity has been realized in the placement of 
the alkyl and acetic acid residues trans on the pyran ring. 
To solve this problem,- isomerization of a cis isomer to the 
natural trans configuration has been employed. Fortunately, 
this is a favorable equilibrium and a preponderance of the 
natural isomer is easily obtained. 
St. Pyrek and coworkers were the first to utilize 
reductive hydroxyalkylation in their synthesis of 
deoxynanaomycin methyl ester (34). In the key step, s-hydroxy 
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ester 22 was reduced and alkylated situ with acetaldehyde. 
After aerial oxidation, the cis-pyran 23 was obtained in 15% 
yield. 
Zn/ HCl 
0 
OH 
2 2  
The probable mechanism of the reductive alkylation was 
established by Li and Ellison in their synthesis of nanaomycin 
A (35). Compound 24, which was prepared in a multistep 
sequence, underwent acetaldehyde addition to provide 
exclusively the cis-pyran 25 in 51% overall yield after 
silver(I) oxide treatment. Operating at lower reaction 
temperatures and omission of the oxidation step led to the 
isolation of acetal 26. Thus, intramolecular delivery of the 
acetaldehyde unit rather than direct hydroxyethylation onto 
the aromatic system is indicated. The cis-pyran 25 was 
converted to nanaomycin A by methyl ether cleavage, acid 
catalyzed isomerization, and ester hydrolysis. 
Similar methodology for pyran ring construction was 
employed by Kometani and coworkers in 1983 (36). Oxidation of 
27 followed by heating induced sulfoxide elimination and 
Claisen rearrangement to produce 28. Treatment of 28 with 
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CO„Et 
1. Zn/ HCl 
2 .  MeCHO/H"'"/A 
3. AggO 
» 
oust 
CO„Et 
CO_H 
base and oxidative cleavage of naphthofuran 29 afforded 30 in 
45% overall yield. Compound 30 was transformed into 
1 .  
2. â, 
SePh 
CO.Me 
Ag 0 
30 0 COgMe 
CO.Me 
28 OH 
K_CO 
Ca^Me 
147 
nanaomycin A with reactions similar to those seen in the Li 
and Ellison synthesis. 
The pyran moiety of nanaomycin A has also been constructed 
via intramolecular alkoxide Michael addition (37), Benzindene 
31 underwent Lemieux-Johnson oxidation (periodate-osmium 
tetroxide) and Wittig olefination to yield 32. Reduction of 
32 with sodium borohydride generated an alkoxide which 
underwent conjugate addition to provide 33 as a 2:1 mixture of 
pyrans with the trans isomer predominating. A similar route 
to frenolicin was also reported by Ichihara and coworkers 
(38). 
iMe )Me 
OMe 31 
iMe 
CO^Me 
OMe 32 
NaBK 
-"4 
•Me iMe 
OMe 
OMe OMe 
OMe COgMe 33 
The complex carbon framework of (+)-griseusin A was 
established by a bisketalization reaction (39). This elegant 
synthesis, performed by Kometani and coworkers, began with 
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bromonaphthalene 34. Coupling of the lithio derivative of 
34 with the L-dideoxygulose 35 (40) and oxidation afforded 36 fWfW fWfW 
in 33% overall yield. Treatment of 36 with M-bromoacetaniide 
(NBA) produced an epimeric mixture of bromohydrins. Exposure 
of the bromohydrins to protic acid resulted in selective 
removal of the acetonide protecting group of the sugar moiety 
and bisketalization yielding 37. After conversion to the 
nitrile, hydrolysis to the corresponding acid occurred with 
quantitative epimerization at C-3 (41) affording 39. 
Conversion of 39 to (+)-griseusin A was easily accomplished in 
four steps. 
Br 1. t-BuLi 
3. PCC 
X Î 
' 9 —^OH 
N 
OH 
CO_H 
1. NBA 
2. H 
(+)-18 
X = CN 
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Organometallic reactions have played an important role in the 
preparation of pyranonaphthoquinone antibiotics. In 1982, 
Semmelhack and coworkers demonstrated the utility of acylate-
nickel complexes for the establishment of the isochromane 
skeleton in nanaomycin A and deoxyfrenolicin (42). 
Accordingly, the nickel complexes underwent conjugate addition 
to the juglone monoketal derivative 40 followed by enolate 
trapping to provide 41 and 42 in high yield. Hydrolysis, to 
the hydroquinone, reduction, and reoxidation yielded quinones 
43 and 44. Reaction of the hydroxyquinones under 
alkoxycarbonylation conditions (43) provided pyrans 45 and 46. 
OMe 0 
/~A 
0 -
1. [RCNi(C0)2]Li 
2 .  
41 R = n-Pr 
42 R = Me 
4^ R = n-Pr 
44 R = Me 
PdClg(MeCN)2 
CuCl, 
CO/ MeOH COgMe 
45 R = n-Pr 
R = Me 
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A strategy for the synthesis of deoxyfrenolicin based on 
intramolecular chromium-carbene cycloaddition was also 
reported by Semmelhack and coworkers (44). Cyclization of 47 
occurred under mild conditions to provide the n^-arylchromium 
tricarbonyl complex 48. Décomplexâtion with concomitant 
oxidation occurred upon treatment with DDQ providing quinone 
49. In a five step sequence involving the alkoxycarbonylation 
reaction, 49 was converted to deoxyfrenolicin. 
J \ 
OMe 0 
47 
iMe 
48 
(CO)Cr 
.OH OMe 0 
14 49 
Another intramolecular cycloaddition route involving 
organometallic intermediates was reported by South and 
Liebeskind (45); although in this instance phthaloyl-cobalt 
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complexes were employed. Complex 50, which was prepared from 
the corresponding benzocyclobutenedione, and tris(triphenyl-
phosphine)cobalt chloride, does not react upon warming as in 
the chromium-carbene route. However, treatment with 
silver(I) tetrafluoroborate opens a coordination site on 
cobalt and results in an overall insertion-reductive 
elimination to afford 51 in 47% yield. Conversion of 51 to 
nanaomycin A was accomplished in three steps involving 
reductive pyran formation and hydrolysis of the nitrile. 
L = PPhg, R = SiMegt-Bu 
The addition of enolate equivalents to acylnaphthoquinones 
constitutes a particularly facile route to the pyranonaphtho-
quinone antibiotics. Naruta and coworkers have shown that 
2-silylbutenoate esters react only from the gamma position 
(46). Exploiting this selectivity, reaction of silylbutenoate 
52 with the activated naphthoquinone 53 in the presence of 
tin tetrachloride produced 54. After aromatization, phenol 
CN 
50 51 
NC-^ 
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protection, and reduction, base promoted alkoxide Michael 
addition afforded 56 as a 1:1 mixture of cis and trans pyrans 
52 
SlMe^Ph 
iMe 
SnCl 
•CO-Me 
O 54 
OMe 
0 53 
iMe OH >Me 
NaOMe OH 
OR OR 56 55 
R = SiMegt-Bu 
In 1978, Kraus and Roth reported a direct synthesis of 
racemic 9-deoxykalafungin utilizing a 2-alkoxyfuran as a 
masked butenolide anion (48), Later, racemic kalafungin 
itself was prepared by this route. Thus, 53 underwent Michael 
addition without the aid of catalysis to produce naphthalene 
57 after aromatization and phenolic methylation. Reduction 
followed by hydrolysis afforded butenolide 58. Ring closure 
to the pyrano-y-lactoms, oxidation, and phenolic demethylation 
yielded kalafungin in excellent overall yield 
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53 
^T^-O-t-Bu 
2. MSgSO^, KgCOg 
)Me QMe 
OMe 0 
1. LiAlH, 
2. CFgCOgH 
0-t-Bu 
Me OMe 1. DBU 
2. AgnO, H 
' W 
(49). It is noteworthy that during the oxidative 
demethylation step, the initially produced epimeric mixture of 
pyranolactones were completely equilibrated to the natural 
configuration. 
In summary, the pyranonaphthoquinones are a valued group 
of antimicrobial agents. Their unique structure and 
biological activity has prompted considerable synthetic 
attention. Many elegant syntheses of these compounds have 
been achieved; however, the problem of initial stereocontrol 
in pyran ring construction remains largely unsolved. Although 
the approaches involving organometallic intermediates are 
highly convergent, the synthetic routes involving nucleophilic 
additions to activated naphthoquinones are the most direct and 
practical. 
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RESULTS AND DISCUSSION 
Our synthetic approach to the pyranonaphthoquinone 
antibiotics stemmed from the earlier observation (Part II) 
that blocked anthraquinone tautomers such as 59 and 60 
underwent facile retro-aldol and retro-Claisen reactions upon 
treatment with aqueous base. 
We anticipated that the semi-blocked anthraquinone tautomer 
61 would behave similarly (Scheme IV). If this were the case, 
then cleavage with methoxide anion would provide 62. 
Reduction and intramolecular alkoxide addition would afford 
63, an excellent precurser to nanaomycins A and D. 
Scheine IV. 
OTMS 
60 
6^  ^
OMe OH 0 
0 
MeO 
6 2  
H 
OH 
63 
COgMe 
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To test this approach, diketone 64 was treated with sodium 
methoxide. Upon workup, however, only anthraquinone 65 
resulting from undesired cleavage of the acetyl group and 
aerial oxidation was isolated. A variety of other conditions 
0 
NaOMe 
0 
M ^ 
including acidic catalysis were attempted, unfortunately none 
of the desired ring-cleavage product could be detected. 
In view of these results, a method to site-specifically 
generate the requisite tetrahedral intermediate was needed. A 
mixed ketal such as 66 appeared promising. Following its 
generation via a Diels-Alder reaction, fluoride induced 
cleavage of 65 would produce the desired transformation 
(Scheme V). 
Reaction of acetylnaphthoquinone 67 (50) with 
1-ethoxy-l-tert-butyldimethylsilyloxybutadiene 68a (51) was 
rapid. Due to the known instability of mixed ketals (52,53), 
the presumed Diels-Alder adduct was treated with 
tetrabutylammonium fluoride. Surprisingly, upon workup, 
dihydronaphthofuran 69 was isolated in good yield. 
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Scheme V. 
OSiR. 
OR' 
QR'^OSiR-
OR'.O 
Apparently, the cis crotonate subunit that was liberated by 
the retro-Claisen reaction rapidly reacted with the 
neighboring phenol to produce 69. This cyclization had 
previously been observed by Naruta and coworkers (47) in their 
synthetic studies toward the pyranonaphthoquinones. To avoid 
this "undesirable" cyclization, they protected the phenol. 
OH O 
67 
f/ ^6 8 a 
1. f' y^^OSiMSgR 
OEt ^ 
2. (BuX^N+F" 
R = t-Bu CO^Et 
Although other workers viewed the formation of 
dihydronaphthofuran products as undesirable, we envisioned the 
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Diels-Alder/retro-Claisen (DARC) sequence as a synthetically 
useful transformation. Indeed, a new approach to the 
pyranonaphthoquinone antibiotics was formulated based on this 
new reaction sequence. Our strategy is outlined in Scheme VI, 
Scheme VI. 
OMe OH 
DARC Sequence 
CO.R' CO.R' 
Anticipating that the new Diels-Alder/retro-Claisen (DARC) 
sequence would be general, an alkoxy substituted acylnaphtho-
quinone such as 70 would produce 71, Oxidative dealkylation 
and subsequent attack of the liberated 3-hydroxyl group at the 
C-1 carbonyl was expected to afford hemiketal 72. Finally, 
selective reduction of the hemiketal would yield 73. 
The known 8-methoxy-2-acetyl-l,4-naphthoquinone 76 (54) 
was prepared employing improved cyanophthalide annulation 
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conditions (49). Thus, treatment of cyanophthalide 74 (55) 
with methyl vinyl ketone and potassium tert-butoxide in 
dimethylsulfoxide produced multigram quantities of 
hydroquinone 75 in 65-70% yield. Oxidation to quinone 76 was 
effected in nearly quantitative yield with eerie ammonium 
nitrate (CAN) (56). Performing the DARC sequence with 76 and 
iMe iMe 
CAN 
t-BuOK 
DMSO 
MeCN (aq\ 
OH 
75 76 
iMe 
CN 
74 
diene 68 generated 77 in high yield. Naphthoquinone 76 is 
somewhat unstable and in practice it was submitted, without 
additional purification, to the DARC sequence to provide 77 in 
76-78% yield from 75. 
•OSiMe«t-Bu 
OEt 
ÇMe 
76 
77 
CuEt 
Oxidative dealkylation (57) of 77 occurred upon treatment 
with CAN in aqueous acetonitrile at ambient temperature. The 
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product, produced in 91% yield as a single diastereomer, was 
assigned structure 78 based on its spectroscopic data. The 
300 MHz NMR spectrum of 78 showed a geminally coupled 
iMe 
•Me 
O CO^Et 
78 
doublet of doublets (J = 18.6 and 2.7 Hz) at 2.88 ppm, and a 
similar resonance at 2.27 ppm with a vicinal coupling constant 
of 11.1 Hz. By selective irradiation experiments, these 
signals were assigned to the pyran methylene protons. A 
signal at 94.2 ppm in the broad-band noise decoupled 
spectrum was indicative of a hemiketal unit (58). These 
observations are consistent with a pseudoequatorial 
disposition of the acetic ester moiety, and assuming a strong 
anomeric effect, a pseudoaxial hemiketal hydroxyl group. 
These assignments were confirmed by a single crystal X-ray 
structure of a closely related hemiketal (vide infra). 
We next turned our attention to the critical hemiketal 
reduction. To realize this goal, we envisioned reduction of 
the quinone moiety in 78 to a naphthhydroquinone followed by 
expulsion of water and conjugate hydride addition (Scheme 
VII). Treatment of 78 with zinc dust in acetic acid (59) 
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Scheme VII. 
OMe (OH "^2^ 
-k 
C^Me 0 I 
78 
1 ° "  
COzEt 
COgEt 
reoxidation 
O OH C02Et 
resulted in a rapid decolorization of the solution indicative 
of hydroquinone formation. Unfortunately, upon reoxidation 
with CAN, none of the desired pyran was formed. Catalytic 
hydrogenolysis with palladium on charcoal (60) also failed. 
If reduction of the naphthoquinone unit in 78 was 
accompanied by hemiketal ring opening, further reduction to a 
pyran would be difficult. Ionic hydrogénation has been 
employed by several researchers to reduce acetals, hemiketals, 
and some alcohols (61-63). Additionally, naphthoquinones and 
anthraquinones are reduced with difficulty under standard 
ionic hydrogénation conditions (H^/R^SiH) (64). Thus, ionic 
hydrogénation appeared promising for selective reduction of 
the hemiketal unit in 78. 
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In the event, treatment of 78 with triethylsilane and 
trifluoroacetic acid proceeded stereospecifically to afford 
the cis-pyran 79 in quantitative yield. 
iMe 
CF-CO,H, Et.SiH 
-78°C to 25°C 0 
The assignment of cis stereochemistry to 79 was based on its 
NMR spectrum. At 300 MHz, the methylene protons of the 
pyran ring gave rise to two ddd patterns at g 2.83 
(pseudoeguatorial H as an apparent dt with J = 18.1, 2.5, and 
2.5 Hz) and g 2.28 (pseudoaxial H with J = 18.1, 10.5, and 3.7 
Hz) which are identical with regard to multiplicity and 
magnitudes of coupling constants to the corresponding methyl 
ester reported by others (37, 44). 
The observed stereospecificity is best explained by the 
initial formation of a transient oxonium ion 80. This oxonium 
ion then preferentially accepts hydride from the a (axial) 
side due to the anomeric effect (65) from the ring oxygen. 
Axial hydride delivery to cyclic oxonium ions such as 80 is 
well precedented (66, 67). Additionally, carbon nucleophiles 
such as allylic silanes take a similar stereoelectronic course 
in reactions with cyclic oxonium ions (57-69). 
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80 
MeO 
CFoCOoH 
CH 
Compound 79 has previously been converted to nanaomycin by 
Li and Ellison (35). Although the melting point of 79 
corresponds well with that reported by Li and Ellison, a 
comparison of spectral data was impossible. For this reason, 
79 was converted to racemic epinanaomycin A, a well 
characterized compound. Phenolic demethylation produced 81 in 
94% yield. 
AlCl 
0. IN KOH 
HCl 
COuEt 81 82 
Saponification afforded epinanaomycin A 82 which was identical 
in every respect with the analytical data reported by others 
(45, 47). 
The synthesis of deoxyfrenolicin paralleled that of 
nanaomycin A and is depicted in Scheme VIII. Phthalide 
annulation with l-hexen-3-one produced 83 in an unoptimized 
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Scheme VIII. 
•Me 
OH 
•Me 
1. CAN 
•OMe 68^ 
OSiMe-t-Bu 84 
CAN 
MeCN (aq) 
OH >Me 
85 
CF.CO^H, Et,SiH 
COgMe 
1. BBr^ 
2. KOH, MeOH 
(Ref. #44) 
8 6  
14 
yield of 59%. Performing the DARC sequence with 
1-methoxy-l-tert-butyldlmethylsilyloxy-l3-butadiene (70) 
afforded dihydronaphthofuran 84 in 70% overall yield from 83. 
Oxidative dealkylation of 84 occurred in 94% yield. Single 
crystal X-ray analysis of 85 clearly indicated that the 
hemiketal hydroxyl group was in a pseudoaxial position (Figure 
3) (71). Ionic hydrogénation of 85 occurred in 84% yield to 
afford exclusively the cis-pyran 86. 
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Figure 1. X-ray crystal structure of 85 
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The spectroscopic data and melting point of 86 were 
identical with that of the cis-pyran reported by Semmelhack et 
al. (44). Since 86 has been converted to deoxyfrenolicin by 
demethylation accompanied by complete isomerization to the 
trans isomer, and saponification, a formal synthesis of 
deoxyfrenolicin is completed. 
Our next goal was a total synthesis of griseusins A and B. 
Since the y-lactone unit of griseusin A is established by 
aerial oxidation of griseusin B (21), the latter compound was 
our immediate target. We envisioned that the spiroketal 
moiety of griseusin B would result from the selective 
deprotection of the secondary alcohol (OR) in 87. This 
compound would result from the DARC sequence performed on 88 
followed by oxidative dealkylation. In keeping with our 
earlier starting material preparations, phthalide annulation 
with an enone, such as 89, would be employed. Our 
retrosynthetic plan for the construction of griseusin B is 
depicted in Scheme IX. 
The correct relative stereochemistry for the northern half 
of the spiroketal unit in 19 was established from readily 
available parasorbic acid 90 (72). Hydroxylation (73) 
followed by treatment of the crude diol with acidic acetone 
afforded the known ribo-hexonic acid g-lactone derivative 91 
(74). To prepare 89, we envisioned lactone ring opening with 
a vinyl Grignard reagent (75) followed by protection of the 
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Scheme IX. 
CO-, H 
OMe 
89 
0 
o  
COgMe 
RO-^ 
liberated secondary alcohol. However, treatment of 91 with 
vinyl magnesium bromide or vinyl lithium under a variety of 
conditions did not afford any of the desired enone. In every 
instance, an anomeric mixture of hemiketals 92 were produced. 
Additionally, all attempts to induce ring opening with 
concomitant alcohol protection failed. 
O 
V 
1. OsO^, KClO 
THF(aa) 
2. MegCO, H 
V™ 
90 91 92 
167 
In view of these results, a route to enone 89 involving 
protection of the secondary alcohol prior to enone formation 
was developed. Saponification of 91 followed by silylation of 
the potassium salt (76) produced the bisprotected ester 93 in 
high yield. Reduction to the primary alcohol and reoxidation 
afforded aldehyde 94 in 66% overall yield. Finally, Grignard 
addition followed by two-phase Jones' oxidation (77) produced 
enone 95 in moderate yield. However, the six step preparation 
of 95 could be conducted in 15% overall yield from 91 without 
purification of intermediates. 
Q 
91 
.X 1. KOH, MeOH 2. t-BuMegSiCl 
imidazole 
93 
R = SiMegt-Bu 
With ample quantities of 95 available, the preparation of 
the complex acylnaphthoquinone was undertaken. Unfortunately, 
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phthalide annulation with 95 proved difficult; affording 96 in 
only 15% yield. Variation of the protecting group at the C-2 
position of 95 did not produce better yields of the annulation 
product, and in one instance (R = CH^OCHg) the annulation 
failed completely. 
74 
95, t-BuOK 
0 ^ > 
DMSO "x 
" I l  0 
t-BuMegSiO B 
Evidently, the strongly basic conditions of the phthalide 
annulation promoted g-elimination of the acetonide unit in 95 
and the annulation product. 
In view of the poor yields obtained above, an alternative 
route to 88 involving milder conditions was probed. 
Metallation of 97 (78) followed by treatment with lactone 91 
afforded a mixture of ketals 98. Unlike the earlier vinyl 
Grignard addition product, treatment with chloromethyl methyl 
ether and Hunig's base effected ring opening and protection of 
the C-2 alcohol in 45% overall yield. Unfortunately, CAN 
oxidation of 99 failed, producing highly polar uncharacteriz-
able materials. Additionally, oxidative demethylation 
employing Rapoport's procedure (AgO, 6N HNOg) (79) was also 
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OH 
i-PrgNEt 
MeOCHjCl 
g g ÔMe 
0 X 
97 OMe OMe g g 
\0>^0 H 
ineffective. Rationalizing that the failure of the oxidation 
was due, at least in part, to the lability of the protecting 
group at C-2; the diketone 100 was prepared by oxidation of 
98. Regrettably, its oxidation also failed. At this point 
we were convinced that the acetonide group was being cleaved 
due to the acidic conditions required for oxidation (80). A 
ready solution to this problem could not be found, thus a 
complete change in strategy was necessary. 
Toward this end, the coupling of a five carbon 
carbohydrate derivative to an intact DARC product was 
envisioned (Scheme X). In order to alleviate the problems of 
protecting group instability, a trianion such as 102 was 
chosen. Literature precedent indicated that 102 would 
PCC, NaOAc 
170 
preferentially attack electrophiles from the dithioketal 
position (81,82). After monoaddition, CAN oxidative 
dealkylation was anticipated to occur with concomitant 
spiroketalization (39). Additionally- a coworker from these 
laboratories had demonstrated that the DARC sequence could be 
carried out with carboalkoxynaphthoquinones (83). Thus, the 
obtention of an acid chloride such as 101 seemed likely. 
SR 102 
For use in model system studies, D-xylose was chosen as 
the carbohydrate starting material. Thioketalization followed 
by selective formation of the most hindered benzylidene acetal 
(84) afforded 104 (85). To produce the 3,5-dideoxythioketal, 
104 was tosylated and deoxygenated with sodium borohydride in 
hexamethylphosphoric triamide (86) to produce 105 in 39% 
yield. Finally, hydrolysis of the benzylidene protecting 
group occurred selectively (87) to afford 106 in 66% yield. 
Scheme X 
<^C0C1 
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To test our new strategy, we employed benzoyl chloride as 
a model electrophile. Unfortunately, after treatment with a 
slight excess of n-butyllithium and quenching the presumed 
trianion with benzoyl chloride, only ester 107 was isolated. 
Despite several experimental modifications, only products of 
alkoxide attack on the acid chloride were obtained. 
Evidently, metallation of the thioacetal is not favored,-
perhaps due to steric reasons (88). 
106 
1. n-BuLi 
THEDA 
2. PhCOCl 
RS^^R 
-OH 
H •H 
OBz 
107 
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Fortunately, 1,3-dithianes are readily raetallated 
regardless of the alkyl group present (89). Efforts to 
prepare the 1,3-dithiane analog of 106 are currently in 
progress, 
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EXPERIMENTAL 
General 
Unless otherwise noted.- materials were obtained from 
commercial suppliers and were used without purification. THF 
and diethyl ether were distilled from sodium benzophenone 
ketyl under nitrogen prior to usage. Benzene was distilled 
from lithium aluminum hydride. Dichloromethane was distilled 
from calcium hydride. Unless otherwise noted, all reactions 
were conducted under an argon atmosphere. Unless otherwise 
noted, all organic extracts were dried over anhydrous sodium 
sulfate. Melting points were determined on a Fisher-Johns 
melting point apparatus and are uncorrected. Infrared spectra 
were obtained on a Beckman IR-4250 or a Perkin-Elmer model 
1320 spectrophotometer. Nuclear magnetic resonance spectra 
were determined on a Varian EM-360 spectrometer. High field 
(300 MHz) proton spectra were obtained with a Nicolet 
Magnetics Corporation NMC-1280 spectrometer. All chemical 
shifts are reported in g relative to tetramethylsilane as an 
internal standard. Coupling constants (J) are reported in Hz. 
Abbreviations; s = singlet, d = doublet, t = triplet, q = 
quartet, bs = broad singlet, m = multiplet, ABq, AB quartet. 
Carbon-13 NMR spectra were determined on a Nicolet NMC-1280 
spectrometer and are reported in ppm relative to the central 
peak of CDClg (77.06 ppm). High-resolution mass spectra were 
recorded on a Kratos model MS-50 spectrometer. Low-resolution 
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mass spectra were recorded on a Finnegan 4023 mass 
spectrometer. Silica gel used for flash chromatography (90) 
was 230-400 mesh (Kieselgel 50) purchased from EM Science. 
Gravity column chromatography was performed on 60-200 mesh 
silica gel purchased from Davison Chemical (WR Grace Inc.). 
Elemental analyses were performed by Galbraith Laboratories, 
Inc. 
Ethyl[5-Acetyl-6-hydroxy-3,4-dihydronaphtha[1,2-b] 
furan-3-yl]acetate (69) 
To a solution of 2-acetyl-l,4-naphthoquinone (160 mg, 0.80 
mmole) in 10 mL of methylene chloride at -78°C was added 
l-ethoxy-l-(tert-butyldimethylsilyl)oxy-l,3-butadiene (370 mg, 
1.60 mmole) in 0.5 mL of methylene chloride. The solution was 
warmed slowly to ambient temperature over 30 minutes, and was 
then recooled to 0°C. The reaction mixture was then treated 
sequentially with 5 mL of acetonitrile, 2 mL of a pH = 7.5 
phosphate buffer, and tetra-n-butylammonium fluoride (1.6 mL 
of a 1.0 M solution in THF). The mixture was slowly warmed to 
ambient temperature and made slightly acidic with 2 N HCl. 
The resulting two-phase mixture was poured into 50 mL of brine 
and extracted with three 20 mL portions of diethyl ether. The 
organic extracts were combined, washed with brine, and dried. 
The solvents were removed vacuo and the residue of flash 
chromatographed on silica gel eluting with 3:1 hexanes/ethyl 
acetate to afford 175 mg (70%) of 69 ; mp 103-104°C; 300 MHz 
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NMR (CDGI3) S 1.27 (t, 3 H, J = 7.2 Hz), 2.42 (s, 3 H), 
2.68 (ddr 1 H, J = 16.5 Hz, and 6.9 Hz), 2.90 (dd, 1 H, J = 
16.5 and 6.9 Hz), 3.09 (dd, 1 H, J = 15.6 and 7.2 Hz), 3.53 
(dd, 1 H, J = 15.6 and 11.1 Hz), 4.18 (m, 2 H), 5.16 (m, 1 H), 
7.41 (t, 1 H, J = 8.1 Hz), 7.52 (t, 1 H, J = 7.2 Hz), 7.21 (d, 
1 H, J = 8.4 Hz), 8.29 (d, 1 H, J = 8.1 Hz), 14.16 (s, 1 H); 
IR (CDClg) 3055, 2980, 1725, 1610, 1580, 1450, 1250, 1150, 
1010, 840 cm'l; NMR 14.15, 30.86, 39.60, 40.94, 60.83, 
78.32, 111.15, 114.01, 121.23, 124.72, 124.91, 125.92, 129.97, 
146.78, 158.69, 170.43, 203.60 ppm; MS m/e 314, 269, 226; high 
resolution mass spectrum for C^gH^gOg requires 314.11543, 
determined 314.1149. 
2-Acetyl-l,4-dihydroxy-8-methoxynaphthalene (76) 
To a solution of phthalide 74 (2.15 g, 11.37 mmole) and 
methyl vinyl ketone (1.04 mL, 12.5 mmole) in 57 mL of 
dimethylsulfoxide at ambient temperature was added potassium 
tert-butoxide (1.945 g, 17.35 mmole). After stirring 90 
minutes at ambient temperature an equal portion of potassium 
tert-butoxide was"added and stirring continued for 90 min. 
The reaction mixture was diluted with 30 mL of diethyl ether 
and acidified with excess 2 N HCl. The resulting yellow 
solution was poured into 500 mL of ice water and extracted 8 
times with 50 mL portions of diethyl ether. The organic 
extracts were combined, washed with brine, and dried. The 
solvents were removed in vacuo and the residue chromatographed 
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on 175 g of silica gel eluting with 2.5:1 hexanes/ethyl 
acetate to afford 1.74 g (66%) of 76; 300 MHz NMR (CDCI3) 5 
2.65 (s, 3 H); 4.05 (s, 3 H), 6.96 (d, 1 H, J = 7.8 Hz), 7.16 
(s, 1 H), 7.54 (t, 1 H, J = 8.1 Hz), 7.82 (d, 1 H, J = 8.1 
Hz), 8.14 (s, 1 H), 13.6 (s, 1 H); IR (CDCI3) 3600-3400, 1640, 
1600 cm~^. 
Ethyl [5-Acetyl-6-hydroxy-7-niethoxy-3,4-
dihydronaphtha[1,2-b]furan-3-yl]acetate (77) 
To a solution of 76 (540 mg, 2.32 mmole) in 25 mL of 
acetonitrile at ambient temperature was added eerie ammonium 
nitrate (2.92 g, 5.34 mmole) in 4 mL of water. After stirring 
20 minutes at ambient temperature, the reaction mixture was 
diluted with 20 mL of methylene chloride and poured into 100 
mL of water containing 10 mL of a 1 M pH = 7.2 phosphate 
buffer. The layers were separated and the aqueous phase was 
extracted with 30 mL of methylene chloride. The organic 
extracts were combined, washed with water, dried over 
magnesium sulfate, and concentrated iji vacuo. The quinone was 
diluted with 19 mL of methylene chloride and transfered to a 
dry two-neck flask under positive argon pressure. To this 
solution was added l-ethoxy-l-(tert-butyl-dimethylsilyl)-
oxy-1,3-butadiene (1.12 g, 4.9 mmole) in 1 mL of methylene 
chloride at -78®C. The reaction mixture was stirred 15 
minutes at -78°C , warmed slowly to ambient temperature, and 
then recooled to 0®C. The resulting pale yellow solution was 
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treated sequentially with 10 mL of acetonitrile, 5 itiL of a pH 
= 7.5 phosphate buffer, and tetra-r\-butylainmonium flouride 
(4.8 mL of a 1.0 M solution in THF). The resulting dark brown 
solution was warmed to ambient temperature, acidified with 2 N 
HCl, and poured into 100 mL of brine. The aqueous phase was 
extracted with three 40 mL portions of diethyl ether, the 
organic extracts combined, washed with brine, and dried over 
magnesium sulfate. The solvents were removed vacuo and the 
residue flash chromatographed on silica gel eluting with 2.7:1 
hexanes/ethyl acetate to afford 613 mg (77%) of 77, yellow 
needles from ethyl acetate/hexanes: mp 103-104.5*0; 300 MHz 
^H NMR (CDCI3) 5 1.27 (t, 3 H, J = 6.9 Hz), 2.65 (s, 3 H), 
2.68 (dd, 1 H, J = 15.6 and 6.3 Hz), 2.87 (dd, 1 H, J = 15.6 
and 7.2 Hz), 3.23 (dd, 1 H, J = 16.8 and 7.2 Hz), 3.69 (dd, 1 
H, J = 16.8 and 9.6 Hz), 4.01 (s, 3 H), 4.19 (q, 2 H, J = 6.9 
Hz); 5,24 (m; 1 H).- 6=75 (d, 1 H, J = 7 = 5 Hz), 7 = 30-7.50 (m,- 2 
H), 11.35 (s, 1 H); IR (film) 3005, 1730, 1610, 1390, 1310, 
1220, 1150, 1080 cm"^; NMR 14.37, 32.50, 38.38, 41.09, 
56.22, 60.64, 78.87, 105.40, 114.75, 115.08, 116.26, 118.56, 
124.94, 128.62, 146.79, 154.03, 157.72, 170.40, 201.11 ppm; MS 
m/e 344, 270, 257, 241; high resolution mass spectrum for 
*"19^20^6 fëguirës 344. 12599, determined 344.1259; Anal. Calcd: 
C, 66.28; H, 5.81. Found: C, 66.31; H, 5.87. 
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trans-Ethyl [l-Hydroxy-9-inethoxy-l-methyl-5,10-dioxo-
3,4,5,10-tetrahydronaphtho[2,3-c]pyran-3-yl]acetate (78) 
To a solution of 77 (613 mg, 1.78 mmoie) in 40 mL of 
acetonitrile at ambient temperature was added eerie ammonium 
nitrate (2.36 g, 4.30 mmole) in 8.5 mL of water. The reaction 
mixture was stirred 30 minutes at ambient temperature, poured 
into 50 mL of water containing 5 mL of a pH = 7.5 phosphate 
buffer,, and the layers separated. The aqueous phase was 
extracted twice with 30 mL portions of methylene chloride, the 
organic extracts combined, washed with water, and dried over 
magnesium sulfate. The solvents were removed in vacuo and the 
residue crystallized from methylene chloride/hexanes to afford 
553 mg (91%) of 78 as yellow needles: mp 153-154*0; 300 MHz 
NMR (CDÇI3) 6 1.29 (t, 3 H, J = 7.2 Hz), 1.73 (s, 3 H), 
2.28 (dd, 1 H, J = 18.7 and 11.1 Hz), 2.64 (dd, 1 H, J = 15.6 
and 6.6 Hz), 2.76 (dd, 1 H, J = 15.6 and 6.6 Hz), 2.88 (dd, J 
= 18.7 and 2.7 Hz), 3.87 (bs, 1 H), 4.02 (s, 3 H), 4.19 (q, 2 
H, J = 7.2 Hz), 4.48 (m, 1 H), 7.32 (dd, 1 H, J = 8.1 and 0.9 
Hz), 7.64-7.80 (m, 2 H); IR (CHCI3) 3600-3400, 3010, 1730, 
1655, 1585, 1270-cm""; NMR 14.02, 27.64, 28.23, 40.09, 
56.71, 60.69, 65.00, 94.30, 118.34, 119.06, 120.01, 133.97, 
135.27, 140.35, 146.33, 159.84. 170.19, 182.02, 182=18 ppm; MS 
m/e 342, 296, 268, 244, 229, 201; high resolution mass 
spectrum for C.gHggO^ requires 360.12091, determined 
360.12032; Anal. Calcd: C, 63.33; H, 5.56. Found: 
C, 63.16; H, 5.62. 
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cis-Ethyl [9-Methoxy-l-inethyl-5/ lO-dioxo-3,4, 5,10-
tetrahydro-lH-naphtho[2,3-c]pyran-3-yl]acetate (79) 
To a solution of 78 (102 mg, 0.30 mmole) in 15 mL of 
methylene chloride at -78*0 was added trifluoroacetic acid 
(0.14 mL/ 1.8 mmole) and the resulting slurry stirred at -78°C 
for 15 minutes. To the slurry was added triethylsilane (0.29 
mL, 1.8 mmole) at -78°C. The reaction mixture was slowly 
warmed to ambient temperature over three hours. The resulting 
yellow solution was concentrated ^  vacuo and the residue 
crystallized from diethyl ether/hexanes to afford 93 mg (95%) 
of 79 as yellow needles: mp 118-119*C, lit. (35) 113-115°C; 
300 MHz NMR (CDCl^) 5 1.29 (t, 3 H, J = 7.2 Hz), 1.52 (d, 3 
H, J = 6.6 Hz), 2.28 (ddd, 1 H, J = 18.1, 10.5, and 3.7 Hz), 
2.60 (dd, 1 H, J = 15.6 and 7.5 Hz), 2.70 (dd, 1 H, J = 15.6 
and 7.5 Hz), 2.83 (apparent dt, 1 H, J = 18.1, 2.5, and 2.5 
Hz), 3.93 (m, 1 H), 4.00 (s, 3 H), 4.19 (q, 2 H, J = 7.2 Hz), 
4.87 (m, 1 H), 7.28 (bd, 1 H, J = 8.4 Hz), 7.64 (t, 1 H, J = 
7.8 Hz), 7.73 (dd, 1 H, J = 7.8 and 0.9 Hz); IR (film) 2980, 
1730, 1660, 1585, 1270 cm"^; MS m/e 344, 298, 270, 257, 240; 
high resolution"mass ^spectrum for C^gHggO^ requires 344.12599, 
determined 344.1255; Anal. Calcd: C, 66.28; H, 5.81. Found; 
C, 66.56; H, 5.85. 
cis-Ethyl[9-Hydroxy-l-methyl-5,lO-dioxo-3,4,5,10-
tetrahydro-lH-naphtho[2,3-c]pyran-3-yl]acetate (81) 
To a solution of 79 (58.0 mg, 0.168 mmole) in 12.5 mL of 
methylene chloride at ambient temperature was added aluminum 
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trichloride (106 mg, 0.79 mmole) and stirred at ambient 
temperature for one hour. The reaction mixture was decomposed 
with 10 mL of water, transferred to a separatory funnel, and 
50 mL of water added. The layers were separated and the 
aqueous layer was extracted five times with 10 mL portions of 
methylene chloride. The organic extracts were combined, 
washed with water and brine, and dried over magnesium sulfate. 
The solvents were removed ^  vacuo and the residue 
chromatographed on silica gel eluting with methylene chloride 
to afford 52.3 mg (94%) of 81 as a bright yellow viscous oil; 
300 MHz NMR (CDClg) 5 1.26 (t, 3 H, J = 7.2 Hz), 1.52 (d, 3 
H, J = 6.6 Hz), 2.29 (ddd, 1 H, J = 18.6, 10.4, and 3.9 Hz), 
2.58 (dd, 1 H, J = 15.8 and 5.6 Hz), 2.67 (dd, 1 H, J = 15.8 
and 7.5 Hz), 2.80 (apparent dt, 1 H, J = 18.6, 2.5, and 2.5 
Hz), 3.90 (m, 1 H), 4.15 (q, 2 H, J = 7.2 Hz), 4.82 (m, 1 H), 
7.18 (m, 1 H); 7.50-7.60 (m,- 2 H), 11.93 (s, 1 H); IR {CDClg) 
2980, 1730, 1660, 1635, 1610, 1455, 1270, 1240 cm"-; NMR 
14.29, 21.01, 28.69, 40.61, 60.72, 69.22, 69.99, 115.03, 
119.03, 124.44, 131.79, 136.16, 143.49, 146.38, 161.48, 
170.51, 182.86, 189.00 ppm. 
Epinanaomycin (82) 
To a solution of 81 (13.0 mg, 0.0393 mmole) in absolute 
ethanol was added potassium hydroxide (20 mL of a 0.10 N 
aqueous solution) and the mixture stirred at ambient 
temperature 90 minutes. The mixture was carefully acidified 
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with 2 N HCl and transferred to a separatory funnel. The 
aqueous phase was extracted four times with 10 mL portions of 
methylene chloride. The organic extracts were combined, 
washed with brine, and dried over magnesium sulfate. The 
solvents were removed vacuo and the residue crystallized 
from methylene chloride/hexanes to afford 9.8 mg (82%) of 82 ; 
mp 176-184°C dec, lit. (47) 175-187°C dec, lit. (45) 
168-170°C; 300 MHz NMR (CDCl^) 6 1.58 (d, 3 H, J = 6.6 Hz), 
2.36 (ddd, 1 H, J = 18.6, 10.3, and 3.9 Hz), 2.64-2.83 (m, 2 
H), 2.88 (apparent dt, 1 H, J = 18.6, 2.5, and 2.5 Hz), 
3.87-4.02 (m, 1 H), 4.84-4.96 (m, 1 H), 7.22-7.30 (m, 1 H), 
7.56-7.68 (m, 2 H), 11.98 (s, 1 H); IR (CDCl^) 2920, 1710, 
1660, 1635, 1610, 1455, 1275, 1240 cm"^; MS m/e 302, 284, 242, 
214; high resolution mass spectrum for C^^H^^Og requires 
302.07894, determined 302.07894. 
1,4=Dihydroxy=8-m8thoxy-2(1-oxobuty1)naphthalene (83) 
To a solution of phthalide 74 (1.10 g, 5.81 mmole) and 
propyl vinyl ketone (665 mg, 6.10 mmole, approximately 90% 
pure) in 29 mL of dimethylsulfoxide at ambient temperature was 
added potassium tert-butoxide (1.01 g, 9.0 mmole). After 
stirring 90 minutes at ambient temperature an equal portion of 
potasium tert-butoxide was added and stirring continued for 90 
min. The deep purple solution was diluted with 20 mL of 
diethyl ether and acidified with 2 N HCl. The resulting 
yellow solution was poured into 300 mL of ice water and 
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extracted several times with 1:1 ethyl acetate/diethyl ether. 
The organic extracts were combined, washed with brine, and 
dried, "The drying agent was removed by filtration and the 
solvents removed vacuo to provide a yellow-brown solid, 
which was triturated with diethyl ether/hexanes to afford 
889 mg (59%) of 83 as a yellow-orange solid; mp softens at 
160°C, melts at 186-188®C; 300 MHz NMR (CDgCOCDg) g 1.00 
(t, 3 H, J = 7.5 Hz), 1.75 (m, 4 H), 3.02 (t, 2 H, J = 7.2 
Hz), 4.01 (s, 3 H), 7.01 (d, 1 H, J = 8.1 Hz), 7.21 (s, 1 H), 
7.52 (t, 1 H, J = 8.1 Hz), 7.77 (d, 1 H, J = 8.1 Hz), 9.45 (s, 
1 H), 13.08 (s, 1 H); IR (CHCl^) 3600, 3400-3200, 3005, 1625, 
1610, 1390, 1220 CM"1; NMR 13.50, 18.35, 41.20, 56.31, 
114.72, 114.85, 116.86, 129.10, 132.10, 132.29, 144.91 144.79, 
156.25, 159.50, 204.68 ppm; MS m/e 260, 217; high resolution 
mass spectrum for requires 260.10486, determined 
260.10481. 
(E/Z)-1-Methoxy-1-(tert-butyId imethyls ilyl)oxy-1,3-
butadiene 68b 
To a solution of diisopropylamine (5,76 mL, 41.3 mmole) in 
80 mL of THF at -10°C was slowly added n-butyllithium (16.26 
mL of a commercial 2.52 M solution, 41.0 mmole) over 5 min. 
The amide base thus formed was cooled to -78°C and 7.8 mL of 
hexamethylphosphoric triamide added to afford a white 
suspension. After stirring for 30 minutes at -78*0, methyl 
crotonate (4.24 mL, 40 mmole) was added via a double-ended 
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needle from a precooled (-78°C) 2.6 M solution in THF under 
positive argon pressure over 10 minutes. The resulting pale 
yellow solution was stirred at -78®C for 30 minutes and 
treated with tert-butyldimethylsilyl chloride (6.38 g, 42.4 
mmole) in 10 mL of THF and warmed slowly to ambient 
temperature. After stirring for 3 h at ambient temperature, 
the solvents were removed vacuo and the residue treated 
with 50 mL of pentanes and filtered. The clear nearly 
colorless filtrate was concentrated iji vacuo and distilled at 
reduced pressure to afford 4.5 g (53%) of 68b as a clear 
colorless liquid: bp 59-60°C at 0.70 mmHg; 300 MHz ^H NMR 
(CDCI3) 5 0.18 (bs, 6 H), 0.96 (bs, 9 H), 3.55 (s, 3 H), 
4.4-4.65 (m, 2 H), 4.80-4.91 (m, 1 H), 6.45-6.62 (m, 1 H). 
NMR -4.15, -3.6 (minor), 18.21 (minor), 25.69, 54.83, 
80.54, 80.63, 106.83, 132.47, 158.79 ppm. 
Methylr6-Hydroxy-7-methoxy-5-(1-oxobutyl)-3,4-
dihydronaphtha [1,2-b]furan-3-yl]acetate (84) 
To a solution of 83 (830 mg, 3.19 mmole) in 40 mL of 
acetonitrile and 10 mL of THF at ambient temperature was added 
eerie ammonium nitrate (4.02 g, 7.34 mmole) in 5 mL of water. 
After stirring 30 minutes at ambient temperature, the bright 
yellow solution was diluted with 40 mL of methylene chloride 
and poured into 125 mL of water containing 10 mL of a 1 M pH = 
7.2 phosphate buffer. The layers were separated and the 
aqueous phase extracted with two 40 mL portions of methylene 
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chloride. The organic extracts were combined, washed with 
water, dried over magnesium sulfate, and concentrated in 
vacuo. The quinone was dissolved in 35 mL of methylene 
chloride and transferred to a dry 100 mL two-neck flask with 
positive argon pressure. The solution was cooled to -78®C, 
and the ketene acetal 68b (0.72 g, 3.34 mmole) in 1 mL of 
methylene chloride added dropwise over 1 minute. The reaction 
mixture was stirred at -78°C for 15 minutes, warmed to 0°C, 
and treated sequentially with 15 mL of acetonitrile, 10 mL of 
a dilute pH = 7.5 phosphate buffer, and tetra-n-butylammonium 
fluoride (7.5 mL of a 1.0 M solution in THF). After warming 
to ambient temperature, the reaction mixture was acidified 
with 2 N HCl and poured into 150 mL of brine. The aqueous 
solution was extracted four times with 30 mL portions of 
diethyl ether, the organic extracts combined, washed with 
brine, and dried. The drying agent was filtered and the 
solvents were removed jji vacuo to provide a yellow-orange 
solid. Flash chromatography on silica gel eluting with 3:1 
hexanes/ethyl acetate afforded 0.793 g (70%) of 84 as a yellow 
solid, yellow-green needles from diethyl ether/hexanes; mp 
99.5-100.5°C; 300 MHz NMR (CD^COCD^) ô 0.96 (t, 3 H, J = 
7.5 Hz), 1.62-1.80 (m, 4 H), 2.77 (dd, 1 H, J = 15.6 and 6.3 
Hz), 2.86 (dd, 1 H, J = 15.6 and 7.2 Hz), 3.01 (t, 2 H, J = 
7.2 Hz), 3.20 (dd, 1 H, J = 16.8 and 7.2 Hz), 3.64 (dd, 1 H, J 
= 16.8 and 9.3 Hz), 5.23 (m, 1 H), 6.86-6.98 (m, 1 H), 
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7.31-7.45 (m, 2 H), 10.65 (s, 1 H); IR (CHCl^) 3360, 3005, 
1732, 1630, 1405 cm""; ""C NMR 12.58, 16.79, 36.51, 39.47, 
44.93, 50.09, 55.15, 78.18, 104.48, 113.76, 116.75, 118.28, 
123.12, 127.16, 145.83, 149.97, 150.38, 156.56, 169.43, 202.13 
ppm; MS m/e 358, 315, 298, 285, 252, 241; high resolution mass 
spectrum for fSQuirGS 358.14164, determined 358.1410; 
Anal. Calcd: C 67.03; H, 6.14. Found; C, 66.86; H, 6.30. 
trans-Methyl[l-Hydroxy-9-methoxy-5,10-dioxo-l-N-propyl-
3,4,5,10-tetrahydronaphtho[2,3-c]pyran-3-yl]acetate (85) 
To a suspension of 84 (474 mg, 1.32 mmole) in 30 mL of 
acetonitrile at ambient temperature was added eerie ammonium 
nitrate (1.66 g, 3.03 mmole) in 6 mL of water. After stirring 
at ambient temperature for 30 minutes, the solution was poured 
into 100 mL of a dilute pH = 7.5 phosphate buffer. The 
aqueous solution was extracted three times with 20 mL portions 
of methylene chloride, the organic extracts combined, and 
dried over magnesium sulfate. The drying agent was filtered 
and the solvents removed ûi vacuo to provide a yellow foamy 
solid which was crystallized from methylene chloride/hexanes 
to afford 470 mg (94%) of 85 as yellow needles; mp 
133.5-135°C; 300 MHz NMR (CDCl^) Ô .84 (t, 3 H, J = 7.2 
Hz), 0.9-1.50 (m, 4 H), 1.86-2.01 (m, 1 H), 2.03-2.20 (m, 1 
H), 2.25 (dd, 1 H, J = 18.6 and 10.8 Hz), 2.66 (dd, 1 H, J = 
15.8 and 6.5 Hz), 2.78 (dd, 1 H, J = 15.8 and 6.5 Hz), 2.87 
(dd, J = 18.6 and 2.7 Hz), 3.73 (s, 3 H), 4.02 (s, 3 H), 
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4.38-4.47 (m, 1 H), 7.28-7.36 (m, 1 H), 7.63-7.74 (m, 2 H); IR 
(CHCI3) 2970, 1735, 1650, 1585, 1270, 1205 NMR 
13.82, 16.92, 27.56, 39.71, 42.50, 51.44, 51.52, 56.28, 64.27, 
96.15, 118.03, 118.80, 133.89, 134.84, 141.01, 144.48, 159.54, 
170.55, 183.52, 183.92 ppm; MS m/e 356, 324, 313, 296, 272, 
257, 229, 201; high resolution mass spectrum for *^20^22*^7 
requires 374.13656, determined 374.1367. 
cis-Methyl[9-Methoxy-9,lO-dioxo-l-N-propyl-3,4,5,10-
tetrahydro-lH-naphtho[2,3-c]pyran-3-yl]acetate 
To a solution of 85 (470 mg, 1.32 mmole). in 30 mL of 
methylene chloride at -78°C was added trifluoroacetic acid 
(0.61 mL, 7.92 mmole) and the resulting slurry stirred at 
-78°C for 10 minutes. To the slurry was added triethylsilane 
(1.26 mL, 7.92 mmole) and the reaction mixture warmed to 
ambient temperature over 1 hour. The volatiles were removed 
in vacuo and the residue flash chromatographed on silica gel 
eluting with 2:1:0.4 hexanes/ethyl acetate/methylene chloride 
to afford 398 mg (84%) of 8^, yellow needles from diethyl 
ether/hexanes; mp 148-149s5°C,- lit= (44) 144-148.5®C| 300 MHz 
NMR (CDCI3) 6 0.90 (t, 3 H, J = 7.2 Hz), 1.30-1.60 (m, 2 
H), 1.62-1.82 (m, 1 H), 1.93-2.08 (m, 1 H), 2.24 (ddd, J = 
18.0, 10,5, and 3.9 Hz), 2.61 (dd, 1 H, J = 15.6 and 5.6 Hz), 
2.70 (dd, 1 H, J = 15.6 and 7.5 Hz), 2.83 (apparent dt, 1 H, J 
= 18.0, 2.4, and 2.4 Hz), 3.72 (s, 3 H), 3.82-3.94 (m, 1 H), 
3.99 (s, 3 H), 4.76-4.85 (m, 1 H), 7.26 (dd, 1 H, J = 8.1 and 
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0.6 Hz), 7.62 (t, 1 H, J = 8.1 Hz), 7.72 (dd, 1 H, J = 7.8 and 
0.9 Hz); IR (film) 2960, 1735, 1658, 1585, 1270, 730 cm"^? 
NMR 13.87, 18.55, 28.07, 36.26, 40.60, 51.65, 56.56, 69.21, 
73.91, 118.02, 119.09, 120.57, 134.20, 134.48, 139.98, 148.11, 
159.60, 171.02, 183.34, 183.54 ppm; Anal. Calcd for ^20^22'^6' 
C, 67.03; H, 6.14. Found: C, 66.91; H, 6.37. 
3 a,4 a-(Isopropylidened ioxy)-66-3,4,5,6-
tetrahydropyran-2-one (91) 
To a solution of 90 (7.38 g, 65.9 mmole) in 175 mL of 4:3 
water/THF at ambient temperature was added potassium chlorate 
(9.7 g, 71.7 mmole) and osmium tetroxide (22 mL of an aqueous 
solution containing 5 mg/mL) and the mixture stirred at 45°C 
for 12 hours. The solvents were removed iji vacuo and the 
residue coevaporated three times with 100 mL portions of 1:1 
benzene/ethanol. The residue was dried under high vacuum for 
three hours and the solid residue extracted with three 50 mL 
portions of 4:1 ethyl acetate/acetone. The organic extracts 
were dried over magnesium sulfate, the drying agent filtered, 
and the solvents removed vacuo to afford the diol as a 
clear syrup. The crude diol was dissolved in 400 mL of 
absolute acetone and treated with 0.8 mL of concentrated 
sulfuric acid. The clear solution was stirred at ambient 
temperature for 16 hours, neutralized with saturated aqueous 
sodium bicarbonate solution, and the solvents removed in 
vacuo. The residue was flash chroraatographed on silica gel 
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eluting with 2.5:1 hexanes/ethyl acetate to afford 6.28 g 
(51%) of 91 as a clear liquid; 300 MHz NMR (CDCI3) 5 1.38 
(s, 3 H), 1.39 (d, 3 H, J = 6.3 Hz), 1.51 (s, 3 H), 1.71-1.83 
(m, I H), 2.01-2.08 (m, 1 H), 4.57 (d, 1 H, J = 6.9 Hz), 
4.62-4.68 (m, 1 H), 4.69-4.81 (in, 1 H); IR (neat) 2995, 2940, 
1750, 1380, 1260, 1210, 1080 cm~^; NMR 20.64, 23.87, 
25.87, 35.42, 71.30, 71.82, 72.46, 110.38, 168.00 ppm. 
tert-Butyldimethylsilyloxyl[4,6-Dideoxy-2,3-0-
isopropylidene-5-0-(tert-butyldimethylsilyl)gulonate (93) 
To a solution of potassium hydroxide (0.40 g, 6.2 mmole) 
in 20 mL of 95% aqueous methanol at ambient temperature was 
added 91 (895 mg, 4.80 mmole) in 10 mL of 95% methanol. The 
solution was stirred at ambient temperature for 16 hours and 
concentrated to dryness ûi vacuo. 
To a suspension of the crude salt in 20 mL of 
dimethylforraamide at ambient temperature was added imidazole 
(2.5 g, 38.4 mmole) and tert-butyldimethylsilyl chloride (2.88 
g, 19.2 mmole). The resulting clear solution was stirred at 
ambient temperature for 16 hours, poured into 100 mL of 
brine, and extracted with three 50 mL portions of 1:1 
hexanes/diethyl ether. The organic extracts were combined, 
washed with 50 mL of cold 1 N HCl and brine, and dried. The 
drying agent was filtered and the solvents removed iji vacuo to 
afford 2.22 g (107%) of 93 as a clear oil contaminated with an 
undetermined silicon containing by-product: 300 MHz ^H NMR 
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(CDCI3) 5 0.08 (s, 3 H), 0.10 (s, 3 H), 0.25 (s, 3 H), 0.31 
(s, 3 H), 0.85 (s, 9 H), 0.88 (s, 9 H), 1.16 (d, 3 H, J = 6.0 
Hz), 1.34 (s, 3 H), 1.58 (s, 3 H), 1.60-1.66 (m, 1 H), 
1.68-1.79 (m, 1 H), 4.00 (m, 1 H), 4.35-4.44 (m, 1 H), 4.49 
(d, 1 H, J = 6.9 Hz). 
4,6-Dideoxy-2,3-0-isopropylidene-5-0-tert-
butyldimethylsilylgulonaldehyde (94) 
To a suspension of lithium aluminium hydride (390 mg, 10.2 
mmole) in 30 mL of THF at 0°C was added the crude ester 93 
from above in 4 mL of THF dropwise via syringe. The 
suspension was slowly warmed to ambient temperature and 
stirred two hours. With vigorous stirring, the suspension was 
treated with saturated sodium sulfate solution until a fine 
microcrystalline precipitate formed (ca. 2 mL). The 
precipitated salts were filtered and the filtrate concentrated 
in vacuo to afford 1.47 g of the primary alcohol of sufficient 
purity for further transformations: 300 MHz "'"H NMR (CDCl^) 6 
0.12 (bs, 6 H), 0.88 (s,- 9 H), 1.18 (d,- 3 H, J = 6.3 Hz), 1.36 
(s, 3 H), 1.45 (s, 3 H), 1.51-1.62 (m, 1 H), 1.74-1.86 (m, 1 
H), 2.06 (t, 1 H, J = 6.6 Hz), 3.62 (t, 2 H, J = 6.6 Hz), 
3.94-4.06 (m, 1 H), 4.12-4.19 (m, 1 H),- 4.24-4.37 (m, 1 H). 
To a solution of the crude alcohol from above in 30 mL of 
methylene chloride at ambient temperature was added sodium 
acetate (2.0 g, 23.8 mmole), followed by pyridinium 
chlorochromate (3.10 g, 14.4 mmole). The orange-brown 
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solution was stirred three hours and diluted with 50 mL of 
diethyl ether. The brown suspension was filtered through a 
short plug of Florosil and the filtrate was concentrated in 
vacuo to provide 0.96 g (66%) of 94. Aldehyde 94 is unstable 
and darkens on standing at 0°C: 300 MHz NMR (CDCl^) S 0.05 
(s, 3 H), 0.08 (s, 3 H), 0.98 (s, 9 H), 1.15 (d, 3 H, J = 6.3 
Hz), 1.40 (s, 3 H), 1.57 (s, 3 H), 1.60-1.78 (m, 2 H), 3.97 
(apparent ABq? 1 H, J = 12.3 and 6.0 Hz), 4.22 (dd, 1 H, J = 
6.9 and 3.6 Hz), 4.42-4.50 (m, 1 H), 9.62 (d, 1 H, J = 3.6 
Hz) . 
4R*,5R*,7R*-3,4-Isopropylidenedioxy-7-(tert-
butyldimethylsilyloxy)-oct-l-ene-3-one (95 ) 
To a solution of aldehyde 94 (0.96 g, 3.17 mmole) in 20 mL 
of diethyl ether at 0°C was added vinyl magnesium bromide (3.5 
mL of a commercial 1.0 M solution in THF). The grey-brown 
solution was warmed to ambient temperature and quenched with 3 
mL of saturated aqueous ammonium chloride solution. The 
two-phase mixture was transferred to a separatory funnel and 
extracted twice with 15 mL portions of ether. The ethereal 
layers were combined, washed with brine, and dried. The 
solvents were removed vacuo and the residue was dissolved 
in 3 mL of diethyl ether. To this stirred solution was added 
the Jones' reagent (1.6 mL of a solution prepared by the 
method of Brown et al. (77)) and the mixture vigorously 
stirred for 30 minutes at ambient temperature. The two-phase 
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mixture was diluted with 10 rtiL of 1:1 pentanes/diethyl ether 
and the phases separated. The organic phase was washed with 
brine, dried, and filtered. The filtrate was concentrated in 
vacuo and the residue flash chromatographed on silica gel 
eluting with 6:1 hexanes/diethyl ether to afford 240 mg (23%) 
of 95 as a clear oil which was used immediately: 300 MHz 
NMR (CDCI3) 6 0.28 (s, 3 H), 0.03 (s, 3 H), 0.86 (s, 9 H), 
1.13 (d, 3 H, J = 6.6 Hz), 1.37 (s, 3 H), 1.41-49 (m, 1 H), 
1=54-1.65 (m, 4 H), 3.93 (m, 1 H). 4,45-4.54 (m, 1 H), 4.59 
(d, 1 H, J = 7.8 Hz), 5.74 (dd, 1 H, J = 10.-5 and 1.8 Hz), 
6.34 (dd, 1 H, J = 17.4 and 1.8 Hz), 6.77 (dd, 1 H, J = 17.4 
and 10.5 Hz). 
1,4-Dihydroxy-2-[2R*,3R*,5R*-2,3-isopropylidenedioxy-l-oxo-5-
(tert-butyldimethyls ilyloxy)hexyl]-8-methoxynaphthalene (96) 
To a solution of phthalide 74 (133 mg, .708 mmole) in 10 
mL of dimethylsulfoxide at ambient temperature was added the 
enone 95 (240 mg, 0.73 mmole) followed by potassium 
tert-butoxide (122 mg, 1.10 mmole). The reaction mixture was 
stirred at ambient temperature for 30 minutes an additional 
portion of base (122 mg, 1.10 mmole) was added and the 
reaction mixture stirred 90 minutes at ambient temperature. 
The solution was carefully neutralized with 1 N HCl to pH = 5 
and diluted with 20 mL of diethyl ether. The resulting yellow 
solution was poured into 20 mL of water and the aqueous phase 
extracted with 20 mL of diethyl ether. The organic extracts 
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were combined, washed with brine, and dried. The solvents 
were decanted from the drying agent and removed ûi vacuo. 
Flash chromatography of the residue on silica gel eluting with 
4:1 hexanes/ethyl acetate afforded 51 mg (15%) of 
96 as a yellow oil; 300 MHz NMR (CDCI3) 6 0.19 (s, 3 H), 
0.21 (s, 3 H), 1.02 (s, 9 H), 1.37 (d, 3 H, J = 6.0 Hz), 1.59 
(s, 3 H), 1.69 (s, 3 H), 1.95-2.05 (m, 1 H), 2.14-2.23 (m, 1 
H), 4.22 (s, 3 H), 4.73-4.80 (m, 1 H), 5.24 (d, 1 H, J = 6.3 
Hz), 7.10 (d, 1 H, J = 7.8 Hz), 7.44 (s, 1 H), 7.71 (t, 1 H, J 
= 7.8 Hz), 7.96 (d, 1 H, J = 7.8 Hz). 
2-[2R*,3R*,5R*-2,3-Isopropylidenedioxy-5-methoxyraethyl-
1-oxo-hexyl]-1,4,8-trimethoxynaphthalene (99) 
To a solution of the bromide 97 (303 mg, 1.19 mmole) in 10 
mL of THF at -78°C was added n-butyllithium (0.46 mL of a 
commercial 2.6 M solution in hexanes, mmole). The resulting 
light yellow solution stirred at -78°C for 20 minutes and 91 
(218 mg, 1.17 mmole) in 1 mL of THF was added dropwise via 
syringe. The light yellow solution was stirred at -78®C for 
one hour and then quenched with saturated ammonium chloride 
solution (ca. 5 mL). The resulting suspension was warmed to 
ambient temperature and transferred to a separatory funnel 
containing 15 mL of brine and 5 mL of diethyl ether. The 
layers were partitioned and the aqueous layer extracted twice 
with 10 mL portions of 1:1 pentanes/diethyl ether. The 
organic extracts were combined, washed with brine, and dried. 
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The solvents were removed in vacuo to provide a yellow viscous 
oil, which was dissolved in 5 mL of methylene chloride and 
cooled to 0°C. To this solution was added diisopropylethyl-
amine (1.9 mL, 11.2 mmole) followed by chloromethyl methyl 
ether (0,77 mL, 5.6 mmole) and the resulting dark yellow 
solution warmed to ambient temperature. After stirring 48 
hours at ambient temperature, the mixture was diluted with 50 
mL of 1:1 pentanes/diethyl ether and transferred to a 
separatory funnel containing 50 mL of brine. The organic 
phase was separated and washed successively with 2 N HCl, 
water, 5% aqueous sodium bicarbonate, and brine. The extracts 
were dried, filtered from the drying agent, and concentrated 
in vacuo to provide a yellow oil. Flash chromatography of the 
residue on silica gel eluting with hexanes/ethyl acetate 
afforded 210 mg (45%) of 99 as a pale yellow oil: 300 MHz 
NMR (CDCI3) S 1.04 (d, 3 H, J = 6.3 Hz), 1.23-1.40 (m, 1 H), 
1.41 (s, 3 H), 1.64 (s, 3 H), 1.69-1.83 (m, 1 H), 3.22 (s, 3 
H), 3.68-3.79 (iti, 1 H), 3.80 (s, 3 H), 3.96 (s, 3 H), 4.01 (s, 
3 K), 4.46-4.57 (m, 2 H), 5.85 (d, 1 H, J = 6.6 Hz), 6.93 (s, 
1 H), 6.96 (d, 1 H, J = 8.1 Hz), 7.48 (t, 1 H, J = 8.1 Hz), 
7.85 (dd, 1 H, J = 7.8 and 0.9 Hz); IR (film) 2930, 1680, 
1595, 1370, 1265, 1070, 815 cm~^. 
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3,5-Dideoxy-2,4-0-benzylidene-D-xylose,dibutylthio 
Acetal (105) 
To a solution of 104 (0.62 g, 1.55 mmole) in 15 mL of 
pyridine was added tosyl chloride (1.45 g, 4.65 mmole) and the 
pale yellow solution stirred at ambient temperature for 48 h. 
The solution was poured into 100 mL of water and extracted 
with three 20 mL portions of diethyl ether. The organic 
extracts were combined, washed with 2 N HCl and brine, and 
dried. The solvents were removed iji vacuo and the residue 
chromatographed on silica gel eluting with 3:1 hexanes/diethyl 
ether to afford 760 mg (69%) of the bistosylate as a light 
yellow semi-solid: 300 MHz NMR (CDCl^) 5 0.85 (t, 3 H, J = 
6.9 Hz), 0.96 (t, 3 H, J = 6.9 Hz), 1.22-1.69 (m, 8 H), 2.41 
(s, 3 H), 2.43 (s, 3 H), 2.54 (t, 2 H, J = 6.9 Hz), 2.68 (t, 2 
H, J = 6.9 Hz), 3.85 (ABq, 2 H, J = 12.8 Hz), 4.04-4.29 (m, 
3 H), 5.32 (s, 1 H), 5.55 (s, 1 H), 7.20-7.45 (m, 9 H), 
7.70-7.86 (m, 4 H); IR (film) 3040, 2960, 1595, 1360, 1175, 
730 cm ^. 
To a solution of the bistosylate (200 mg, 0.282 mmole) in 
10 mL of hexamethylphosphoric triamide at ambient temperature 
was added sodium borohydride {55 mg, 1.41 mmole) and the 
mixture warmed to 100®C. After stirring 36 hours at 100°C, 
the reaction mixture was cooled and poured into 50 mL of 
brine. The aqueous phase was extracted three times with 20 mL 
portions of diethyl ether, the organic extracts combined, 
washed several times with brine, and dried. Flash 
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chromatography on silica gel elating with 10:1 hexanes/diethyl 
ether afforded 40 mg (39%) of 105 as a clear oil: 300 MHz 
NMR (CDCl,) 6 0.91 (t, 6 H, J = 6.6 Hz), 1.30-1.50 (m, 7 H), 
1.5-1.65 (m, 4 H), 1.65-1.88 (m, 2 H), 2.63-2.85 (m, 4 H), 
3.89 (d, 1 H, J = 6.9 Hz), 3.92-4.00 (m, 1 H), 4.03-4.12 (m, 1 
H), 5.52 (s, 1 H); 7.29-7.42 (m, 3 H), 7.45-7.52 (m, 2 H); IR 
(film) 2950, 1450, 1020, 730 cm"^. 
3,5-Dideoxy-D-xylose,dibutylthio Acetal (1^6) 
To a solution of 105 (16 mg, 0.043 mmole) in 1 mL of 
methylene chloride at ambient temperature was added 
trifluoroacetic acid (100 yL of a 70% aqueous solution) and 
the mixture stirred vigorously for 90 min. To this two-phase 
mixture was added 1 raL of saturated sodium bicarbonate 
solution and the whole transferred to a separatory funnel. 
The organic layer was separated, the aqueous layer diluted 
with 10 mL of brine.- and extracted with two 10 mL portions of 
methylene chloride. The organic extracts were combined, 
washed with brine, and dried. The solvents were removed in 
vacuo and the residue filtered through a short column of 
silica gel eluting with 4:1 hexanes/ethyl acetate to afford 
8.0 mg (66%) of 106 as a clear oil: 300 MHz ^H NMR (CDCl,) 6 
0.93 (s, 6 H), 1.22 (d, 3 H, J = 6.3 Hz), 1.34-1.51 (m, 4 H), 
1.52-1.71 (m, 6 H), 1.92-2.08 (m, 1 H), 2.56-2.74 (m, 4 H), 
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3.37 (bs, 1 H), 3.50 (bs, 1 H), 3.72 (d, 1 H, J = 6.6 Hz), 
3.79-3.91 (m, 1 H), 3.96-4.11 (m, 1 H); IR 3600-3200, 2960, 
1560, 1280, 840 cm"^. 
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OVERALL SUMMARY 
Part I describes the construction of the major carbon 
framework of olivin, the aglycone of a number of antitumor 
antibiotics collectively known as the olivomycins. A 
palladium(O) mediated cross-coupling of a metallated ethyl 
vinyl ether unit and an enol triflate derived from a readily 
available carbohydrate was accomplished. In this first key 
step, most of the carbon and oxygen atoms of the side chain 
and A ring of the aglycone were assembled in the form of a 
diene. The second key step was the Diels-Alder cycloaddition 
of the complex carbohydrate substituted diene to a highly 
functionalized naphthoquinone. The resulting cycloadduct, 
which was formed with complete regiochemical control, has all 
of the necessary functionality intact for eventual conversion 
to olivin. 
Part II describes a direct and operationally convenient 
synthesis of the DCB ring subunit of aklavinone, the aglycone 
of the potent cytostatic agent aclacinomycin A. The synthesis 
begins with a Diels-Alder reaction between 1-trimethylsilyl-
oxy-1,3-butadiene and 2-cyano-5-methoxy-3-phenylthio-l,4-
naphthoquinone. Oxidation of the Diels-Alder adduct produced 
a novel blocked anthraquinone tautomer. The blocked 
anthraquinone was converted to the DCB subunit of aklavinone 
by conjugate addition of a mixed ketene acetal, selective 
mercaptan oxidation, and elimination of benzenesulfenic acid 
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and hydrocyanic acid. The three rings of the aklavinone p-
recurser were constructed in high yield and with complete 
stereochemical control. In addition, the novel reactivity 
patterns of two phenylsulfinyl substituted naphthoquinones 
were investigated. In the case of 2-allyl-8-methoxy-3-
phenylsulfinylnaphthoquinone, a tandem Diels-Alder-sulfoxide 
elimination-retro-Claisen sequence occurred upon heating with 
1-trimethylsilyloxy-l,3-butadiene to produce a anthracene 
derivative, 
Part III describes successful syntheses of nanaomycin A 
and deoxyfrenolicin, important members of the naphtho [2,3-c]-
pyran-5,10-quinone class of antibiotics. In addition, 
synthetic efforts toward the more complex members, griseusins 
A and B, are described. A key step in the syntheses of the 
two former members is a tandem Diels-Alder-retro-Claisen 
reaction between 3-acyl-5-methoxy-l,4-naphthoquinones and 
mixed vinyl ketene acetals. The resulting 2,3-dihydro-
naphtho[1,2-b]furans are oxidized in high yield to 
intermediate 3-acyl-2-(2-hydroxyalkyl) substituted 
naphthoquinones which spontaneously form hemiketals. Finally, 
the hemiketals were stereospecifically reduced to afford 
advanced intermediates in previously published syntheses of 
nanaomycin A and deoxyfrenolicin. 
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